Document:

SUPPLY AGREEMENT

 

This
Supply Agreement (this “Agreement”), dated as of November 7, 2021 (“Effective Date”), is by
and between by and between Quoin Pharmaceuticals, Inc., a Delaware corporation located at 42127 Pleasant Forest Court, Ashburn, VA
20148 (“Quoin”) and Genpharm Services FZ LLC, a company incorporated under the laws of the United Arab Emirates
located at Al-Manara Tower, Business Bay, Dubai (“Licensee”). Quoin and Licensee are sometimes referred to herein individually
as a “Party,” and together as the “Parties.”

 

WITNESSETH:

 

WHEREAS,
Quoin and Licensee are parties to that certain License and Distribution Agreement, dated as of the date hereof (“License Agreement”),
pursuant to which Quoin granted to Licensee an exclusive license under the Product Technology for Licensee to obtain the Regulatory Approvals
and Exploit the Product in the Territory, subject to the terms of the License Agreement;

 

WHEREAS,
Section 4.4 of the License Agreement provides that the Parties shall enter into a commercial supply agreement pursuant to which Quoin
will manufacture and supply, or have manufactured and supplied, to Licensee the Product for sale in the Territory; and

 

WHEREAS,
the Parties now desire to enter into this Supply Agreement to establish the terms and conditions under which Quoin will have the Product
manufactured and supplied to Licensee for sale in the Territory.

 

NOW,
THEREFORE, in consideration of the premises and mutual covenants contained herein and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Parties hereto agree as follows:

 

Article I

 

DEFINITIONS

 

Section 1.1           Definitions.
Capitalized terms used in this Agreement have the meanings specified in Schedule 1 to this Agreement. As used herein the words “including”
or “includes” shall be deemed to mean “including, without limitation,” or “includes, without limitation.”

 

Article II

 

MANUFACTURE AND SALE OF PRODUCT

 

Section 2.1           Engagement.
During the Term and upon the terms and subject to the conditions set forth herein, Quoin agrees that it will manufacture and supply the
Product to Licensee, and, in turn, Licensee agrees that it will exclusively purchase one hundred percent (100%) of the Licensee’s
requirements of the Product from Quoin for commercialization solely within the Territory. Quoin shall have the right to subcontract its
obligations under this Agreement to a third party (it being agreed that wherever Quoin makes a commitment under this Agreement with respect
to the manufacture and supply of Product, such obligation shall be deemed satisfied if performed by such subcontractor).

 

Section 2.2           Sale
and Distribution. The Licensee will sell the Product only in the Territory and will not directly or indirectly sell or otherwise distribute
the Product outside of the Territory.

 

    

     

    

 

Section 2.3           Packaging
and Labeling. The Licensee will be responsible for ensuring the accuracy of all information contained in the labels or labeling for
Product and the compliance of all such labels and labeling with applicable Law and the Regulatory Approvals. Licensee will approve all
artwork and labeling information necessary for the packaging and labeling of the Product. Quoin will, or will cause its contractors to,
supply all packaging and labels for Product under this Agreement. Such packaging and labels will be in accordance with the Specifications.
Quoin will make any changes to labeling and packaging Specifications required in writing by the Licensee, at its sole cost and expense
(including the cost of any obsolete labeling inventory), within a reasonable timeframe to be agreed upon in writing by both Parties.
The Licensee will be responsible for submitting any such changes to all applicable Governmental Authorities for approval.

 

Section 2.4           Facility
Maintenance; Inspection; Reports.

 

(a)          Quoin
shall, at all times, maintain and operate, or cause its contractors to maintain and operate, all facilities where Product is manufactured,
packaged, tested, stored, warehoused or shipped in compliance with cGMP. Not more than once every twelve (12) months, Quoin shall permit,
or cause its contractors to permit, quality assurance representatives of the Licensee or designated third parties (subject to appropriate
confidentiality obligations) to inspect such facilities, operations, documents, and records directly related to the handling, manufacture,
testing, inspection, packaging, storage, disposal and transportation of the Product by Quoin or the applicable contractor upon reasonable
notice (which shall not be less than ten (10) days), during normal business hours and on a confidential basis. Quoin shall also permit,
and cause its contractors to permit, representatives of the applicable Governmental Authority to inspect such facilities as requested
by the such Governmental Authority.

 

(b)         Quoin
shall maintain adequate and accurate records consistent with the applicable Specifications, including records covering quality control
testing and release of the Product and all other manufacturing services provided hereunder in material compliance with cGMP.

 

(c)          Quoin
shall notify Licensee as soon as reasonably practicable and in any event within five (5) business days following receipt of notice
of any Governmental Authority inspection of the manufacturing facility if such inspection pertains to the Product.

 

Section 2.5
           Adverse Events. Prior to the launch of Product the Parties shall each assign a representative to negotiate in good
faith and agree on a process and procedure for sharing adverse event information which shall be documented in a safety data exchange
(SDEA) agreement which the Parties shall use commercially reasonable efforts to agree upon and execute prior to commercialization of
the Product.

 

Article III

 

FORECASTS, ORDERS AND SHIPMENT

 

Section 3.1           Forecasts.
In order to assist in the planning of production runs for the Product, the Licensee will, at least one hundred and eighty (180) days
prior to the commercial Launch of the Product in the Territory, provide Quoin with a non-binding written forecast of estimated quantities
of Product that the Licensee anticipates ordering from Quoin during the next eighteen (18) month period (the “Forecast”).
This initial Forecast will be updated at least five (5) business days before the first day of the following calendar quarter after
the date hereof and each successive calendar quarter and each such updated Forecast will be promptly delivered to Quoin by the Licensee.
The first three (3) months of each such Forecast (the “Firm Order Period”) shall be binding on Licensee. The
remaining fifteen (15) months of each such forecast shall be non-binding estimates for planning purposes. No Forecast shall be required
for any period of time that extends beyond the Term (as in effect at the time of such Forecast). The Licensee will forecast in amounts
comprising full batch and in multiples of batch quantities, as such quantities are set forth on Schedule 6.1. Each Forecast will
be made by the Licensee in good faith, taking into account reasonable projections of demand for the Product including, without limitation,
allowing for reasonable safety stock of finished Product.

 

    2

     

    

 

Section 3.2           Orders.

 

(a)          The
Licensee will place firm purchase orders (“Firm Orders”) for Product in writing for delivery in line with the agreed
upon prices and delivery terms. A Firm Order shall only be deemed binding on Quoin upon acceptance in writing by Quoin provided that Quoin
shall accept or reject each Firm Order in writing within seven (7) Business Days after Quoin’s receipt of each valid order
which shall require that such order meets the requirements specified below. Each Firm Order will specify the quantity and description
of each Product ordered, the requested delivery date (which delivery dates will not be on a Saturday, Sunday or holiday), the delivery
address, the transportation method and carrier and any special instructions requested. During NPS phase, there will not be any minimum
order quantity. After Regulatory Approval is obtained, the minimum size of any order placed by the Licensee will be in accordance with
Schedule 6.1 that defines the minimum order quantity. The Product set forth in Firm Orders will be delivered to such location as
the Licensee designates in writing to Quoin in the Firm Order. The date an order will be deemed placed (the “Firm Order Date”)
will be the date that Quoin actually receives the Firm Order form. The Licensee will be fully responsible for any changes to a Firm Order.
Orders will be deemed accepted by Quoin unless Quoin provides notification of rejection to the Licensee within seven (7) Business
Days of receipt of the Firm Order.

 

(b)          Quoin
will use its commercially reasonable efforts to supply the Product in accordance with each Firm Order placed pursuant to the terms of
this Agreement by the Licensee to the extent accepted by Quoin including the quantities and delivery dates in each Firm Order. Each Firm
Order will set forth a delivery date, not less than ninety (90) days after the date of such order.

 

(c)          In
the event that at any time Quoin foresees that it will be unable to supply to Licensee (or its nominee) in whole or in part an ordered
or forecasted quantity of Product by the delivery date for any reason, including a Force Majeure event, Quoin shall notify Licensee of
such inability as soon as possible, the reasons therefor and the date such inability is expected to end, the quantities of Product available
during such period and the proposed amount of the raw materials and/or resources prioritized to Licensee in the event such inability is
caused by a shortage of raw materials and/or resources required for the Manufacture of Product. Quoin will be responsible for the cost
of any penalties imposed in the ordinary course by any Governmental Authority as a result of a failure by Quoin to supply Product by the
delivery date set forth in any Firm Order. Licensee shall cooperate with Quoin and use commercially reasonable efforts to mitigate the
amount of any such penalties.

 

(d)          Quoin
shall deliver the Product to Licensee with at least 75% (seventy five percent) of remaining shelf life at the shipment date in accordance
with Section 3.2(b).

 

(e)          The
terms of this Agreement shall prevail over any conflicting, inconsistent or additional terms set forth in any Firm Order, invoice, or
acceptance form.

 

    3

     

    

 

Section 3.3           Delivery.

 

(a)          Except
for shipments to the Kingdom of Saudi Arabia, all Product shipped under this Agreement will be shipped FOB the facility where the Product
is manufactured. The Licensee shall make necessary arrangements to pick up the shipment and will pay all freight, insurance charges,
taxes, import and export duties, inspection fees and other charges applicable to the sale and transport of Product purchased by the Licensee.
Title and risk of loss and damages to Product purchased by the Licensee will pass to the Licensee upon pickup of the Product by the Licensee’s
carrier at the facility of manufacture. In the event of damage or loss to the Product after delivery, the Licensee will be responsible
to file claims with the carrier. Notwithstanding the foregoing, for shipments to the Kingdom of Saudi Arabia, delivery will be CIF (Incoterms
2010) to the port of destination specified by Licensee, with an invoice issued by Quoin for customs clearance purposes. Quoin shall notify
Licensee of the following information concurrently with each shipment of Product: (i) date of shipment, (ii) quantity and type
of Product shipped, and (iii) order number or other identifying information.

 

(b           Quoin
shall perform quality assurance testing with respect to the Product sold hereunder, including stability testing, so that the Product
conforms with the Specifications. Quoin shall provide Licensee with a Certificate of Analysis (“COA”) and a Certificate
of Compliance (“COC”) confirming that the Product in such shipment has been tested in accordance with the Regulatory
Approval and meets the Specifications via facsimile transmission. Any deviations and investigations related to such Product shall be
completed in compliance with applicable Regulatory Approval and the Quality Agreement (as defined in Section 5.5 hereof).

 

Article IV

 

REPRESENTATIONS AND WARRANTIES

 

Section 4.1           Representations
and Warranties of Quoin. Quoin hereby represents and warrants to the Licensee as follows:

 

(a)          Product
Compliance. All Product delivered pursuant to this Agreement by Quoin (or any sub-contractor thereof) to the Licensee or its designee
during the Term will at shipment be in compliance in all material respects with this Agreement, the Specifications and the Quality Agreement.
At the time Quoin makes each shipment of Product available for pick-up by Licensee (or Licensee’s carrier), the Product shall be
free of any lien or other encumbrance.

 

(b)         Authorization.
This Agreement has been duly executed and delivered by Quoin and, assuming due execution and delivery by the Licensee, constitutes a
valid and binding obligation, enforceable against Quoin in accordance with its terms, except as enforceability may be limited by bankruptcy,
fraudulent conveyance, insolvency, reorganization, moratorium and other laws relating to creditors’ rights generally and by general
equitable principles. The execution, delivery and performance of this Agreement have been duly authorized by all necessary action on
the part of Quoin and its respective officers and directors.

 

(c)          Absence
of Conflicts. The execution, delivery and performance of this Agreement by Quoin does not conflict with or constitute a default under
any agreement, instrument or understanding, oral or written to which it is a party or by which it may be bound, does not conflict with
any provision of any of its organizational documents and does not conflict with or violate any applicable Law or court order or decree.

 

(d)         Organization
and Standing. Quoin is a corporation, duly organized, validly existing and in good standing under the laws of Delaware.

 

    4

     

    

 

(e)          Power
and Authority. Quoin has the corporate power and authority to execute, deliver and perform this Agreement and to consummate the transactions
contemplated hereby.

 

(f)           Compliance
With Law. Quoin has and will maintain throughout the Term of this Agreement all permits, licenses, registrations and other forms of
governmental authorization and approval as required in order for Quoin to execute and deliver this Agreement and to perform its obligations
hereunder.

 

(g)          No
Debarment. Quoin is not debarred and has not and will not use in any capacity the services of any person debarred under subsection
306(a) or (b) of the Generic Drug Enforcement Act of 1992. If at any time this representation and warranty is no longer accurate,
Quoin shall promptly notify Licensee of such fact.

 

Section 4.2           Representations
and Warranties of the Licensee. The Licensee hereby represents and warrants to Quoin as follows:

 

(a)          Authorization.
This Agreement has been duly executed and delivered by the Licensee and, assuming due execution and delivery by Quoin, constitutes a
valid and binding obligation, enforceable against the Licensee in accordance with its terms, except as enforceability may be limited
by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium and other laws relating to creditors’ rights generally
and by general equitable principles. The execution, delivery and performance of this Agreement have been duly authorized by all necessary
action on the part of the Licensee and its respective officers and directors.

 

(b)         Absence
of Conflicts. The execution, delivery and performance of this Supply Agreement by the Licensee does not conflict with or constitute
a default under any agreement, instrument or understanding, oral or written to which it is a party or by which it may be bound, does not
conflict with any provision of any organizational documents of the Licensee and does not conflict with or violate any applicable Law or
court order or decree.

 

(c)          Organization
and Standing. The Licensee is a corporation, duly organized, validly existing and in good standing under the laws of the United Arab
Emirates.

 

(d)          Power
and Authority. The Licensee has the corporate power and authority to execute, deliver and perform this Agreement and to consummate
the transactions contemplated hereby.

 

(e)          Product
Compliance in the Territory. Product delivered by Quoin in accordance with this Agreement is and shall be during the Term consistent
in all respects with all Laws applicable to the manufacture, import, sale, use, storage and commercialization of the Product in the Territory.

 

Section 4.3           Disclaimer.
THE REPRESENTATIONS AND WARRANTIES SET FORTH IN THIS AGREEMENT ARE THE PARTIES’ ONLY WARRANTIES AND NO OTHER WARRANTY, EXPRESS, IMPLIED
OR STATUTORY, WILL APPLY. EACH PARTY EXPRESSLY DISCLAIMS ALL OTHER WARRANTIES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING
WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. FOR THE AVOIDANCE OF DOUBT, EACH PARTY EXPRESSLY DISCLAIMS ANY AND
ALL WARRANTIES OF NON-INFRINGEMENT THAT ARE NOT EXPRESSLY SET FORTH IN THIS AGREEMENT.

 

    5

     

    

 

Article V

 

QUALITY ASSURANCE

 

Section 5.1           Quoin’s
Covenants. Quoin hereby covenants during the Term that it will:

 

(a)          manufacture,
fill, package, test, handle, store, warehouse and ship the Product in conformity with this Agreement, Quality Agreement (subject to Section 5.5
of this Agreement) and the Specifications;

 

(b)          promptly
(but in any event no later than five (5) Business Days after becoming aware) inform Licensee of any adverse events related to the
Product and any inspections, communications, or material issues raised by the FDA in connection with the Manufacturing of the Product,
and shall provide Licensee with copies of any correspondence (including emails) relating thereto;

 

(c)          obtain
and maintain all permits reasonably necessary to manufacture and supply Product in accordance with this Agreement; and

 

(d)          if
Quoin becomes aware of any Product supplied to Licensee hereunder that have not been manufactured in accordance with the Specifications,
promptly inform Licensee in writing.

 

Section 5.2           The
Licensee’s Covenants. The Licensee hereby covenants during the Term that it will:

 

(a)          hold,
store, handle, ship, deliver, distribute, offer for sale, and/or sell the Product in accordance with applicable Law and the terms of the
License Agreement, and in compliance with the Specifications;

 

(b)          except
as set forth herein or in the Quality Agreement between the Parties, upon delivery of the Product to the Licensee, the Licensee will
be solely responsible for compliance with all quality control testing and other testing requirements set forth in this Agreement and,
further, all applicable Law with respect to the manufacture, import, sale, use, storage and commercialization of the Product in the Territory;

 

(c)          where
appropriate maintain the Regulatory Approvals for the Product in full force and effect throughout the Term.

 

Section 5.3           Rejection
of Delivered Product. Within thirty (30) days of receipt of any shipment of Product and applicable COA and COC by the Licensee at
its applicable warehouse, the Licensee will inspect the Product, COA and COC and advise Quoin of any defect revealed from such inspection
whereby the Product does not conform to the Specifications. Any Product not refused within thirty (30) days will be deemed accepted.
If the Licensee wishes to refuse acceptance, the Licensee will, within such 30-day period, provide written notice to Quoin of its refusal
to accept the defective Product and the reason(s) therefor. In the event a hidden defect (i.e., one which could not have been reasonably
identified during the initial 30-day Licensee inspection period) is discovered at a later date whereby the Product does not conform to
the Specifications, the Licensee shall inform Quoin within fifteen (15) days after Licensee becomes aware of the alleged hidden defect.
In the event that the Licensee refuses acceptance or rejects the Product due to a hidden defect, Quoin, upon confirmation of the reasons
for refusal or rejection of the Product, will replace within ninety (90) days or as soon as reasonably practicable the defective Product
at Quoin’s sole cost and expense (including the cost of shipping) or refund the Transfer Price and reimburse the shipping expense,
at the Licensee’s option. If Quoin and the Licensee do not agree on the refusal or rejection of Product, then either Party may
refer the matter for final analysis to a specialized laboratory of national reputation acceptable to both Parties for the purpose of
determining the results. Any determination by such laboratory will be final and binding upon the Parties. The cost of any such review
by a laboratory shall be borne by the Licensee if it is determined that the Product conforms to the Specifications, and by Quoin if determined
that it does not. Except as set out in this Section 5.3 and Section 10.1, Quoin shall have no liability to Licensee for any
defect for which it has not received notice from the Licensee as specified herein.

 

    6

     

    

 

Section 5.4           Recall.
Licensee, in consultation with Quoin, shall have the exclusive right to institute a recall and shall be responsible for managing the
recall and communications with customers and Governmental Authorities. The Parties shall cooperate with each other in connection with
any such efforts. In the event that any Product is quarantined or recalled by Licensee, or is subject to stop-sale action, whether voluntary
or by governmental action, it is agreed and understood that any reasonable and documented expenses, including any out-of-pocket administrative
costs and reasonable and documented fees of any experts or attorneys that may be utilized by either Party, government fines or penalties,
related to such recall, quarantine or stop-sale, will be borne by the Licensee unless it is determined that the reason for the quarantine,
recall or stop-sale action is solely the result of the failure by Quoin to manufacture and supply (or have manufactured and supplied)
Product that meets the Specifications therefor under this Agreement, and in such case such expenses will be the responsibility of Quoin.
If the Parties do not mutually agree on which Party is responsible for the recall or other field action, the responsibility for the recall
or field action shall be determined by a mutually acceptable independent qualified third party whose fees shall be shared equally by
the Parties.

 

Section 5.5           Quality Procedures.
Quoin and Licensee shall comply with the terms of the quality requirements set forth in a quality agreement to be negotiated in good
faith by the Parties and entered into by the Parties as soon as practicable after the date hereof (the “Quality Agreement”)
with respect to the manufacture of the Product. To the extent that any inconsistencies or conflicts exist between the Quality Agreement
and this Agreement with regard to quality requirements and compliance with applicable Law, the provisions in this Agreement shall prevail.

 

Section 5.6           Manufacturing
Changes.

 

(a)          Licensee
may unilaterally and in its sole discretion make one or more Required Manufacturing Changes by giving written notice thereof to Quoin,
whereupon the Parties shall cooperate in implementing such Required Manufacturing Changes as promptly as reasonably practicable. Licensee
may request one or more Discretionary Manufacturing Changes by giving at least ninety (90) days written notice thereof to Quoin, whereupon
if Quoin accepts the requested Discretionary Manufacturing Changes (such acceptance not to be unreasonably withheld or delayed), the Parties
shall cooperate in implementing such Discretionary Manufacturing Changes as promptly as reasonably practicable. Quoin shall promptly provide
to Licensee Quoin’s good faith and detailed estimate of the actual and reasonable costs that will be incurred by Quoin resulting
directly from any such Required or Discretionary Manufacturing Changes, including the cost of any obsolete inventory resulting from the
changes. All such reasonable and documented costs shall be borne by Licensee.

 

(b)         Quoin
shall not in any respect amend, modify or supplement the Specifications or the manufacturing process or any materials or sources of materials
used in connection with manufacturing the Product without the prior written consent of Licensee. Quoin may request or recommend one or
more Discretionary Manufacturing Changes by giving at least ninety (90) days written notice thereof to Licensee and shall provide Licensee
with appropriate documentation relating to any such changes to the Specifications or manufacturing process. If Licensee approves any such
Discretionary Manufacturing Change, Quoin may implement such change in accordance with the specifications provided by Quoin to Licensee.
All costs arising out of any Discretionary Manufacturing Changes requested by Quoin shall be borne by Quoin.

 

    7

     

    

 

Article VI

 

PRICE AND PAYMENTS

 

Section 6.1           Prices.
The price payable by the Licensee for Product will be the prices agreed to by Quoin and Licensee during NPS as well as Post Regulatory
approval is obtained in the territory. (the “Transfer Price”).

 

Section 6.2           Any
additional costs such as stability costs, scale-up expenses, and additional analytical or testing expenses that may be specifically incurred
at the request of Licensee or as required for the Manufacture of the Product in accordance with the Specifications and/or cGMP compliance
in the Territory will not be charged to the Licensee

 

Section 6.3            Adjustment.
Quoin shall be permitted to increase the Transfer Price of Product to the extent of any documented actual increase in the Manufacturing
Costs.

 

Section 6.4           Invoices.
Quoin will send all invoices in respect of any Product to a single address specified in writing by the Licensee to Quoin following the
date that such Product subject to any Firm Order shall have been made available to the Licensee under Section 3.3(a). Payments for
Product sold hereunder will be made by the Licensee to Quoin within one hundred twenty (120) days for all countries except KSA for which
it will be one hundred fifty (150) days after the date of the invoice by electronic funds transmission in United States dollars as specified
in any invoice, without any offset or deduction of any nature whatsoever. All payments will be made to such account as Quoin will have
specified in writing to the Licensee with written confirmation of payment sent by email or facsimile to such address as Quoin will have
specified in writing to the Licensee. Licensee shall advise Quoin within ten (10) calendar days of any disputed invoice. If the Licensee
fails to pay any undisputed invoiced amount when due, a service charge will be imposed by Quoin equal to the lesser of one percent (1%)
per month or the highest rate permitted by law of the outstanding amount for each month or portion thereof that such undisputed amount
is overdue.

 

Section 6.5           Taxes, etc.
The Licensee will bear the cost of any taxes, levies, duties or fees of any kind, nature or description whatsoever applicable to the import,
sale, transportation, and Exploitation of the Product in the Territory (“Licensee Taxes”). Quoin shall be responsible
for any taxes imposed on Quoin in the United States.

 

Section 6.6           Separate
Sale. Each shipment of Product to the Licensee will constitute a separate sale, obligating the Licensee to pay therefor, whether
said shipment is in whole or only partial fulfillment of any order or confirmation issued in connection therewith.

 

Section 6.7           Deductions.
Except as otherwise required by applicable law, the Licensee agrees not to make any deductions of any kind from any payments becoming
due to Quoin unless the Licensee will have received prior written authorization from Quoin authorizing such deduction.

 

    8

     

    

 

Article VII

 

TERM AND TERMINATION

 

Section 7.1            Term.
The provisions of this Agreement will commence on the date hereof and will expire in 5 years from the Effective Date, unless earlier
terminated in accordance with this Article VII (the “Initial Term”). This Agreement may be extended for an additional
one (1) year term at least ninety (90) days prior to the end of the Initial Term, subject to a mutually agreed upon price increase
at the time of the extension, (the “Extended Term” and together with the Initial Term, the “Term”).

 

Section 7.2           Termination.
Either Quoin, on the one hand, or the Licensee, on the other hand, as applicable, will have the right to terminate this Agreement with
immediate effect (except as otherwise stated below) upon written notice to the other upon the occurrence of the following:

 

(a)          Quoin,
on the one hand, or the Licensee, on the other hand, files a petition in bankruptcy, or enters into an agreement with its creditors,
or applies for or consents to the appointment of a receiver or trustee, or makes an assignment for the benefit of creditors, or becomes
subject to involuntary proceedings under any bankruptcy or insolvency Law;

 

(b)          Quoin,
on the one hand, or the Licensee, on the other hand, fails to cure any non-compliance with any of the terms and conditions hereof within
the time period specified in any prior written notice (which will be at least thirty (30) days) delivered to the non-compliant Party
by another Party; provided; however, that Quoin shall be permitted to terminate immediately upon delivery of written notice to Licensee
in the event that Licensee has failed at least two (2) times in any twelve (12) month period to pay to Quoin any amount invoiced
hereunder when such amount is due, other than where such failure is due to a good faith dispute over the amount owed;

 

(c)          The
termination of the License Agreement.

 

Section 7.3           Effects
of Termination.

 

If this Agreement is terminated
pursuant to Section 7.2:

 

(a)          Upon
termination of this Agreement by Quoin pursuant to Section 7.2(a) or Section 7.2(b), or if the License Agreement is terminated
by Quoin pursuant to Section 11.2.3 or 11.2.4: (i) Licensee acknowledges and agrees that Quoin will be entitled (but shall
not be required) to cancel any Firm Order accepted prior to the date of termination, and will not be obligated to supply any Product
ordered by the Licensee pursuant to such Firm Order, with respect to any Product to be delivered after the effective date of the termination.
In all other cases, upon termination of this Agreement, Quoin will fill any Firm Order accepted prior to the date of termination.

 

(b)         Subject
to Section 7.3(a) hereof, termination or expiration of this Agreement for any reason will not relieve the Parties of any obligation
accruing prior to such termination or expiration (including in respect of any Firm Orders). The rights and obligations of the Parties
under Sections 5.3, 5.4, 5.5, 7.3, Article IX, Article X, and Article XI of this Agreement will survive the expiration
or termination of this Agreement.

 

    9

     

    

 

Section 7.4: Termination
for Convenience by Quoin

 

In the event that Quoin decides
to terminate this Agreement for reasons unrelated to clauses described in section 7.2 and including but not limited to:

 

		·	An acquisition of Quoin by a third party, where such third party does not assume all of Quoin’s
obligations hereunder

 

		·	A licensing or distribution deal between Quoin and a third party that covers all or part of the agreed
Licensee “territory” as defined in this Agreement

 

		·	That Quoin becomes insolvent or is unable to trade due to insolvency or a winding up agreement

 

		·	That Quoin is liquidated in favor of a new trading entity

 

Then Licensee may claim compensation
calculated as follows:

 

		§	Termination during Commercial Year 1: Compensation equivalent to USD 750,000

 

		§	Termination during Commercial Year 2: Compensation equivalent to USD 900,000

 

		§	Termination during Commercial Year 3: Compensation equivalent to 150% of difference between Transfer Price
and CIF price for quantities purchased during Year 2 or USD 1 million, whichever is the higher amount.

 

		§	Termination during Commercial Year 4: Compensation equivalent to 125% of difference between Transfer Price
and CIF price for quantities purchased during Year 3 or USD 1.25 million, whichever is the higher amount.

 

		§	Termination during Commercial Year 5: Compensation equivalent to 100% of difference between Transfer Price
and CIF price for quantities purchased during Year 4 or USD 1.5 million, whichever is the higher amount.

 

    10

     

    

 

Article VIII

 

FORCE MAJEURE

 

Section 8.1           Force
Majeure. Neither Party will be deemed to have defaulted under or breached this Agreement for failure or delay in fulfilling or performing
any term or provision of this Agreement (other than the payment of money) when such failure or delay will be caused (directly or indirectly)
by a circumstance beyond the reasonable control of the affected Party, including, without limitation, fire; flood; accident; explosion;
terrorism, sabotage; strike, or any labor disturbance (regardless of the reasonableness of the demands of labor); civil commotions; riots;
invasions; wars (present or future); acts, restraints, requisitions, regulations, or directions of any Governmental Authority, except
where such acts, restraints, requisitions, regulations or directions are the result of a Party’s violation of applicable Law; shortage
of labor, fuel, or power; any failure of a third party supplier of the Product or raw materials to deliver timely; inability to obtain
or delays of transportation facilities; any act of God; any act of the other Party or any cause (whether similar or dissimilar to the
foregoing) beyond the reasonable control of such Party (each a “Force Majeure”). Any Party asserting its inability
to perform any obligation hereunder for any such contingency shall promptly notify the other Party of the existence of any such contingency
and shall use commercially reasonable efforts to mitigate such contingency and re-commence its performance of such obligation as soon
as commercially practicable. Neither Party shall suffer penalty or incur any liability for its inability to perform hereunder by reason
of Force Majeure. If a Party fails to perform any of its obligations under this Agreement by reason of Force Majeure and such non-performance
continues for a period of one hundred and eighty (180) days from the first occurrence of the event of Force Majeure, the other Party
may terminate this Agreement by providing written notice to that effect to the non-performing Party. In the event of such termination,
the provisions contained in Section 7.3 shall apply.

 

Article IX

 

CONFIDENTIALITY

 

Section 9.1           Non-disclosure
and Non-use Obligation. Each Party or its Affiliates or contractors may, from time to time, prior to or after the date hereof, disclose
to the other Party information of a technical or non-technical nature that is not generally known to the trade or public. Each Party agrees
that it will not, and will cause its Affiliates, and will use reasonable best efforts to cause its contractors, not to, use for any purpose
other than as necessary to perform its obligations under this Agreement, and will not disclose to anyone in any manner whatsoever, any
such information including, without limitation, information relating in any way to the products, processes, and services of each Party
or its Affiliates or contractors, which becomes known to the other Party on or prior to the date of the termination or expiration of this
Agreement. The obligations of this Section 9.1 will not apply to information (i) that is known to a Party as shown by written
records prior to its disclosure by Quoin or its contractors; (ii) that becomes public information or is generally available to the
public other than by an unauthorized act or omission of the other Party; or (iii) that is received by a Party from third parties
who are in rightful possession of such information and who are lawfully entitled to disclose such information and did not receive such
information from the other Party. Upon the termination or expiration of this Agreement, each Party will return or destroy (with written
confirmation thereof) to the other Party all documents that include confidential information of each Party or its contractors including
all copies of such documents or extracts therefrom, if any, and will make no further use of such information. This Agreement shall not
be deemed to restrict the receiving Party from complying with a lawfully issued governmental order or any other requirement of applicable
Law to produce or disclose confidential information of the other Party; provided that the receiving Party shall have complied with
the requirements of this Section 9.1. With respect to any such governmental order or requirement of applicable Law, the receiving
Party shall promptly notify the disclosing Party of such order so that the disclosing Party may seek to quash such order or to obtain
an appropriate protective order requiring that the confidential information that is the subject of such order or requirement of applicable
Law be held in confidence or, if disclosed, be used only for the purposes for which such order was issued or such requirement of applicable
Law covers. The receiving Party shall reasonably cooperate with the disclosing Party in any such proceeding. With respect to any such
order that is not quashed or any other requirement of applicable Law to disclose confidential information of the disclosing Party, the
receiving Party shall furnish only that portion of such confidential information that the receiving Party is advised by counsel is legally
required to be disclosed and the receiving Party shall, at the disclosing Party’s cost, exercise its reasonable efforts, in its
sole discretion, to obtain a protective order or other reliable assurance that confidential treatment shall be accorded to the confidential
information so disclosed. The receiving Party’s obligations shall be qualified to the extent it is reasonably able to comply with
the terms of this Section 9.1 depending upon the order or other legal requirement and the timing within which the receiving Party
is obligated to comply therewith.

 

    11

     

    

 

Article X

 

INDEMNIFICATION

 

Section 10.1         By
Quoin. From and after the Effective Date, subject to Section 10.5(a) hereof, Quoin will indemnify, defend and hold harmless,
and pay and reimburse, the Licensee, its Affiliates and their respective officers, directors, employees, agents, advisors, and shareholders
from and against any and all liabilities, losses, claims, damages, costs, and expenses (including reasonable attorneys’ fees) (“Losses”)
resulting from or relating to any claim by a Third Party resulting from or arising out of: (i) Quoin’s or its contractors’
or Affiliate’s negligence or willful misconduct, or (ii) any breach by Quoin of any of its representations and warranties,
covenants, agreements or obligations contained in this Agreement; except to the extent such Losses arise as a result of the breach of
this Agreement, or the negligence, willful misconduct, or breach of this Agreement by Licensee or its contractors or Affiliates.

 

Section 10.2         By
the Licensee. From and after the Effective Date, the Licensee will indemnify, defend and hold harmless, and pay and reimburse, Quoin
and its Affiliates and their respective officers, directors, employees, agents, advisors and shareholders from and against any and all
Losses resulting from or relating to any claim by a Third Party resulting from or arising out of: (a) the Licensee’s negligence
or willful misconduct, or (b) breach of any of its representations and warranties, covenants, agreements or obligations contained
in this Agreement; or (c) regarding any Product sold by Licensee or its Affiliates from and after the Effective Date, including
but not limited to (i) any claim for patent infringement, personal injury, death or property damage or (ii) the use of the
Product by any person; provided, however, that the Licensee shall not be liable for any Losses to the extent arising from Quoin’s
or it contractors’ negligence, willful misconduct, or breach of its representations and warranties, covenants, agreements or obligations
contained in this Agreement.

 

Section 10.3         Procedures.
With respect to each event, occurrence or matter (an “Indemnification Matter”) as to which Quoin or Licensee, as the
case may be (the “Indemnitee”) is entitled to indemnification from the other Party (the “Indemnitor”)
under this Article X:

 

(a)          Within
ten (10) days after the Indemnitee receives written documents underlying the Indemnification Matter or, if the Indemnification Matter
does not involve a third party action, suit, claim or demand, promptly after the Indemnitee first has actual knowledge of the Indemnification
Matter, the Indemnitee shall give notice to the Indemnitor of the nature of the Indemnification Matter and the amount demanded or claimed
in connection therewith (“Indemnification Notice”), together with copies of any such written documents.

 

(b)          If
a third party action, suit, claim or demand is involved, then, upon receipt of the Indemnification Notice, the Indemnitor shall, at its
expense and through counsel of its choice, promptly assume and have sole control over the litigation, defense or settlement (the “Defense”)
of the Indemnification Matter, except that (i) the Indemnitee may, at its option and expense and through counsel of its choice,
participate in (but not control) the Defense; (ii) if the Indemnitee reasonably believes that the handling of the Defense by the
Indemnitor may have a material adverse effect on the Indemnitee, its business or financial condition, or its relationship with any customer,
prospect, supplier, employee, salesman, consultant, agent or representative, then the Indemnitee may, at its option and expense and through
counsel of its choice, assume control of the Defense, provided that the Indemnitor shall be entitled to participate in the Defense at
its expense and through counsel of its choice; (iii) the Indemnitor shall not consent to any Judgment, or agree to any settlement,
without the Indemnitee’s prior written consent; and (iv) if the Indemnitor does not promptly assume control over the Defense
or, after doing so, does not continue to prosecute the Defense in good faith, the Indemnitee may, at its option and through counsel of
its choice, but at the Indemnitor’s expense, assume control over the Defense. In any event, the Indemnitor and the Indemnitee shall
fully cooperate with each other in connection with the Defense including by furnishing all available documentary or other evidence as
is reasonably requested by the other.

 

    12

     

    

 

(c)          All
amounts owed by the Indemnitor to the Indemnitee (if any) shall be paid in full within fifteen (15) business days after a final Judgment
(without further right of appeal) determining the amount owed is rendered, or after a final settlement or agreement as to the amount owed
is executed.

 

Section 10.4         Insurance.
At all times from the Effective Date the Licensee shall maintain a valid general liability insurance in line with the local laws and
regulations in place by the local authorities in each country of the territory. Quoin will maintain general liability insurance and product
liability insurance (or self-insurance), which is reasonable and customary in the USA pharmaceutical industry for companies of comparable
size, provided that in no event shall the product liability insurance amounts be less than USD $5,000,000 per occurrence and USD $5,000,000
in the aggregate limit of liability per year.

 

Section 10.5         Limitations.

 

(a)          Notwithstanding
anything to the contrary in this Agreement, Licensee’s sole recourse with respect to any Losses that arise, directly or indirectly,
from the actions or omissions of Quoin’s contract manufacturer of the Product shall be limited to the amounts that Quoin is able
to collect from such contract manufacturer in connection with such actions or omissions. Quoin, with the cooperation of Licensee, will
enforce the rights available to Quoin under its agreement with the contract manufacturer with respect to the Product supplied to the
Territory, to the same extent as if the loss or damage was directly incurred by Quoin, rather than Licensee.

 

(b)          In
no event shall either Party be liable by reason of any breach of any representation, warranty, condition or other term of this Agreement
or any duty of common law, for any consequential, special, indirect or incidental or punitive loss or damage (whether for loss of current
or future profits, loss of enterprise value or otherwise) and each Party agrees that it shall not make any such claim; provided, however,
that the foregoing does not limit any of the obligations or liability of either Party or its Affiliates under Sections 10.1 and 10.2 with
respect to claims of unrelated third parties or liability arising from fraud or willful misconduct of a Party or its Affiliates or contractors.

 

(c)          Notwithstanding
any other provision of this Agreement, in the event that the Licensee asserts or claims that Quoin has breached any of its obligations
hereunder or that Quoin is liable pursuant to Section 10.1, Quoin’s maximum liability under or in connection with any such
claim herein shall be limited to Two Million Dollars ($2,000,000); provided, however, that the foregoing shall not limit any liability
arising from fraud or willful misconduct of Quoin or its Affiliates or contractors.

 

    13

     

    

 

Article XI

 

MISCELLANEOUS

 

Section 11.1         Assignment.
Neither Party may assign its rights or obligations under this Agreement without the prior written consent of the other Party ; provided,
however either Party may assign its rights and obligations under this Agreement, without the prior written consent of the other Party,
to an Affiliate or to a successor of the assigning Party by reason of merger, sale of all or substantially all of its assets or the portion
of its business which relates to a Product, or any similar transaction. Any permitted assignee or successor-in-interest will assume all
obligations of its assignor under this Agreement. No assignment will relieve either Party of its responsibility for the performance of
any obligation. This Agreement will be binding upon and inure to the benefit of the Parties hereto and their respective successors and
permitted assigns.

 

Section 11.2         Severability.
If any provision of this Agreement is held to be illegal, invalid or unenforceable by any Law or public policy, the remaining provisions
of this Agreement will nevertheless remain in full force and effect and will not be affected by the illegal, invalid or unenforceable
provision or by its severance herefrom as long as the economic or legal substance of the transactions contemplated hereby is not affected
in any manner materially adverse to either Party. Upon such determination that any term or other provision is invalid, illegal or unenforceable,
the Parties will negotiate reasonably and in good faith to modify this Agreement so as to effect the original intent of the Parties as
closely as possible in an acceptable manner in order that the transactions contemplated hereby are consummated as originally contemplated
to the greatest extent possible.

 

Section 11.3         Notices.
All notices and other communications required or permitted to be given or made pursuant to this Agreement shall be in writing signed
by the sender and shall be deemed duly given (a) on the date delivered, if personally delivered, (b) on the date sent by telecopier
with automatic confirmation by the transmitting machine showing the proper number of pages were transmitted without error, (c) on
the Business Day after being sent by Federal Express or another recognized overnight mail service which utilizes a written form of receipt
for next day or next Business Day delivery or (d) two (2) Business Days after mailing, if mailed by United States postage-prepaid
certified or registered mail, return receipt requested, in each case addressed to the applicable Party at the address set forth below;
provided that a Party may change its address for receiving notice by the proper giving of notice hereunder:

 

(a)          if
to the Licensee, to:

 

With a copy (which shall not constitute
notice) to:

 

Genpharm Services Fz LLC

Al manara Tower, office 2805

Business Bay, Dubai

United Arab Emirates

Attention: Kamel Ghammachi

Facsimile: +971.4.4227011

Email: kamel.ghammachi@genpharmservices.com

 

    14

     

    

 

(b)          if
to Quoin, to:

 

with a copy (which shall not constitute
notice) to:

 

Blank Rome LLP

One Logan Square, 130 N 18th St.

Philadelphia, PA 19103-6998

Attention: Peter I Tsoflias, Esq.

Facsimile: 202.379.9021

Email: PTsoflias@blankrome.com

 

It is understood and agreed that this Section 11.3
is not intended to govern the ordinary course business communications necessary between the Parties in performing their duties, in due
course, under the terms of this Agreement, including the placement of orders and the delivery of Forecasts.

 

Section 11.4         Applicable
Law. THIS AGREEMENT IS MADE UNDER, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, UNITED
STATES OF AMERICA, APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED SOLELY THEREIN, WITHOUT GIVING EFFECT TO PRINCIPLES OF CONFLICTS
OF LAW.

 

Section 11.5         Arbitration.
If a matter cannot be resolved by the Parties, any said dispute shall be submitted to binding arbitration for final decision, and only
through binding arbitration. Any such arbitration shall be held in New York, New York, in the English language in accordance with the
then-existing Rules of Arbitration of the International Chamber of Commerce (the “ICC Rules”), except where those
rules conflict with this Section 11.5, in which case this Section 11.5 controls. Unless otherwise agreed by the Parties,
the tribunal shall be comprised of three (3) arbitrators; each Party shall nominate one arbitrator and the two Party-nominated arbitrators
shall nominate the third arbitrator. The arbitrators shall decide the merits of any dispute in accordance with the law governing this
Agreement, without application of any principle of conflict of laws that would result in reference to a different law. Judgment upon the
award rendered by the arbitrators may be entered or enforced in any court having jurisdiction thereof. The decision of the arbitrators
shall be final and binding on the Parties and shall be accompanied by a written opinion of the arbitrators explaining the arbitrators’
rationale for their decision. Unless otherwise agreed by the Parties in writing, the Party losing the arbitration shall pay all fees and
costs of the arbitrators and the ICC, but each Party shall bear its own attorney and expert fees. The Parties agree that, notwithstanding
any provision of Applicable Law, they will not request, and the arbitrators shall have no authority to award, punitive or exemplary damages
against either Party. Pending the selection of the arbitrators or pending the arbitrators’ determination of the merits of any dispute,
either Party may seek appropriate interim or provisional relief from any court of competent jurisdiction as necessary to protect the rights
or property of that Party. The intent of the Parties is that except for seeking appropriate interim or provisional relief or the entering
of an arbitration order in a court of competent jurisdiction, disputes shall be resolved finally in arbitration as provided above, without
appeal, and without recourse to litigation in the courts. The Parties acknowledge that the 1958 United Nations Convention on the Recognition
and Enforcement of Foreign Arbitral Awards (the “New York Convention”) applies to this Agreement and to any arbitral
award or order resulting from any arbitration concluded hereunder.  The award may be made a judgment of a court of competent jurisdiction.

 

    15

     

    

 

Section 11.6         Entire
Agreement. This Agreement and the attached Schedules, which are incorporated herein constitute the entire agreement between the Parties
with respect to the subject matter hereof and all prior agreements with respect hereto are superseded. Each Party confirms that no representations,
warranties, covenants or understandings of any kind, nature or description whatsoever are being made or relied upon by any Party. No amendment
or modifications hereof will be binding upon the Parties unless set forth in a writing specified to be an explicit amendment to this Agreement
duly executed by authorized representatives of each of the Parties. The Parties recognize that, during the Term of this Agreement, a purchase
order, acknowledgement form or similar routine document (collectively “Forms”) may be used to implement or administer
provisions of this Agreement. Therefore, the Parties agree that the terms of this Agreement, as it may be amended, will prevail in the
event of any conflict between this Agreement and the printed provision of such Forms, or typed provisions of Forms that add to, vary,
modify or are in conflict with the provisions of this Agreement with respect to the Product sold during the Term of this Agreement.

 

Section 11.7         Headings.
The headings used in this Agreement are intended for convenience only and will not be considered part of the written understanding among
the Parties and will not affect the construction of this Agreement.

 

Section 11.8         Independent
Contractors. The relationship between Quoin, on the one hand, and the Licensee, on the other hand, is solely that of Licensee and
seller. It is expressly agreed that Quoin, on the one hand, and the Licensee, on the other hand, will be independent contractors and
that neither the relationship among the Parties nor this Agreement will be construed as creating a partnership, joint venture or agency.
Neither Quoin, on the one hand, nor the Licensee, on the other hand, will have the authority to make any statements, representations
or commitments of any kind, or to take any action or to incur any liability or obligation which will be binding on the other, without
the prior consent of the other Party to do so. All persons employed by a Party will be employees of such Party and not of the other Party
and all costs and obligations incurred by reason of any such employment will be for the account and expense of such Party.

 

Section 11.9         Waiver.
The waiver by either Party of any right hereunder or the failure to perform or of a breach by the other Party will not be deemed a waiver
of any other right hereunder or of any other or subsequent breach or failure by said other Party whether of a similar nature or otherwise.

 

Section 11.10       Counterparts.
This Agreement may be executed in counterparts, each of which will be deemed an original, and all of which together will constitute one
and the same instrument.

 

Section 11.11       No
Benefit to Third Parties. The representations, warranties, covenants and agreements set forth in this Agreement are for the sole
benefit of the Parties and their successors and permitted assigns, and nothing herein, express or implied, is intended to or will confer
upon any person or entity any legal or equitable rights, benefits or remedies, other than to the extent set forth in Sections 10.1 and
10.2.

 

[signature page follows]

 

    16

     

    

 

IN WITNESS WHEREOF, the Parties hereto have caused
this Agreement to be signed by their respective representatives thereunto duly authorized, all as of the date first written above.

 

	By:	/s/ Michael Myers	 
	Name: Michael Myers	 
	Title: CEO	 
	 	 
	 	 
	By:	/s/ Kamel Ghammachi	 
	Name: Kamel Ghammachi	 
	Title: Chairman	 
	 	 

    

     

    

 

Schedule 1.1

DEFINITIONS

 

As used in this Agreement,
the following terms will have the meanings ascribed to them below:

 

(a)           “Active
Pharmaceutical Ingredient” or “API” means the active pharmaceutical ingredient for Product.

 

(b)           “Affiliate”
of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is
under common control with, such Person. The term "control" (including the terms "controlled by" and "under common
control with") means the possession, directly or indirectly, of the power to direct or cause the direction of the management and
policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 

(c)           “cGMPs”
means current good manufacturing practice requirements of the FDA as promulgated under the Federal Food Drug and Cosmetics Act at 21
C.F.R. (parts 11, 210 and 211), and the European Medicines Agency as set forth in Regulation No. 1252/2014 and Commission Directive
91/356/EEC, as amended by Directive 2003/94/EC.

 

(d)           “COA”
has the meaning set forth in Section 3.3(b).

 

(e)           “COC”
has the meaning set forth in Section 3.3(b).

 

(f)            “Discretionary
Manufacturing Change” means change to the Specifications or manufacturing processes that is not a Required Manufacturing Change.

 

(g)           “Extended
Term” has the meaning set forth in Section 7.1.

 

(h)           “FDA”
means the United States Food and Drug Administration and any successor agency thereto

 

(i)            “Firm
Order” has the meaning set forth in Section 3.2.

 

(j)            “Firm
Order Period” has the meaning set forth in Section 3.1.

 

(k)           “Force
Majeure” has the meaning set forth in Section 8.1.

 

(l)            “Forecast”
has the meaning set forth in Section 3.1.

 

(m)          “Forms”
has the meaning set forth in Section 12.6.

 

(n)           “Governmental
Authority” means any court, tribunal, arbitrator, agency, legislative body, commission, official or other instrumentality of
(i) any government of any country, or (ii) a federal, state, province, county, city or other political, administrative or regulatory
subdivision thereof; in each case, in the jurisdiction where the Product is manufactured and/or in the Territory.

 

(o)           “Initial
Term” has the meaning set forth in Section 7.1.

 

(p)           “Law”
means each federal, state, provincial, municipal, local, or foreign law, statute, ordinance, order, determination, judgment, common law,
code, rule, official standard, or regulation, enacted, enforced, entered, promulgated, or issued by any Governmental Authority.

 

    

     

    

 

(q)           “Manufacturing”
or “Manufactured” means the manufacture and packaging of Product, including, without limitation, mix, fill and finish.

 

(r)            “Manufacturing
Costs” means, with respect to a Product, (x) where Quoin is the actual manufacturer of such Product, the actual cost of
manufacturing the Product (expressed on a per unit manufactured basis), which consists of (i) actual direct cost of any raw
materials, intermediates, packaging materials and labor utilized in such Manufacturing, (ii) an appropriate share of factory overhead
costs allocated to Manufacture of the Product, but excluding any costs related to under-utilized capacity, all calculated in accordance
with GAAP, and (iii) any transportation, freight expenses actually incurred by Quoin to ship the material along with any costs
paid to third parties with respect to any portion of manufacturing or testing the Product, or (y) where Product is manufactured by
any subcontractor for any of the foregoing, the aggregate amount paid to such subcontractor and any other
third parties with respect to any portion of manufacturing or testing the Product.

 

(s)           “Party”
or “Parties” means Quoin and/or the Licensee, as applicable.

 

(t)            “Person”
means any individual, corporation, partnership, limited liability company, limited liability partnership, syndicate, person, trust, association,
organization or other entity, and including and successor, by merger or otherwise, of any of the foregoing.

 

(u)           “Product”
means pharmaceutical product QRX003 in finished dosage form for human use.

 

(v)           “Purchase
Order Date” has the meaning set forth in Section 3.2(a).

 

(w)          “Licensee”
has the meaning set forth in the preamble.

 

(x)
            “Licensee Taxes” has the meaning set forth in Section 6.4.

 

(y)           “Licensee
Trademark” has the meaning set forth in Section 11.1.

 

(z)           “Quality
Agreement” has the meaning set forth in Section 5.6.

 

(aa)         “Regulatory
Approval” shall mean the licenses, registrations, clearances, consents, authorizations, and approvals required to have manufactured,
store, import, transport, market, promote, sell, place on the market, and distribute the Product (including, without limitation, pricing
approvals and labeling approvals) in the Territory, and all amendments thereto or supplements thereof.

 

(bb)        “Required
Manufacturing Change” means a change to the Specifications or manufacturing process that is required by a Governmental Authority
or applicable Law.

 

(cc)         “Specifications”
means the requirements and standards for the manufacture, packaging, storage and shipment of the Product set forth in the Quality Agreement,
as amended or supplemented in accordance with this Agreement.

 

(dd)
        “Term” has the meaning set forth in Section 7.1.

 

(ee)         “Territory”
means Gulf Cooperation Council (KSA, UAE, Kuwait, Bahrain, Oman, Qatar) and Algeria, Egypt, Iran, Iraq, Israel, Jordan,
Lebanon, Libya, Morocco, Palestine, Syria, Tunisia, Turkey, and Yemen.

 

    

     

    

 

(ff)          “Third
Party” means any Person, other than Licensee and its Affiliates, and other than Quoin and its Affiliates.

 

(gg)         “Transfer
Price” means the amount to be paid by the Licensee to Quoin pursuant to Section 6.1 and as may be adjusted from time to
time pursuant to Section 6.2.

 

    

     

    

 

Schedule
6.1

Transfer
Price and Batch Quantities

 

TRANSFER PRICES AND BATCH QUANTITIES FOR DOSAGES AS OF EFFECTIVE DATE:EX-4.1

 Exhibit 4.1 

Universal Insurance Holdings, Inc. 

As Issuer, 
 and 

UMB Bank National Association 

As Trustee 
 INDENTURE 

Dated as of November 23, 2021 

5.625% Senior Unsecured Notes due 2026 
  

 TABLE OF CONTENTS 

 

					
	 ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE
	  	 	1	 
		
	 Section 1.01 Definitions
	  	 	1	 
	 Section 1.02 Compliance Certificates and Opinions
	  	 	5	 
	 Section 1.03 Form of Documents Delivered to Trustee
	  	 	5	 
	 Section 1.04 Acts of Holders
	  	 	6	 
	 Section 1.05 Required Notices or Demands
	  	 	7	 
	 Section 1.06 Language of Notices
	  	 	7	 
	 Section 1.07 Incorporation by Reference of Trust Indenture Act; Conflicts
	  	 	7	 
	 Section 1.08 Effect of Headings and Table of Contents
	  	 	8	 
	 Section 1.09 Successors and Assigns
	  	 	8	 
	 Section 1.10 Severability
	  	 	8	 
	 Section 1.11 Entire Agreement
	  	 	8	 
	 Section 1.12 Benefits of Indenture
	  	 	8	 
	 Section 1.13 Governing Law
	  	 	8	 
	 Section 1.14 Legal Holidays
	  	 	8	 
	 Section 1.15 Counterparts; Electronic Transmission
	  	 	8	 
	 Section 1.16 Immunity of Certain Persons
	  	 	9	 
	 Section 1.17 Waiver of Jury Trial
	  	 	9	 
	 Section 1.18 Force Majeure
	  	 	9	 
	 Section 1.19 USA Patriot Act
	  	 	9	 
	 Section 1.20 No Sinking Fund
	  	 	9	 
	 Section 1.21 Rules of Construction
	  	 	9	 
		
	 ARTICLE II THE NOTES
	  	 	10	 
		
	 Section 2.01 Forms Generally
	  	 	10	 
	 Section 2.02 Definitive Notes
	  	 	10	 
	 Section 2.03 Global Notes
	  	 	10	 
	 Section 2.04 Restricted Notes
	  	 	10	 
	 Section 2.05 Execution and Authentication
	  	 	10	 
	 Section 2.06 Registrar and Paying Agent
	  	 	11	 
	 Section 2.07 Registration of Transfer and Exchange
	  	 	11	 
	 Section 2.08 Exchange Offer
	  	 	13	 
	 Section 2.09 Mutilated, Destroyed, Lost and Stolen Notes
	  	 	13	 
	 Section 2.10 Payment of Interest; Rights to Interest Preserved
	  	 	14	 
	 Section 2.11 Persons Deemed Owners
	  	 	15	 
	 Section 2.12 Cancellation
	  	 	15	 
	 Section 2.13 Computation of Interest
	  	 	15	 
	 Section 2.14 Interest Rate Adjustment
	  	 	15	 
	 Section 2.15 CUSIP Numbers
	  	 	16	 
		
	 ARTICLE III SATISFACTION AND DISCHARGE OF INDENTURE
	  	 	16	 
		
	 Section 3.01 Satisfaction and Discharge
	  	 	16	 
	 Section 3.02 Defeasance and Covenant Defeasance
	  	 	16	 
	 Section 3.03 Application of Trust Money
	  	 	18	 
	 Section 3.04 Reinstatement
	  	 	18	 
		
	 ARTICLE IV REMEDIES
	  	 	18	 
		
	 Section 4.01 Events of Default; Acceleration
	  	 	18	 
	 Section 4.02 Failure to Make Payments
	  	 	19	 
	 Section 4.03 Trustee May File Proofs of Claim
	  	 	20	 
	 Section 4.04 Trustee May Enforce Claims Without Possession of Notes
	  	 	20	 
	 Section 4.05 Application of Money Collected
	  	 	20	 
	 Section 4.06 Limitation on Suits
	  	 	20	 
	 Section 4.07 Unconditional Right of Holders to Payments
	  	 	21	 
	 Section 4.08 Restoration of Rights and Remedies
	  	 	21	 
	 Section 4.09 Rights and Remedies Cumulative
	  	 	21	 
	 Section 4.10 Delay or Omission Not Waiver
	  	 	21	 
	 Section 4.11 Control by Holders
	  	 	21	 
	 Section 4.12 Waiver of Past Defaults
	  	 	22	 
	 Section 4.13 Undertaking for Costs
	  	 	22	 

  

					
	 ARTICLE V THE TRUSTEE
	  	 	22	 
		
	 Section 5.01 Duties of Trustee
	  	 	22	 
	 Section 5.02 Certain Rights of Trustee
	  	 	23	 
	 Section 5.03 Notice of Defaults
	  	 	24	 
	 Section 5.04 Not Responsible for Recitals or Issuance of Notes
	  	 	24	 
	 Section 5.05 May Hold Notes
	  	 	24	 
	 Section 5.06 Money Held in Trust
	  	 	24	 
	 Section 5.07 Compensation and Reimbursement
	  	 	24	 
	 Section 5.08 Corporate Trustee Required; Eligibility
	  	 	25	 
	 Section 5.09 Resignation and Removal; Appointment of Successor
	  	 	25	 
	 Section 5.10 Acceptance of Appointment by Successor
	  	 	26	 
	 Section 5.11 Merger, Conversion, Consolidation or Succession to Business
	  	 	27	 
	 Section 5.12 Appointment of Authenticating Agent
	  	 	27	 
	 Section 5.13 Preferred Collection of Claims against Company
	  	 	28	 
		
	 ARTICLE VI HOLDERS LISTS AND REPORTS BY TRUSTEE AND COMPANY
	  	 	28	 
		
	 Section 6.01 Holder Lists
	  	 	28	 
	 Section 6.02 Preservation of Information; Communications to Holders
	  	 	28	 
	 Section 6.03 Reports by Trustee
	  	 	28	 
	 Section 6.04 Reports by Company
	  	 	28	 
		
	 ARTICLE VII SUCCESSORS
	  	 	29	 
		
	 Section 7.01 Merger, Consolidation or Sale of All or Substantially All Assets
	  	 	29	 
	 Section 7.02 Successor Person Substituted for Company
	  	 	30	 
		
	 ARTICLE VIII SUPPLEMENTAL INDENTURES
	  	 	30	 
		
	 Section 8.01 Supplemental Indentures without Consent of Holders
	  	 	30	 
	 Section 8.02 Supplemental Indentures with Consent of Holders
	  	 	30	 
	 Section 8.03 Execution of Supplemental Indentures
	  	 	31	 
	 Section 8.04 Effect of Supplemental Indentures
	  	 	31	 
	 Section 8.05 Reference in Notes to Supplemental Indentures
	  	 	31	 
	 Section 8.06 Conformity with Trust Indenture Act
	  	 	31	 
		
	 ARTICLE IX COVENANTS
	  	 	31	 
		
	 Section 9.01 Payment of Principal and Interest
	  	 	31	 
	 Section 9.02 Maintenance of Office
	  	 	32	 
	 Section 9.03 Money for Notes Payments to Be Held in Trust
	  	 	32	 
	 Section 9.04 Financial Covenants
	  	 	33	 
	 Section 9.05 Waiver of Certain Covenants
	  	 	33	 
	 Section 9.06 Company Statement as to Compliance
	  	 	33	 
		
	 ARTICLE X REDEMPTION OF SECURITIES
	  	 	33	 
		
	 Section 10.01 Applicability of Article
	  	 	33	 
	 Section 10.02 Election to Redeem; Notice to Trustee
	  	 	34	 
	 Section 10.03 Selection by Trustee of Notes to be Redeemed
	  	 	34	 
	 Section 10.04 Notice of Redemption
	  	 	34	 
	 Section 10.05 Deposit of Redemption Price
	  	 	35	 
	 Section 10.06 Notes Payable on Redemption Date
	  	 	35	 
	 Section 10.07 Notes Redeemed in Part
	  	 	35	 

  
 ii 

 CROSS-REFERENCE TABLE 

 

			
	 Trust Indenture Act Section
	  	Indenture Section
	 §310 (a)(1)
	  	Section 5.08
	 (a)(2)
	  	Section 5.08
	 (a)(5)
	  	Section 5.08
	 (b)
	  	Section 5.08, Section 5.09
	 §311 (a)
	  	Section 5.05
	 (b)
	  	Section 5.05
	 §312 (a)
	  	Section 6.01
	 (b)
	  	Section 6.02
	 (c)
	  	Section 6.02
	 §313 (a)
	  	Section 6.03
	 (b)(2)
	  	Section 6.03
	 (c)
	  	Section 6.03
	 (d)
	  	Section 6.03
	 §314 (a)
	  	Section 6.04
	 (a)(4)
	  	Section 9.06
	 (c)(1)
	  	Section 10.02
	 (c)(2)
	  	Section 10.02
	 (e)
	  	Section 10.02
	 §315 (a)
	  	Section 5.01, Section 5.02
	 (b)
	  	Section 5.03
	 (c)
	  	Section 5.01
	 (d)
	  	Section 5.01, Section 5.02
	 (e)
	  	Section 4.13
	 §316 (a) (last sentence)
	  	Section 1.01
	 (a)(1)(A)
	  	Section 4.02, Section 4.11
	 (a)(1)(B)
	  	Section 4.11, Section 4.12
	 (b)
	  	Section 4.07
	 (c)
	  	Section 1.04
	 §317 (a)(1)
	  	Section 4.02
	 (a)(2)
	  	Section 4.03
	 (b)
	  	Section 9.03
	 §318 (a)
	  	Section 1.07
	 (b)
	  	Section 1.07
	 (c)
	  	Section 1.07

 Note: This Cross-Reference table will not, for any purpose, be deemed part of this Indenture. 

  
 iii 

 This INDENTURE dated as of November 23, 2021 is between Universal Insurance Holdings,
Inc., a Delaware corporation (the “Company”), and UMB Bank National Association, as trustee (the “Trustee”). 

RECITALS 
 WHEREAS,
the Company has duly authorized the execution and delivery of this Indenture to provide for an issue of $100,000,000 in aggregate principal amount of 5.625% Senior Unsecured Notes due 2026, subject to the terms and conditions set forth in this
Indenture. 
 NOW, THEREFORE, in order to declare the terms and conditions upon which the Notes are authenticated, issued and delivered, and
in consideration of the premises, and of the purchase and acceptance of the Notes by the Holders thereof, the Company and the Trustee agree as follows for the benefit of each other and for the benefit of the respective Holders from time to time of
the Notes. 
 Article I 

DEFINITIONS AND INCORPORATION BY REFERENCE 

Section 1.01 Definitions. 

Except as otherwise expressly provided in this Indenture, or unless the context otherwise requires, the terms defined in this Section for all
purposes of this Indenture, any Company Order, Company Request, any Board Resolution and any indenture supplemental hereto will have the respective meanings specified in this Section. 

“Act,” when used with respect to any Holders, is defined in Section 1.04. 

“Additional Interest” has the meaning set forth in the Registration Rights Agreement. 

“Affiliate” means, with respect to any specified Person, any other Person directly or indirectly controlling or
controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control,” when used with respect to any specified Person, means the power to direct the management and policies of
such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. 

“Applicable Procedures” means, with respect to any transfer or exchange of, or for beneficial interests in, any Global
Note, the rules and procedures of the Depositary that apply to such transfer or exchange. 
 “Authenticating Agent”
means any Person authorized by the Trustee in accordance with Section 5.12 to act on behalf of the Trustee to authenticate Notes. 

“Authorized Newspaper” means a newspaper, in an official language of the place of publication or in the English
language, customarily published on each day that is a Business Day in the place of publication, whether or not published on days that are not Business Days in the place of publication, and of general circulation in each place in connection with
which the term is used or in the financial community of each such place. Where successive publications are required to be made in Authorized Newspapers, the successive publications may be made in the same or in different newspapers in the same place
meeting the foregoing requirements, and in each case on any day that is a Business Day, in the place of publication. 

“Authorized Officer” means each of the Chairman of the Board, the Chief Executive Officer, the President, any Vice
President and the Chief Financial Officer of the Company. 
 “Bankruptcy Laws” means Title 11, United States Code
(11 U.S.C. §§101 et seq.), or any similar federal or state law for the relief of debtors. 
 “Board of
Directors” means, as to any Person, the board of directors, or similar governing body, of such Person or any duly authorized committee (or subcommittee) thereof. 

“Board Resolution” means one or more resolutions, certified by the Secretary or an Assistant Secretary of the Company
to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification, delivered to the Trustee. 

“Business Day” means any day other than a Saturday, Sunday or other day on which banking institutions in New York, New
York or, with respect to any payment to be made hereunder, a Place of Payment are authorized or obligated by law, regulation or executive order to close. 

  
 1 

 “Commission” means the U.S. Securities and Exchange Commission, as
from time to time constituted, or, if at any time after the execution of this Indenture such Commission is not existing and performing the duties now assigned to it under the Trust Indenture Act, then the body performing such duties at such time.

 “Common Stock” means any and all shares of the common stock, $0.01 per share par value, of the Company, whether
outstanding on the date of this Indenture or issued thereafter, and includes, without limitation all series and classes of such common stock. 

“Company” is defined in the preamble to this Indenture. 

“Company Request” and “Company Order” mean, respectively, a written request or order, as the
case may be, signed on behalf of the Company by an Authorized Officer and delivered to the Trustee. 
 “Consolidated
Indebtedness” means, as of any date, the indebtedness of the Company and its Subsidiaries for borrowed money determined on a consolidated basis in accordance with GAAP. Consolidated Indebtedness excludes operating lease liabilities.

 “Consolidated Indebtedness to GAAP Capitalization Ratio” means, as of any date, the ratio (expressed as a
percentage) equal to Consolidated Indebtedness as of such date divided by the GAAP Consolidated Capitalization as of such date. 

“Corporate Trust Office” means the address of the Trustee specified in Section 1.05, or such other address as the
Trustee may designate from time to time by notice to the Holders and the Company, or the designated address of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Holders and the
Company). 
 “Covenant Defeasance” is defined in Section 3.02(3). 

“Defaulted Interest” is defined in Section 2.10. 

“Definitive Notes” means, individually and collectively, each Restricted Definitive Note and each Unrestricted
Definitive Note, substantially in the form of Exhibit A-l hereto, issued under this Indenture. 

“Depositary” means, with respect to any Note issuable or issued in whole or in part in global form, the Person
designated as depositary by the Company in accordance with this Indenture, and any and all successors thereto appointed as Depositary under this Indenture. 

“Dollars” or “$” means a dollar or other equivalent unit of legal tender for payment of public
or private debts in the United States. 
 “Event of Default” is defined in Section 4.01. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor statute thereto. 

“Exchange Notes” means the Notes issued in the Exchange Offer in accordance with Section 2.08. 

“Exchange Offer” has the meaning set forth in the Registration Rights Agreement. 

“Exchange Offer Registration Statement” has the meaning set forth in the Registration Rights Agreement. 

“Federal Reserve” means the Board of Governors of the Federal Reserve System, or any successor regulatory authority
with jurisdiction over bank holding companies. 
 “GAAP” means generally accepted accounting principles in the
United States set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants, the statements and pronouncements of the Financial Accounting Standards Board and such other
statements by such other entities (including the Commission) as have been accepted by a significant segment of the accounting profession, which are applicable at the date of this Indenture. 

“GAAP Consolidated Capitalization” means, as of any date, the total shareholders’ equity of the Company and its
subsidiaries determined on a consolidated basis in accordance with GAAP plus Consolidated Indebtedness. 
 “Global
Notes” means, individually and collectively, each Restricted Global Note and each Unrestricted Global Note, substantially in the form of Exhibit A-2 hereto, issued under this Indenture.

  
 2 

 “Government Obligations” means securities which are direct
obligations of the United States of America in each case where the payment or payments thereunder are supported by the full faith and credit of the United States of America. 

“Holder” means the Person in whose name the Note is registered in the Note Register. 

“Indenture” means this Indenture, as amended and supplemented from time to time in accordance with its terms. 

“Initial Notes” means the $100,000,000 in aggregate principal amount of the Company’s 5.625% Senior Unsecured
Notes due 2026 issued under this Indenture on the date hereof. 
 “Interest Payment Date” means May 30 and
November 30 of each year, beginning May 30, 2022. 
 “Interest Period” means each six-month period beginning on an Interest Payment Date for the period beginning on the original issue date of the Notes. 

“Legal Defeasance” is defined in Section 3.02(2). 

“Letter of Transmittal” means the letter of transmittal to be prepared by the Company and sent to all Holders for use
by such Holders in connection with an Exchange Offer. 
 “Maturity” or “Maturity
Date” means the date on which the principal of a Note becomes due and payable as provided in or under this Indenture or such Note, whether at the Stated Maturity or by an acceleration of the maturity of such Note in accordance
with the terms of such Note, upon redemption at the option of the Company, upon repurchase or repayment or otherwise, and includes a Redemption Date for such Note and a date fixed for the repurchase or repayment of such Note at the option of the
Holder. 
 “Note” or “Notes” means the Initial Notes and the Exchange Notes and, more
particularly, any Note authenticated and delivered under this Indenture, including those Notes issued or authenticated upon transfer, replacement or exchange. 

“Note Register” is defined in Section 2.06. 

“Officer” means, with respect to any Person, the chairman of the board, the vice chairman of the board, the chief
executive officer, the president, the chief operating officer, the chief financial officer, the treasurer, any assistant treasurer, the controller, the secretary or any vice president of such Person. 

“Officers’ Certificate” means a certificate signed on behalf of the Company by two Officers of the Company, one
of whom must be the principal executive officer, the principal financial officer or the principal accounting officer of the Company, that complies with the requirements of Section 1.02 and is delivered to the Trustee. 

“Opinion of Counsel” means a written opinion from legal counsel who is reasonably acceptable to the Trustee, which
opinion meets the requirements of Section 1.02. The counsel may be an employee of or counsel to the Company or any Subsidiary of the Company. 

“Outstanding,” when used with respect to any Notes, means, as of the date of determination, all such Notes theretofore
authenticated and delivered under this Indenture, except (1) any such Note theretofore cancelled by the Trustee or the Registrar or delivered to the Trustee or the Registrar for cancellation; (2) any such Note for whose payment at the
Maturity thereof money in the necessary amount has been theretofore deposited in accordance with this Indenture (other than in accordance with Section 3.02) with the Trustee or any Paying Agent (other than the Company) in trust or set aside and
segregated in trust by the Company (if the Company will act as its own Paying Agent) for the Holders of such Notes, provided that, if such Notes are to be redeemed, notice of such redemption has been duly given in accordance with this Indenture or
provision therefor satisfactory to the Trustee has been made; (3) any such Note with respect to which the Company has effected Legal Defeasance or Covenant Defeasance in accordance with Section 3.02, except to the extent provided in
Section 3.02; and (4) any such Note that has been paid in accordance with Section 2.09 or in exchange for or in lieu of which other Notes have been authenticated and delivered under this Indenture, unless there will have been
presented to the Trustee proof satisfactory to the Trustee that such Note is held by a bona fide purchaser in whose hands such Note is a valid obligation of the Company; provided, however, that in all cases, in determining whether the Holders of the
requisite principal amount of Outstanding Notes have given any request, demand, authorization, direction, notice, consent or waiver hereunder, Notes owned by the Company or any Affiliate of the Company will be disregarded and deemed not to be
Outstanding, except that, in determining whether the Trustee will be protected in making any such determination or relying upon any such request, demand, authorization, direction, notice, consent or waiver, only Notes that a Responsible Officer of
the Trustee actually knows to be so owned will be so disregarded. Notes so owned that will have been pledged in good faith may be regarded as Outstanding if the pledgee establishes to the satisfaction of the Trustee the pledgee’s right so to
act with respect to such Notes and that the pledgee is not the Company or an Affiliate of the Company. 
 “Participating
Broker-Dealer” has the meaning set forth in the Registration Rights Agreement. 

  
 3 

 “Paying Agent” is defined in Section 2.06. 

“Person” means any individual, corporation, partnership, association, limited liability company, other company,
statutory trust, business trust, joint venture, joint-stock company, trust, unincorporated organization or government or any agency or political subdivision thereof. 

“Place of Payment,” with respect to any Note, means the place or places where the principal of, or interest on, such
Note is payable as provided in or under this Indenture or such Note. 
 “Private Placement Legend” means the legend
set forth in Section 2.04 of this Indenture to be placed on all Notes issued under this Indenture, except where otherwise permitted by the provisions of this Indenture. 

“Purchase Agreements” mean the Note Purchase Agreements concerning the Notes, dated November 23, 2021, by and
among the Company and the purchasers identified therein. 
 “Ratings Agency” means Egan-Jones Ratings Company or any
other “nationally recognized statistical rating organization” as such term is defined in Section 3(a)(62) of the Exchange Act selected by the Company as a replacement agency for Egan-Jones Ratings Company. 

“Redemption Date,” with respect to any Note or portion thereof to be redeemed, means the date fixed for such
redemption by or under this Indenture or such Note. 
 “Redemption Price,” with respect to any Note or portion
thereof to be redeemed, means the price at which it is to be redeemed as determined by or under this Indenture or such Note. 

“Registrar” is defined in Section 2.06. 

“Registration Rights Agreement” means the Registration Rights Agreement in the form attached as Exhibit C to
the Purchase Agreements, dated as of the date of this Indenture, by and among the Company and the purchasers of the Initial Notes identified therein. 

“Regular Record Date,” with respect to any Interest Payment Date, means the close of business on the fifteenth
calendar day prior to the applicable Interest Payment Date, without regard to whether the Regular Record Date is a Business Day. 

“Responsible Officer” means, when used with respect to the Trustee, any officer within the corporate trust department
of the Trustee, including any vice president, assistant vice president, assistant secretary, assistant treasurer, trust officer or any other officer of the Trustee who customarily performs functions similar to those performed by the Persons who at
the time will be such officers, respectively, or to whom any corporate trust matter is referred because of such Person’s knowledge of and familiarity with the particular subject and who will have direct responsibility for the administration of
this Indenture. 
 “Restricted Definitive Note” means a Definitive Note bearing, or that is required to bear, the
Private Placement Legend. 
 “Restricted Global Note” means a Global Note bearing, or that is required to bear, the
Private Placement Legend. 
 “Restricted Note” means a Restricted Global Note or a Restricted Definitive Note. 

“Rule 144” means Rule 144 promulgated under the Securities Act. 

“Rule 144A” means Rule 144A promulgated under the Securities Act. 

“Securities Act” means the Securities Act of 1933, as amended, or any successor statute thereto. 

“Significant Subsidiary” means any Subsidiary of the Company that is a “significant subsidiary” as defined
in Rule 1-02 of Regulation S-X promulgated by the Commission (as such rule is in effect on the date of this Indenture). 

“Special Record Date” for the payment of any Defaulted Interest on any Note means a date fixed in accordance with
Section 2.10. 
 “Stated Maturity” means November 30, 2026. 

“Subsidiary” means a corporation, a partnership, business or statutory trust or a limited liability company, a
majority of the outstanding voting equity securities or a majority of the voting membership or partnership interests, as the case may be, of which is owned or controlled, directly or indirectly, by the Company or by one or more other Subsidiaries of
the Company. For the purposes of this definition, “voting equity securities” means securities having voting power for the election of directors, managers, managing partners or trustees, as the case may be, whether at all times or only so
long as no senior class of stock has voting power by reason of any contingency. 

  
 4 

 “Trust Indenture Act” means the Trust Indenture Act of 1939, as
amended. 
 “Trustee” means UMB Bank National Association, as trustee, until a successor replaces it in accordance
with the provisions of this Indenture and thereafter means the successor serving hereunder. 
 “United States,”
means the United States of America (including the states thereof and the District of Columbia), its territories, its possessions and other areas subject to its jurisdiction. 

“Unrestricted Definitive Note” means a Definitive Note that does not bear, and is not required to bear, the Private
Placement Legend. 
 “Unrestricted Global Note” means a Global Note that does not bear, and is not required to bear,
the Private Placement Legend. 
 Section 1.02 Compliance Certificates and Opinions. 

Except as otherwise expressly provided in or under this Indenture, upon any application or request by the Company to the Trustee to take any
action under any provision of this Indenture, the Company will furnish to the Trustee an Officers’ Certificate in a form reasonably satisfactory to the Trustee stating that, in the opinion of the signers, all conditions precedent (including
covenants compliance with, which constitutes a condition precedent), if any, provided for in this Indenture relating to the proposed action have been complied with and an Opinion of Counsel in a form reasonably satisfactory to the Trustee stating
that, in the opinion of such counsel, all such conditions precedent (including covenants compliance with, which constitutes a condition precedent), if any, have been complied with, except that in the case of any such application or request as to
which the furnishing of such documents or any of them is specifically required by any provision of this Indenture relating to such particular application or request, no additional certificate or opinion need be furnished. 

Each certificate or opinion with respect to which compliance with a condition provided for in this Indenture (other than an Officers’
Certificate provided under Section 9.06) must comply with the provisions of Section 314(e) of the Trust Indenture Act and must include: 

(1) a statement that the person making such certificate or opinion has read such covenant or condition; 

(2) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such
certificate or opinion are based; 
 (3) a statement that, in the opinion of such person, he or she has made such examination or
investigation as is necessary to enable him or her to express an informed opinion as to whether or not such condition has been satisfied; and 

(4) a statement as to whether or not, in the opinion of such person, such condition has been satisfied. 

Section 1.03 Form of Documents Delivered to Trustee. 

In any case where several matters are required to be certified by, or covered by an opinion of, any specified Person, it is not necessary that
all such matters be certified by, or covered by the opinion of, only one such Person, or that they be so certified or covered by only one document, but one such Person may certify or give an opinion with respect to some matters and one or more other
such Persons as to other matters, and any such Person may certify or give an opinion as to such matters in one or several documents. 
 Any
certificate or opinion of an officer of the Company may be based, insofar as it relates to legal matters, upon a certificate or opinion of, or representations by, counsel, unless such officer knows, or in the exercise of reasonable care, but without
investigation, should know, that the certificate or opinion or representations with respect to the matters upon which this certificate or opinion is based is erroneous. 

Any such certificate or opinion of counsel may be based, insofar as it relates to factual matters, upon a certificate or opinion of, or
representations by, an officer or officers of the Company stating that the information with respect to such factual matters is in the possession of the Company, unless such counsel knows, or in the exercise of reasonable care, but without
investigation, should know, that the certificate or opinion or representations with respect to such matters are erroneous. 

  
 5 

 Where any Person is required to make, give or execute two or more applications, requests,
consents, certificates, statements, opinions or other instruments under this Indenture or any Note, they may, but need not, be consolidated and form one instrument. 

Section 1.04 Acts of Holders. 

(1) Any request, demand, authorization, direction, notice, consent, waiver or other action provided by or under this Indenture to be made,
given or taken by Holders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Holders in person or by an agent duly appointed in writing. Except as otherwise expressly provided herein, such
action will become effective when such instrument or instruments or record or both are delivered to the Trustee and, where it is hereby expressly required, to the Company. Such instrument or instruments and any such record (and the action embodied
therein and evidenced thereby) are herein sometimes referred to as the “Act” of the Holders signing such instrument or instruments. Proof of execution of any such instrument or of a writing appointing any such agent, or of
the holding by any Person of a Note, will be sufficient for any purpose of this Indenture and (subject to Section 5.01) conclusive in favor of the Trustee and the Company and any agent of the Trustee or the Company, if made in the manner
provided in this Section. 
 (2) The fact and date of the execution by any Person of any such instrument or writing may be proved in any
reasonable manner that the Trustee deems sufficient and in accordance with such reasonable rules as the Trustee may determine, and the Trustee may, in any instance, require further proof with respect to any of the matters referred to in this
Section. 
 (3) The ownership, principal amount and serial numbers of Notes held by any Person, and the date of the commencement and the date
of the termination of holding the same, will be proven by the Note Register. 
 (4) The Company may, in the circumstances permitted by the
Trust Indenture Act, set a record date for purposes of determining the identity of Holders entitled to give any request, demand, authorization, direction, notice, consent, waiver or take any other act authorized or permitted to be given or taken by
Holders. Unless otherwise specified, if not set by the Company prior to the first solicitation of a Holder made by any Person in respect of any such action, any such record date will be the later of 30 days prior to the first solicitation of such
consent or the date of the most recent list of Holders furnished to the Trustee prior to such solicitation. If a record date is fixed, the Holders on such record date, and only such Persons, will be entitled to make, give or take such request,
demand, authorization, direction, notice, consent, waiver or other action, whether or not such Holders remain Holders after such record date. No such request, demand, authorization, direction, notice, consent, waiver or other action will be valid or
effective if made, given or taken more than 90 days after such record date. 
 (5) Any effective request, demand, authorization, direction,
notice, consent, waiver or other Act by the Holder of any Note will bind every future Holder of the same Note and the Holder of every Note issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof in respect of
anything done or suffered to be done by the Trustee, any Registrar, any Paying Agent or the Company in reliance thereon, whether or not notation of such Act is made upon such Note. 

(6) Without limiting the foregoing, a Holder entitled to take any action hereunder with regard to any particular Note may do so with regard to
all or any part of the principal amount of such Note or by one or more duly appointed agents, each of which may do so in accordance with such appointment with regard to all or any part of such principal amount. Any notice given or action taken by a
Holder or its agents with regard to different parts of such principal amount in accordance with this paragraph will have the same effect as if given or taken by separate Holders of each such different part. 

(7) Without limiting the generality of this Section 1.04, a Holder, including a Depositary that is a Holder of a Global Note, may make,
give or take, by a proxy or proxies, duly appointed in writing, any request, demand, authorization, direction, notice, consent, waiver or other Act provided in or under this Indenture or the Notes to be made, given or taken by Holders, and a
Depositary that is a Holder of a Global Note may provide its proxy or proxies to the beneficial owners of interests in any such Global Note through such Depositary’s Applicable Procedures. The Company may fix a record date for the purpose of
determining the Persons who are beneficial owners of interests in any Global Note entitled under the Applicable Procedures of such Depositary to make, give or take, by a proxy or proxies duly appointed in writing, any request, demand, authorization,
direction, notice, consent, waiver or other action provided in this Indenture to be made, given or taken by Holders. If such a record date is fixed, the Holders on such record date or their duly appointed proxy or proxies, and only such Persons,
will be entitled to make, give or take such request, demand, authorization, direction, notice, consent, waiver or other action, whether or not such Holders remain Holders after such record date. No such request, demand, authorization, direction,
notice, consent, waiver or other action will be valid or effective if made, given or taken more than 90 days after such record date. Promptly upon any record date being set in accordance with this Section 1.04, the Company, at its own expense,
will cause notice of the record date, the proposed action by Holders and the expiration date to be given to the Trustee in writing and the Holders in the manner set forth in Section 1.05. 

  
 6 

 Section 1.05 Required Notices or Demands. 

Any notice or communication by the Company or the Trustee to the other is duly given if in writing and delivered in Person or delivered by
registered or certified mail (return receipt requested), facsimile or overnight air courier guaranteeing next day delivery to the other’s address:

If to the Company:         Universal Insurance Holdings, Inc. 

1110 West Commercial Boulevard, Suite 100 

Fort Lauderdale, Florida 33309 

Attention: Frank C. Wilcox 
 If
to the Trustee:    UMB Bank National Association 
   5555 San Felipe, Suite 870 

  Houston, Texas 77056 

  Attn: Mauri Cowen, Senior Vice President 

  Office: (713) 300-0587 

  Fax:    214-389-5949 

  mauri.cowen@umb.com 

The Company or the Trustee, by notice to the other, may designate additional or different addresses for subsequent notices or communications.

 Any notice required or permitted to be given to a Holder under the provisions of this Indenture will be deemed to be properly delivered
by being deposited postage prepaid in a post office letter box in the United States addressed to such Holder at the address of such Holder as shown on the Note Register. Any report in accordance with Section 313 of the Trust Indenture Act will
be transmitted in compliance with subsection (c) therein. If the Company delivers a notice or communication to Holders, the Company will deliver a copy to the Trustee at the same time. 

In any case where notice to Holders of Notes is delivered by mail, neither the failure to deliver such notice nor any defect in any notice so
delivered to any particular Holder of a Note will affect the sufficiency of such notice with respect to other Holders of Notes. Any notice that is delivered in the manner herein provided will be conclusively presumed to have been duly given or
provided. In the case by reason of the suspension of regular mail service or by reason of any other cause it will be impracticable to give such notice by mail, then such notification as will be made with the approval of the Trustee will constitute a
sufficient notification for every purpose hereunder. 
 Where this Indenture provides for notice in any manner, such notice may be waived in
writing by the Person entitled to receive such notice, either before or after the event, and such waiver will be the equivalent of such notice. Waivers of notice by Holders of Notes will be filed with the Trustee, but such filing will not be a
condition precedent to the validity of any action taken in reliance upon such waiver. 
 Notwithstanding any other provision herein, where
this Indenture provides for notice to any Holder of a Global Note, or of an interest therein, such notice will be sufficiently given if given to the Depositary for such Global Note (or its designee) according to the Applicable Procedures of such
Depositary prescribed for giving such notice. 
 Section 1.06 Language of Notices. 

Any request, demand, authorization, direction, notice, consent, waiver or other Act required or permitted under this Indenture will be in the
English language, except that, if the Company so elects, any published notice may be in an official language of the country of publication. 

Section 1.07 Incorporation by Reference of Trust Indenture Act; Conflicts. 

Whenever this Indenture refers to a provision of the Trust Indenture Act, the provision is incorporated by reference in and made a part of this
Indenture. The Trust Indenture Act term “obligor” used in this Indenture means the Company and any successor obligor upon the Notes. 

All other terms used in this Indenture that are defined by the Trust Indenture Act, reference to another statute or Commission rule under the
Trust Indenture Act have the meanings so assigned to them as of the date of this Indenture. If and to the extent that any provision of this Indenture limits, qualifies or conflicts with another provision included in this Indenture that is required
to be included in this Indenture by any of Sections 310 to 317, inclusive of the Trust Indenture Act, such required provision will control. If any provision of this Indenture limits, qualifies or conflicts with the duties imposed by
Section 318(c) of the Trust Indenture Act, the duties imposed by Section 318(c) of the Trust Indenture Act will control. If any provision of this Indenture modifies or excludes any provision of the Trust Indenture Act that may be so
modified or excluded, the provisions of the Trust Indenture Act will be deemed to apply to this Indenture as so modified or will be excluded, as the case may be. 

  
 7 

 Section 1.08 Effect of Headings and Table of Contents. 

The Article and Section headings in this Indenture and the Table of Contents are for convenience only and will not affect the construction of
this Indenture. 
 Section 1.09 Successors and Assigns. 

All the covenants, stipulations, promises and agreements in this Indenture by or on behalf of the Company or the Trustee will bind its
respective successors and permitted assigns, whether so expressed or not. 
 Section 1.10 Severability. 

In case any provision in this Indenture or any Note will be invalid, illegal or unenforceable, the validity, legality and enforceability of the
remaining provisions will not, to the fullest extent permitted by law, in any way be affected or impaired thereby. 
 Section 1.11
Entire Agreement. 
 This Indenture and the exhibits hereto set forth the entire agreement and understanding of the parties related to
this transaction and supersedes all prior agreements and understandings, oral or written. 
 Section 1.12 Benefits of Indenture.

 Nothing in this Indenture or any Note, express or implied, will give to any Person, other than the parties hereto, any Registrar, any
Paying Agent and any of their respective successors hereunder and the Holders of Notes, any benefit or any legal or equitable right, remedy or claim under this Indenture. 

Section 1.13 Governing Law. 

This Indenture and the Notes will be governed by and construed in accordance with the laws of the State of New York applicable to agreements
made or instruments entered into and, in each case, performed in said State (without reference to principles of conflicts of law). 

Section 1.14 Legal Holidays. 

Unless otherwise specified in or under this Indenture or any Notes, in any case where any Interest Payment Date, Stated Maturity or Maturity or
any other day on which a payment is due with respect to any Note will be a day that is not a Business Day at any Place of Payment, then (notwithstanding any other provision of this Indenture or any Note other than a provision in any Note or in the
Board Resolution, Officers’ Certificate or supplemental indenture establishing the terms of any Note that specifically states that such provision will apply in lieu hereof) payment need not be made at such Place of Payment on such date, but
such payment may be made on the next succeeding day that is a Business Day at such Place of Payment with the same force and effect as if made on the Interest Payment Date, at the Stated Maturity or Maturity or on any such other payment date, as the
case may be, and no interest will accrue on the amount payable on such date or at such time for the period from and after such Interest Payment Date, Stated Maturity, Maturity or other payment date, as the case may be, to the next succeeding
Business Day, 
 Section 1.15 Counterparts; Electronic Transmission. 

This Indenture may be executed in several counterparts, each of which will be an original and all of which will constitute but one and the same
instrument. Any facsimile or electronically transmitted copies hereof or signature hereon will, for all purposes, be deemed originals. Unless otherwise provided herein or in any other related document, the words “execute,”
“execution,” “signed” and “signature,” and words of similar import used in or related to any document to be signed in connection with this Indenture, any other related document or any of the transactions contemplated
hereby (including amendments, waivers, consents and other modifications), shall be deemed to include electronic signatures via DocuSign and the keeping of records in electronic form, each of which shall be of the same legal effect, validity or
enforceability as a manually executed signature in ink or the use of a paper-based recordkeeping system, as applicable, to the fullest extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and
National Commerce Act, the New York State Electronic Signatures and Records Act and any other similar state laws based on the Uniform Electronic Transactions Act, provided that, notwithstanding anything herein to the contrary, the Trustee may
conclusively rely upon any such electronic signature, shall in no instance be responsible for determining if any such electronic signature is permitted by applicable law nor be liable for any loss or damages resulting from its reliance upon the same
electronic signature and is not under any obligation to agree to accept electronic signatures in any form or in any format unless expressly agreed to by such Trustee pursuant to procedures approved by the Trustee. 

  
 8 

 Section 1.16 Immunity of Certain Persons. 

No recourse under or upon any obligation, covenant or agreement contained in this Indenture, or in any Note, or because of any indebtedness
evidenced thereby, will be had against any past, present or future shareholder, employee, officer or director, as such, of the Company or of any predecessor or successor, either directly or through the Company or any predecessor or successor, under
any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all such liability being expressly waived and released by the acceptance of the Notes by the Holders
and as part of the consideration for the issue of the Notes. 
 Section 1.17 Waiver of Jury Trial. 

EACH PARTY HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL
PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

Section 1.18 Force Majeure. 

In no event will the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of
or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, epidemics or pandemics, nuclear or natural catastrophes or
acts of God and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee will use reasonable efforts that are consistent with accepted practices in the
banking industry to resume performance as soon as practicable under the circumstances. 
 Section 1.19 USA Patriot Act. 

The Trustee hereby notifies the Company that in accordance with the requirements of the USA Patriot Act, it is required to obtain, verify and
record information that identifies the Company, which information includes the name and address of the Company and other information that will allow the Trustee to identify the Company in accordance with the USA Patriot Act. 

Section 1.20 No Sinking Fund. 

The Notes are not entitled to the benefit of any sinking fund. 

Section 1.21 Rules of Construction. 

Unless the context otherwise requires: 

(1) a term has the meaning assigned to it; 

(2) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(3) “or” is not exclusive; 

(4) words in the singular include the plural, and in the plural include the singular; 

(5) “including” means including without limitation; 

(6) “will” will be interpreted to express a command; 

(7) provisions apply to successive events and transactions; 

(8) references to sections of, or rules under, the Securities Act will be deemed to include substitute, replacement or successor sections or
rules adopted by the Commission from time to time; 
 (9) unless the context otherwise requires, any reference to an “Article,”
“Section” or “clause” refers to an Article, Section or clause, as the case may be, of this Indenture; and 
 (10) the
words “herein,” “hereof” and “hereunder,” and other words of similar import, refer to this Indenture as a whole and not any particular Article, Section, clause or other subdivision. 

  
 9 

 Article II 

THE NOTES 

Section 2.01 Forms Generally. 

The Notes, the Trustee’s certificate of authentication and the Global Notes will be substantially in the form of Exhibit A-l and Exhibit A-2, as applicable, which are a part of this Indenture. The Notes may have notations, legends or endorsements required by law, stock exchange rule
or usage (provided that any such notation, legend or endorsement is in a form acceptable to the Company). The Company will provide any such notations, legends or endorsements to the Trustee in writing. Each Note will be dated the date of its
authentication. The terms and provisions contained in the Notes will constitute, and are hereby expressly made a part of this Indenture and the Company and the Trustee, by their execution and delivery of this Indenture, agree to such terms and
provisions and to be bound thereby. However, to the extent any provision of any Note irreconcilably conflicts with the express provisions of this Indenture, the provisions of this Indenture will govern and be controlling. 

Section 2.02 Definitive Notes. 

The Initial Notes and the Exchange Notes will be issued initially in the form of one or more Definitive Notes, unless, before the issuance of
such Initial Notes or Exchange Notes, the Company has determined that the Notes may be represented by Global Notes and has so notified the Trustee, in which event the Initial Notes and/or Exchange Notes will be issued in the form of one or more
Global Notes. Except as provided in Section 2.07, Holders of Definitive Notes will not be entitled to transfer Definitive Notes in exchange for beneficial interests in Global Notes, and owners of beneficial interests in Global Notes will not be
entitled to receive physical delivery of Definitive Notes. 
 Section 2.03 Global Notes. 

Each Global Note issued under this Indenture will be deposited with the Trustee at its Corporate Trust Office, as custodian for the Depositary,
and registered in the name of the Depositary or the nominee thereof, duly executed by the Company and authenticated by the Trustee as hereinafter provided. The aggregate principal amount of any Global Note may from time to time be increased or
decreased by adjustments made on the records of the Trustee and the Depositary as hereinafter provided. Any adjustment of the aggregate principal amount of a Global Note to reflect the amount of any increase or decrease in the amount of outstanding
Notes represented thereby will be made by the Trustee in accordance with instructions given by the Holder thereof as required by Section 2.07 hereof and will be made on the records of the Trustee and the Depositary. 

Section 2.04 Restricted Notes. 

Each Restricted Definitive Note and Restricted Global Note will bear a legend in substantially the following form: 

THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”) OR UNDER ANY APPLICABLE STATE SECURITIES LAW. THESE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT
OR (B) AN AVAILABLE EXEMPTION FROM, INCLUDING (BUT NOT LIMITED TO) IN ACCORDANCE AND IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, IF REQUESTED, OR (II) UNLESS SOLD IN ACCORDANCE WITH RULE 144 UNDER SAID ACT. 

The Private Placement Legend set forth above will be removed and a new Note of like tenor and principal amount without such Private Placement
Legend will be executed by the Company, and upon written request of the Company (together with an Officers’ Certificate and an Opinion of Counsel), the Trustee will authenticate and deliver such new Note to the respective Holder, if legal
counsel to the Holder or owner of beneficial interests requesting the removal of such Private Placement Legend delivers to the Trustee, any Registrar and Paying Agent (if a different Person than the Trustee) and the Company an opinion of counsel in
compliance with this Indenture and additionally opining that the Note is eligible for immediate resale, without any remaining holding period, under Rule 144 without regard to the requirement for the Company to be in compliance with the current
public information required under Rule 144 as to such securities. 
 Section 2.05 Execution and Authentication. 

Notes will be executed on behalf of the Company by any Authorized Officer and may (but need not) have the Company’s corporate seal or a
facsimile thereof reproduced thereon. The signature of an Authorized Officer on the Notes may be manual or facsimile. Notes bearing the manual or facsimile signatures of individuals who were, at the time of execution, Authorized Officers of the
Company will, to the fullest extent permitted by law, bind the Company, notwithstanding that such individuals or any of them have ceased to hold such offices prior to the authentication and delivery of such Notes or did not hold such offices at the
date of such Notes. 

  
 10 

 The Trustee or an Authenticating Agent will authenticate and deliver the Initial Notes for
original issue in an aggregate principal amount of up to $100,000,000 upon one or more Company Orders and an Opinion of Counsel. In addition, the Trustee or an Authenticating Agent will, upon receipt of a Company Order, Opinion of Counsel and
Officers’ Certificate, authenticate and deliver any Exchange Notes for an aggregate principal amount not to exceed $100,000,000 specified in such Company Order for Exchange Notes issued hereunder. The aggregate principal amount of Outstanding
Notes at any time may not exceed the amount set forth in the foregoing sentence, except as otherwise provided in this Article II. The Notes will be issued only in registered form without coupons and in minimum denominations of $100,000 and any
integral multiple of $1,000 in excess thereof. 
 The Trustee will not be required to authenticate any Notes if the issue of such Notes
under this Indenture will affect the Trustee’s own rights, duties or immunities under the Notes and this Indenture, or otherwise affect the trustee in a manner that is not reasonably acceptable to the Trustee or if the Trustee, being advised by
counsel, determines that such action may not lawfully be taken. 
 No Note will be entitled to any benefit under this Indenture or be valid
or obligatory for any purpose, unless there appears on such Note a certificate of authentication substantially in the form provided for herein executed by or on behalf of the Trustee or by the Authenticating Agent by the manual signature of one of
its authorized signatories. Such certificate upon any Note will be conclusive evidence, and the only evidence, that such Note has been duly authenticated and delivered hereunder. 

Section 2.06 Registrar and Paying Agent. 

The Company will maintain an office or agency where Notes may be presented for registration of transfer or for exchange
(“Registrar”) and an office or agency where Notes may be presented for payment (“Paying Agent”). The Registrar will keep a register of the Notes (“Note Register”) and of their
transfer and exchange. The registered Holder of a Note will be treated as the owner of the Note for all purposes. The Company may appoint one or more co-registrars and one or more additional paying agents. The
term “Registrar” includes any co-registrar, and the term “Paying Agent” includes any additional paying agent. The Company may change any Paying Agent or Registrar without prior notice to
any Holder; provided that no such removal or replacement will be effective until a successor Paying Agent or Registrar will have been appointed by the Company and will have accepted such appointment. The Company will notify the Trustee in writing of
the name and address of any Registrar or Paying Agent not a party to this Indenture. If the Company fails to appoint or maintain another entity as Registrar or Paying Agent, the Trustee will act as such. The Company or any of its Subsidiaries may
act as Paying Agent or Registrar. 
 The Company initially appoints the Trustee to act as the Paying Agent and Registrar for the Notes and,
in the event that any Notes are issued in global form, to initially act as custodian with respect to the Global Notes. In the event that the Trustee will not be or will cease to be Registrar with respect the Notes, it will have the right to examine
the Note Register at all reasonable times. There will be only one Note Register. 
 Section 2.07 Registration of Transfer and
Exchange 
 (1) Except as otherwise provided in or under this Indenture, upon surrender for registration of transfer of any Note, the
Company will execute, and the Trustee will authenticate and deliver, in the name of the designated transferee or transferees, one or more new Notes denominated as authorized in or under this Indenture of a like aggregate principal amount bearing a
number not contemporaneously outstanding and containing identical terms and provisions. 
 Except as otherwise provided in or under this
Indenture, at the option of the Holder, Notes may be exchanged for other Notes containing identical terms and provisions, in any authorized denominations (minimum denominations of $100,000 and any integral multiple of $1,000 in excess thereof) and
of a like aggregate principal amount, upon surrender of the Notes to be exchanged at any office or agency for such purpose. Whenever any Notes are so surrendered for exchange, the Company will execute, and the Trustee will authenticate and deliver,
subject to the terms hereof, the Notes that the Holder making the exchange is entitled to receive. 
 All Notes issued upon any registration
of transfer or exchange of Notes will be the valid obligations of the Company evidencing the same debt and entitling the Holders thereof to the same benefits under this Indenture as the Notes surrendered upon such registration of transfer or
exchange. 
 Every Note presented or surrendered for registration of transfer or for exchange or redemption will (if so required by the
Company or the Registrar for such Note) be duly endorsed, or be accompanied by a written instrument of transfer in a form satisfactory to the Company and the Registrar for such Note duly executed by the Holder thereof or his attorney duly authorized
in writing. 

  
 11 

 No service charge will be made for any registration of transfer or exchange of Notes, any
redemption or repayment of Notes or any conversion or exchange of Notes for other types of securities or property, but the Company may require payment of a sum sufficient to pay all taxes, assessments or other governmental charges that may be
imposed in connection with the transfer or exchange of the Notes from the Holder requesting such transfer or exchange. 
 Except as
otherwise provided in or under this Indenture, the Company will not be required to (i) issue, register the transfer of or exchange any Notes during a period beginning at the opening of business 15 days before the day of the selection for
redemption of Notes under Section 10.03 and ending at the close of business on the day of such selection, or (ii) register the transfer of or exchange any Note, or portion thereof, so selected for redemption, except in the case of any Note
to be redeemed in part, the portion thereof not to be redeemed. 
 Any Registrar appointed in accordance with Section 2.06 hereof will
provide to the Trustee such information as the Trustee may reasonably require in connection with the delivery by such Registrar of Notes upon transfer or exchange of Notes. No Registrar will be required to make registrations of transfer or exchange
of Notes during any periods designated in the Notes or in this Indenture as periods during which such registration of transfers and exchanges need not be made. 

The Trustee will have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under
this Indenture or under applicable law with respect to any transfer of any interest in any Note (including any transfers between or among Depositary participants or beneficial owners of interests in any Global Note) other than to require delivery of
such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to determine substantial compliance as to form with the express
requirements hereof. 
 Neither the Trustee nor any Paying Agent will have any responsibility for any actions taken or not taken by the
Depositary. 
 (2) When Definitive Notes are presented by a Holder to the Registrar with a request to register the transfer of such
Definitive Notes or to exchange such Definitive Notes for an equal principal amount of Definitive Notes of other authorized denominations, the Registrar will register the transfer or make the exchange as requested if its reasonable requirements for
such transaction are met; provided, however, that the Definitive Notes surrendered for transfer or exchange will be duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Company and the Registrar,
duly executed by the Holder thereof or such Holder’s attorney duly authorized in writing. 
 (3) A Global Note may not be transferred
except by the Depositary to a nominee of the Depositary, by a nominee of the Depositary to the Depositary or to another nominee of the Depositary, or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor
Depositary. All Global Notes will be exchanged by the Company for Definitive Notes if: (i) the Depositary has notified the Company that it is unwilling or unable to continue as Depositary for such Global Note or such Depositary has ceased to be
a “clearing agency” registered under the Exchange Act, and a successor depositary is not appointed by the Company within 90 days, (ii) the Company determines that the Notes are no longer to be represented by Global Notes and so
notifies the Trustee or (iii) an Event of Default has occurred and is continuing with respect to the Notes and the Depositary or its participant(s) has requested the issuance of Definitive Notes. Any Global Note exchanged in accordance with
clause (i) or (ii) above will be so exchanged in whole and not in part, and any Global Note exchanged in accordance with clause (iii) above may be exchanged in whole or from time to time in part as directed by the Depositary. Upon the
occurrence of any of the events in (i), (ii) or (iii) above, Definitive Notes will be issued in fully registered form, without interest coupons, will have an aggregate Principal Amount equal to that of the Global Note or portion thereof to be
so exchanged, will be registered in such names and be in such authorized denominations as the Depositary will instruct the Trustee in writing and will bear such legends as provided herein. Global Notes also may be exchanged or replaced, in whole or
in part, as provided in Section 2.09 hereof. Every Note authenticated and delivered in exchange for, or in lieu of, a Global Note or any portion thereof, in accordance with this Section 2.07 or Section 2.09 hereof, will be
authenticated and delivered in the form of, and will be, a Global Note, except as otherwise provided herein. A Global Note may not be exchanged for another Note other than as provided in this Section 2.07(3); however, beneficial interests in a
Global Note may be transferred and exchanged as provided in Section 2.07(4) hereof. 
 Any Global Note to be exchanged in whole will be
surrendered by the Depositary to the Trustee. With regard to any Global Note to be exchanged in part, either such Global Note will be so surrendered for exchange or, if the Trustee is acting as custodian for the Depositary or its nominee with
respect to such Global Note, the principal amount thereof will be reduced by an amount equal to the portion thereof to be so exchanged by means of an appropriate adjustment made on the records of the Trustee. Upon any such surrender or adjustment,
the Trustee will authenticate and deliver the Note issuable on such exchange to or upon the order of the Depositary or an authorized representative thereof. 

(4) The transfer and exchange of beneficial interests in the Global Notes will be effected through the Depositary in accordance with the
Applicable Procedures and this Section 2.07. 

  
 12 

 (5) A Definitive Note may not be exchanged for a beneficial interest in a Global Note unless
the Company determines that the Notes may be represented by Global Notes and so notifies the Trustee. After the Company has determined that the Notes may be represented by Global Notes and so notifies the Trustee, then upon receipt by the Trustee of
a Definitive Note duly endorsed or accompanied by appropriate instruments of transfer in form satisfactory to the Trustee, together with written instructions from such Holder directing the Trustee to make, or to direct the Registrar to make, an
adjustment on its books and records with respect to such Global Note to reflect an increase in the aggregate principal amount of the Notes represented by the Global Note, such instructions to contain information regarding the Depositary account to
be credited with such increase, the Trustee will cancel such Definitive Note and cause, or direct the Registrar to cause, in accordance with the standing instructions and procedures existing between the Depositary and the Registrar, the aggregate
principal amount of Notes represented by the Global Note to be increased by the aggregate principal amount of the Definitive Note to be exchanged, and will credit or cause to be credited to the account of the Person specified in such instructions a
beneficial interest in the Global Note equal to the principal amount of the Definitive Note so cancelled. If no Global Notes are then outstanding, the Company will issue and the Trustee will authenticate, upon Company Order, a new Global Note in the
appropriate principal amount. 
 (6) At such time as all beneficial interests in a particular Global Note have been exchanged for Definitive
Notes or a particular Global Note has been repurchased or canceled in whole and not in part, each such Global Note will be returned to or retained and canceled by the Trustee in accordance with Section 2.12 hereof. At any time prior to such
cancellation, if any beneficial interest in a Global Note is exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Note or for Definitive Notes, the principal amount of Notes
represented by such Global Note will be reduced accordingly by adjustments made on the records of the Trustee to reflect such reduction; and if the beneficial interest is being exchanged for or transferred to a Person who will take delivery thereof
in the form of a beneficial interest in another Global Note, such other Global Note will be increased accordingly by adjustments made on the records of the Trustee to reflect such increase. 

(7) No Restricted Note will be transferred or exchanged except in compliance with the Private Placement Legend or as provided in accordance
with Section 2.08. In addition to the provisions for transfer and exchange set forth in this Section 2.07, the Trustee, any Registrar and Paying Agent (if a different Person than the Trustee) and the Company may, prior to effecting any
requested transfer or exchange of any Restricted Notes, other than an exchange in accordance with Section 2.08, require that legal counsel to the Holder or owner of beneficial interests requesting such transfer or exchange deliver to the
Trustee, any Registrar and Paying Agent (if a different Person than the Trustee) and the Company an Opinion of Counsel in compliance with this Indenture and additionally opining that the transfer or exchange is in compliance with the requirements of
the Private Placement Legend and that the Note issued to the transferee or in exchange for the Restricted Note may be issued free of the Private Placement Legend. Any un-transferred or un-exchanged balance of a Restricted Note will be reissued to the Holder with the Private Placement Legend unless the Private Placement Legend may be omitted in accordance with Section 2.04, as evidenced by the
Opinion of Counsel. 
 Section 2.08 Exchange Offer. 

Upon the occurrence of an Exchange Offer in accordance with the Registration Rights Agreement, the Company will issue, and upon receipt of a
Company Order in accordance with Section 2.05 hereof, the Trustee will authenticate, (i) Unrestricted Definitive Notes in an aggregate principal amount equal to the principal amount of the Restricted Definitive Notes tendered in such
Exchange Offer for acceptance by Persons that certify in the applicable Letters of Transmittal that (x) they are not Participating Broker-Dealers, (y) they are not participating in a distribution of the applicable Exchange Notes and
(z) they are not Affiliates of the Company, and accepted for exchange in such Exchange Offer or, if permitted by the Company, (ii) one or more Unrestricted Global Notes in an aggregate principal amount equal to the principal amount of the
beneficial interests in the Restricted Global Notes tendered in such Exchange Offer for acceptance by Persons that certify in the applicable Letters of Transmittal that (x) they are not Participating Broker-Dealers, (y) they are not
participating in a distribution of the applicable Exchange Notes and (z) they are not Affiliates of the Company, and accepted for exchange in such Exchange Offer. Concurrently with the issuance of such Unrestricted Global Notes upon exchange of
Restricted Global Notes, the Trustee will cause the aggregate principal amount of the applicable Restricted Global Notes to be reduced accordingly, and the Company will execute and the Trustee will authenticate and deliver to the Persons designated
the Holders of Restricted Definitive Notes so accepted Unrestricted Definitive Notes in the applicable principal amount. Any Notes that remain outstanding after the consummation of such Exchange Offer, and Exchange Notes issued in connection with
such Exchange Offer, will be treated as a single class of securities under this Indenture. For the avoidance of doubt, the only remedy for breach of registration rights by the Company is the Additional Interest set forth in Section 2(e) of the
Registration Rights Agreement. 
 Section 2.09 Mutilated, Destroyed, Lost and Stolen Notes. 

If any mutilated Note is surrendered to the Trustee, subject to the provisions of this Section 2.09, the Company will execute and the
Trustee will authenticate and deliver in exchange therefor a new Note containing identical terms, of like principal amount and bearing a number not contemporaneously outstanding. 

  
 13 

 If there be delivered to the Company and to the Trustee (i) evidence to their
satisfaction of the destruction, loss or theft of any Note and (ii) such security or indemnity as may be required by them to save each of them and any agent of either of them harmless, then, in the absence of notice to the Company or the
Trustee that such Note has been acquired by a bona fide purchaser, the Company will execute, and upon the Company’s request, the Trustee will authenticate and deliver, in exchange for or in lieu of any such destroyed, lost or stolen Note, a new
Note containing identical terms, of like principal amount and bearing a number not contemporaneously outstanding. 
 Notwithstanding the
foregoing provisions of this Section 2.09, in case the outstanding principal balance of any mutilated, destroyed, lost or stolen Note has become or is about to become due and payable, or is about to be redeemed by the Company pursuant to
Article X hereof, the Company in its discretion may, instead of issuing a new Note, pay or redeem such Note, as the case may be. 
 Upon the
issuance of any new Note under this Section, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the
Trustee) connected therewith. 
 Every new Note issued in accordance with this Section in lieu of any destroyed, lost or stolen Note will
constitute a separate obligation of the Company, whether or not the destroyed, lost or stolen Note will be at any time enforceable by anyone, and will be entitled to all the benefits of this Indenture equally and proportionately with any and all
other Notes duly issued hereunder. 
 The provisions of this Section, as amended or supplemented in accordance with this Indenture with
respect to particular Notes or generally, will (to the extent lawful) be exclusive and will (to the extent lawful) preclude all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Notes. 

Section 2.10 Payment of Interest; Rights to Interest Preserved. 

Any interest on any Note that will be payable and punctually paid or duly provided for on any Interest Payment Date will be paid to the Person
in whose name such Note is registered as of the close of business on the Regular Record Date for such Interest Payment Date. 
 Any interest
on any Note that will be payable, but will not be punctually paid or duly provided for, on any Interest Payment Date for such Note (herein called “Defaulted Interest”) will cease to be payable to the Holder thereof on the
relevant Regular Record Date by virtue of having been such Holder; and such Defaulted Interest may be paid by the Company, at its election in each case, as provided in either clause (1) or (2) below: 

(1) The Company may elect to make payment of any Defaulted Interest to the Person in whose name such Note will be registered at the close of
business on a Special Record Date for the payment of such Defaulted Interest, which will be fixed in the following manner. The Company will notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on such Note and the
date of the proposed payment, and at the same time the Company will deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or will make arrangements satisfactory to the
Trustee for such deposit on or prior to the date of the proposed payment, such money when so deposited to be held in trust for the benefit of the Person entitled to such Defaulted Interest as in this clause provided. Thereupon, the Company will fix
or cause to be fixed a Special Record Date for the payment of such Defaulted Interest, which will be no less than 15 days from the proposed payment. The Company (or, upon the written request of the Company, the Trustee in the name and at the expense
of the Company) will cause notice of the proposed payment of such Defaulted Interest and the Special Record Date therefor to be delivered to the Holder of such Note at the Holder’s address as it appears in the Note Register not less than 10
days prior to such Special Record Date. The Company may, at its discretion, in the name and at the expense of the Company, cause a similar notice to be published at least once in an Authorized Newspaper of general circulation in the City of New
York, New York, but such publication will not be a condition precedent to the establishment of such Special Record Date. Notice of the proposed payment of such Defaulted Interest and the Special Record Date therefor having been delivered as
aforesaid, such Defaulted Interest will be paid to the Person in whose name such Note will be registered at the close of business on such Special Record Date. 

(2) The Company may make payment of any Defaulted Interest in any other lawful manner not inconsistent with the requirements of any securities
exchange on which such Note may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the Trustee of the proposed payment under this Clause, such payment will be deemed practicable by the
Trustee. 
 Unless otherwise provided in or under this Indenture or the Notes, at the option of the Company, interest on Notes that bear
interest may be paid by mailing a check to the address of the Person entitled thereto as such address will appear in the Note Register or by transfer to an account maintained by the payee with a bank located in the United States. 

  
 14 

 Subject to the foregoing provisions of this Section 2.10 and Section 2.07, each
Note delivered under this Indenture upon registration of transfer of or in exchange for or in lieu of any other Note will carry the rights to interest accrued and unpaid, and to accrue, which were carried by such other Note. 

Section 2.11 Persons Deemed Owners. 

Prior to due presentment of a Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat
the Person in whose name such Note is registered in the Note Register as the owner of such Note for the purpose of receiving payment of principal of and (subject to Section 2.07 and Section 2.10) interest on such Note and for all other
purposes whatsoever, whether or not any payment with respect to such Note will be overdue, and neither the Company, the Trustee or any agent of the Company or the Trustee will be affected by notice to the contrary. 

No holder of any beneficial interest in any Global Note held on its behalf by a Depositary will have any rights under this Indenture with
respect to such Global Note, and such Depositary may be treated by the Company, the Trustee, and any agent of the Company or the Trustee as the owner of such Global Note for all purposes whatsoever. None of the Company, the Trustee, any Paying Agent
or the Registrar will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests of a Global Note or for maintaining, supervising or reviewing any records relating to
such beneficial ownership interests. 
 Notwithstanding the foregoing, nothing herein will prevent the Company, the Trustee, any Paying
Agent or the Registrar from giving effect to any written certification, proxy or other authorization furnished by the applicable Depositary, as a Holder, with respect to a Global Note or impair, as between such Depositary and the owners of
beneficial interests in such Global Note, the operation of customary practices governing the exercise of the rights of such Depositary (or its nominee) as the Holder of such Global Note. 

Section 2.12 Cancellation. 

All Notes surrendered for payment, redemption, registration of transfer or exchange will, if surrendered to any Person other than the Trustee,
be delivered to the Trustee, and any such Note, as well as Notes surrendered directly to the Trustee for any such purpose, will be cancelled promptly by the Trustee. The Company may at any time deliver to the Trustee for cancellation any Notes
previously authenticated and delivered hereunder which the Company may have acquired in any manner whatsoever, and all Notes so delivered will be cancelled promptly by the Trustee. No Notes will be authenticated in lieu of or in exchange for any
Notes cancelled as provided in this Section, except as expressly permitted by or under this Indenture. All cancelled Notes held by the Trustee will be disposed of in accordance with its procedure for the disposition of cancelled Notes, and the
Trustee, upon the written request of the Company, will deliver to the Company a certificate of such disposition, unless by a Company Order the Company shall direct that cancelled Notes shall be returned to the Company. 

Section 2.13 Computation of Interest. 

Interest will be computed from and including the original issue date of the Notes to but excluding November 30, 2026, or the earlier
redemption date contemplated by Article X of this Indenture, at the rate of 5.625% per annum (subject to adjustment in accordance with Section 2.14 hereof), computed on the basis of a 360-day year
consisting of 12 30-day months and payable semi-annually in arrears on each Interest Payment Date. Dollar amounts resulting from this calculation shall be rounded to the nearest cent, with one-half cent being rounded up. 
 In the event that any Interest Payment Date falls on a day that is not
a Business Day (as defined for purposes of this Section 2.13 and the Notes below), the interest payment due on that date shall be postponed to the next day that is a Business Day and no additional interest shall accrue as a result of that
postponement. The term “Business Day” as used in this Section 2.13 and in the Notes means any day other than Saturday, Sunday or any other day on which banking institutions in the State of New York are generally authorized or required
by law or executive order to be closed. 
 Section 2.14 Interest Rate Adjustment. 

From and after the original issue date of the Notes, in the event the Notes are downgraded by the Ratings Agency below A- but equal to or above BBB-, the rate of interest on the Notes shall increase by 0.50% to 6.125%. If the rating is subsequently increased back to A- or higher, the rate of interest will decrease by 0.50% to 5.625%. If the rating is further downgraded to BB+ or lower, the rate of interest will increase by another 0.50% to 6.625%. If the rating is subsequently
improved back to BBB- or higher, the rate of interest will decrease by 0.50% to 6.125%. Each adjustment required by any event described in this Section 2.14 will take effect from the first Interest Payment Date following the date on which the
Company receives notice that such event has occurred. As such, interest will not accrue at such increased or decreased rate until the next Interest Payment Date following the date on which the event occurs. If the Ratings Agency changes its rating
of the Notes more than once prior to any particular Interest Payment Date or ceases to provide a rating of the Notes, the last change by Ratings Agency prior to such Interest Payment Date 

  
 15 

 
will control for purposes of any interest rate increase or decrease with respect to the Notes described in this Section 2.14 relating to Ratings Agency’s action. The Company shall
promptly thereafter provide the holders of the Notes with notice of any such change in the rating of the Notes. If the interest rate payable on the Notes is increased or decreased as described above, the term “interest,” as used with
respect to the Notes, will be deemed to include any such additional or lesser interest unless the context otherwise requires. For the avoidance of doubt, no interest rate increase or decrease described in this Section 2.14 will have any effect
on interest that will have accrued on the Notes prior to such date or have any other retroactive effect. 
 Section 2.15 CUSIP
Numbers. 
 The Company may issue the Notes with one or more “CUSIP” numbers (if then generally in use). The Company will
promptly notify the Trustee of any change in the “CUSIP” numbers. The Trustee may use “CUSIP” numbers in notices (including, but not limited to, notices of redemption or exchange) as a convenience to Holders; provided that any
such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice (including any notice of redemption or exchange) and that reliance may be placed only on the
other identification numbers printed on the Notes, and any such notice will not be affected by any defect in or omission of such numbers. 

Article III 
 SATISFACTION AND
DISCHARGE OF INDENTURE 
 Section 3.01 Satisfaction and Discharge. 

This Indenture will cease to be of further effect, and the Trustee, on receipt of a Company Order, at the expense of the Company, will execute
proper instruments acknowledging satisfaction and discharge of this Indenture when: 
 (1) either 

(a) all Notes theretofore authenticated and delivered (other than (i) Notes that have been destroyed, lost or stolen and which have been
replaced or paid as provided in Section 2.09 and (ii) Notes for whose payment money has theretofore been deposited in trust or segregated and held in trust by the Company and thereafter repaid to the Company or discharged from such trust,
as provided in Section 9.03) have been delivered to the Trustee for cancellation; or 
 (b) all Notes that have not been delivered to
the Trustee for cancellation (i) have become due and payable, (ii) will become due and payable at their Stated Maturity within one year, or (iii) if redeemable at the option of the Company, are to be called for redemption within one
year under arrangements satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Company, and the Company, in the case of (i), (ii) or (iii) above, has deposited or caused to be
deposited with the Trustee as trust funds in trust for such purpose, an amount sufficient to pay and discharge the entire indebtedness on such Notes not theretofore delivered to the Trustee for cancellation, including the principal of, and interest
on, such Notes, to the date of such deposit (in the case of Notes which have become due and payable) or to the Maturity thereof, as the case may be; 

(2) the Company has paid or caused to be paid all other sums payable hereunder by the Company with respect to the Outstanding Notes; and 

(3) the Company has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions
precedent herein provided for relating to the satisfaction and discharge of this Indenture have been satisfied. 
 Notwithstanding the
satisfaction and discharge of this Indenture with respect to the Notes, the obligations of the Company to the Trustee under Section 5.07 and, if money will have been deposited with the Trustee in accordance with Section 3.01(1)(b), the
obligations of the Company and the Trustee with respect to the Notes under Section 3.03 and Section 9.03, will survive. 

Section 3.02 Defeasance and Covenant Defeasance. 

(1) The Company may, at its option and at any time, elect to have Section 3.02(2) or Section 3.02(3) be applied to such Outstanding
Notes upon compliance with the conditions set forth below in this Section 3.02. Legal Defeasance and Covenant Defeasance may be effected only with respect to all, and not less than all, of the Outstanding Notes. 

(2) Upon the Company’s exercise of the above option applicable to this Section 3.02(2), the Company will be deemed to have been
discharged from its obligations with respect to such Outstanding Notes on the date the conditions set forth in clause (4) of this Section 3.02 are satisfied (“Legal Defeasance”). For this purpose, Legal Defeasance
means that the Company will be deemed to have paid and discharged the entire indebtedness represented by such Outstanding Notes, which will thereafter be deemed to be “Outstanding” only for the purposes of Section 3.02(5) and the
other Sections of this Indenture referred to in clauses (i) through (iv) of this paragraph, and to have satisfied all of its other obligations under such Notes and this Indenture insofar as such Notes are concerned (and the Trustee, at the
expense of the Company, will execute proper instruments 

  
 16 

 
acknowledging the same), except for the following, which will survive until otherwise terminated or discharged hereunder: (i) the rights of Holders of such Outstanding Notes to receive,
solely from the trust fund described in Section 3.02(4)(a) and as more fully set forth in this Section 3.02 and Section 3.03, payments in respect of the principal of and interest, if any, on such Notes when such payments are due,
(ii) the obligations of the Company and the Trustee with respect to such Notes under Section 2.07, Section 2.09, Section 9.02 and Section 9.03, (iii) the rights, powers, trusts, duties and immunities of the Trustee hereunder
and (iv) this Section 3.02 and Section 3.03. The Company may exercise its option under this Section 3.02(2) notwithstanding the prior exercise of its option under Section 3.02(3) with respect to such Notes. 

(3) Upon the Company’s exercise of the above option applicable to this Section 3.02(3), the Company will be released from its
obligations under clauses (ii) and (iii) of Section 9.04 and under Section 9.05, Section 9.06 and Section 9.07 on and after the date the conditions set forth in Section 3.02(4) are satisfied (“Covenant
Defeasance”), and such Notes will thereafter be deemed to be not “Outstanding” for the purposes of any direction, waiver, consent, declaration or Act of Holders (and the consequences of any thereof) in connection with any such
covenant, but will continue to be deemed “Outstanding” for all other purposes hereunder. For this purpose, such Covenant Defeasance means that with respect to such Outstanding Notes, the Company may omit to comply with, and will have no
liability in respect of, any term, condition or limitation set forth in any such Section or any such other covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such Section or such other covenant or by reason
of reference in any such Section or such other covenant to any other provision herein or in any other document, and such omission to comply will not constitute a default, but, except as specified above, the remainder of this Indenture and such Notes
will be unaffected thereby.
 (4) The following will be the conditions to application of Section 3.02(2) or Section 3.02(3) to any
Outstanding Notes: 
 (a) The Company will irrevocably have deposited or caused to be deposited with the Trustee (or another trustee
satisfying the requirements of Section 5.08 who will agree to comply with the provisions of this Section 3.02 applicable to it) trust funds in trust for the purpose of making the following payments, specifically pledged as security for,
and dedicated solely to, the benefit of the Holders: (i) an amount in Dollars, (ii) Government Obligations that through the scheduled payment of principal and interest in respect thereof in accordance with their terms will provide, not
later than one day before the due date of any payment of principal of and interest, if any, on such Notes, money or (iii) a combination thereof, in any case, in an amount sufficient without consideration of any reinvestment of such principal
and interest, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge, and which will be applied by the Trustee (or other qualifying
trustee) to pay and discharge, the principal of and interest, if any, on such Outstanding Notes on the Stated Maturity of such principal or installment of principal or interest or the applicable Redemption Date, as the case may be. 

(b) Such Legal Defeasance or Covenant Defeasance will not result in a breach or violation of, or constitute a default under, this Indenture or
any other material agreement or instrument to which the Company or any Subsidiary is a party or by which it is bound. 
 (c) No Event of
Default or event which, with notice or lapse of time or both, would become an Event of Default with respect to such Notes, will have occurred and be continuing on the date of such deposit, and, solely in the case of Legal Defeasance under
Section 3.02(2), no Event of Default, or event which, with notice or lapse of time or both, would become an Event of Default, under Section 4.01 will have occurred and be continuing at any time during the period ending on and including the
91st day after the date of such deposit (it being understood that this condition to Legal Defeasance under Section 3.02(2) will not be deemed satisfied until the expiration of such period). 

(d) In the case of Legal Defeasance, the Company will have delivered to the Trustee an Opinion of Counsel reasonably acceptable to the
Trustee, stating that (i) an Internal Revenue Service ruling has been received by the Company or has been published or (ii) since the date of this Indenture there has been a change in applicable federal income tax law, in either case to
the effect that, and based thereon such opinion of independent counsel will confirm that, the Holders of such Outstanding Notes will not recognize income, gain or loss for federal income tax purposes as a result of such Legal Defeasance and will be
subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred. 

(e) In the case of Covenant Defeasance, the Company will have delivered to the Trustee an Opinion of Counsel reasonably acceptable to the
Trustee to the effect that the Holders of such Outstanding Notes will not recognize income, gain or loss for federal income tax purposes as a result of such Covenant Defeasance and will be subject to federal income tax on the same amounts, in the
same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred. 

  
 17 

 (f) The Company will have delivered to the Trustee an Officers’ Certificate and an
Opinion of Counsel, each stating that all conditions precedent to the Legal Defeasance or Covenant Defeasance, as the case may be, under this Indenture have been satisfied. 

(g) If the moneys or Government Obligations or combination thereof, as the case may be, deposited under Section 3.02(4)(a) above are
sufficient to pay the principal of, and interest, if any, on such Notes, provided such Notes are redeemed on a particular Redemption Date, the Company will have given the Trustee irrevocable instructions to redeem such Notes on such date and to
provide notice of such redemption to Holders as provided in or under this Indenture. 
 (h) The Trustee will have received such other
documents, assurances and Opinions of Counsel as the Trustee will have reasonably required. 
 (5) Subject to the provisions of the last
paragraph of Section 9.03, all money and Government Obligations deposited with the Trustee (or other qualifying trustee, collectively for purposes of this Section 3.02(5), the “Trustee”) in accordance with
Section 3.02(4)(a) in respect of any Outstanding Notes will be held in trust and applied by the Trustee in accordance with the provisions of such Notes and this Indenture, to the payment, either directly or through any Paying Agent (other than
the Company or any Subsidiary or Affiliate of the Company acting as Paying Agent) as the Trustee may determine, to the Holders of all sums due and to become due thereon in respect of principal and interest, but such money and Government Obligations
need not be segregated from other funds, except to the extent required by law. 
 The Company will pay and indemnify the Trustee against any
tax, fee or other charge imposed on or assessed against the Government Obligations deposited in accordance with this Section 3.02 or the principal or interest received in respect thereof other than any such tax, fee or other charge which by law
is for the account of the Holders of the Outstanding Notes. 
 Section 3.03 Application of Trust Money. 

Subject to the provisions of the last paragraph of Section 9.03, all money and Government Obligations deposited with the Trustee in
accordance with Section 3.01 or Section 3.02 will be held in trust and applied by the Trustee in accordance with the provisions of such Notes subject to discharge under Section 3.01 or Legal Defeasance or Covenant Defeasance under
Section 3.02 and this Indenture, to the payment, either directly or through any Paying Agent (including the Company, acting as its own Paying Agent) as the Trustee may determine, to the Persons entitled thereto, of the principal and interest
for whose payment such money has or Government Obligations have been deposited with or received by the Trustee; but such money and Government Obligations need not be segregated from other funds, except to the extent required by law. 

Section 3.04 Reinstatement. 

If the Trustee (or other qualifying trustee appointed in accordance with Section 3.02(4)(a)) or any Paying Agent is unable to apply any
moneys or Government Obligations deposited in accordance with Section 3.01(1) or Section 3.02(4)(a) to pay any principal of, or interest, if any, on the Notes, by reason of any legal proceeding or any order or judgment of any court or
governmental authority enjoining, restraining or otherwise prohibiting such application, then the Company’s obligations under this Indenture and the Notes will be revived and reinstated as though no such deposit had occurred, until such time as
the Trustee (or other qualifying trustee) or Paying Agent is permitted to apply all such moneys and Government Obligations to pay the principal of, and interest, if any, on the Notes as contemplated by Section 3.01 or Section 3.02 as the
case may be; provided, however, that if the Company makes any payment of the principal of, or interest, if any, on the Notes following the reinstatement of its obligations as aforesaid, the Company will be subrogated to the rights of the Holders of
such Notes to receive such payment from the funds held by the Trustee (or other qualifying trustee) or Paying Agent. 
 Article IV 

REMEDIES 

Section 4.01 Events of Default; Acceleration. 

An “Event of Default” means any one of the following events (whatever the reason for such Event of Default and whether
it will be voluntary or involuntary or be effected by operation of law or in accordance with any judgment, decree, or order of any court or any order, rule or regulation of any administrative or governmental body): 

(1) the entry of a decree or order for relief in respect of the Company by a court having jurisdiction in the premises in an involuntary case
or proceeding under any applicable bankruptcy, insolvency or reorganization law, now or hereafter in effect of the United States or any political subdivision thereof, and such decree or order will have continued unstayed and in effect for a period
of 60 consecutive days; 

  
 18 

 (2) the commencement by the Company of a voluntary case under any applicable bankruptcy,
insolvency or reorganization law, now or hereafter in effect of the United States or any political subdivision thereof, or the consent by the Company to the entry of a decree or order for relief in an involuntary case or proceeding under any such
law; 
 (3) the failure of the Company to pay any installment of interest on any of the Notes as and when the same will become due and
payable, and the continuation of such failure for a period of 30 days; 
 (4) the failure of the Company to pay all or any part of the
principal of any of the Notes as and when the same will become due and payable under this Indenture; 
 (5) the failure of the Company to
perform any other covenant in Section 9.01, Section 9.02, Section 9.03, Section 9.04(1), (2) or (3) or Section 9.06 and the continuation of such failure for a period of 90 days after the date on which notice specifying
such failure, stating that such notice is a “Notice of Default” hereunder and demanding that the Company remedy the same, will have been given, in the manner set forth in Section 10.05, to the Company by the Trustee, or to the Company
and the Trustee by the Holders of at least 30% in aggregate principal amount of the Notes at the time Outstanding; or 
 (6) the default by
the Company under any bond, debenture, note or other evidence of indebtedness for money borrowed by the Company having an aggregate principal amount outstanding of at least $20,000,000, whether such indebtedness now exists or is created or incurred
in the future, which default (i) constitutes a failure to pay any portion of the principal of such indebtedness when due and payable after the expiration of any applicable grace period or (ii) results in such indebtedness becoming due or
being declared due and payable prior to the date on which it otherwise would have become due and payable without, in the case of clause (i), such indebtedness having been discharged or, in the case of clause (ii), without such indebtedness having
been discharged or such acceleration having been rescinded or annulled. 
 Upon becoming aware of any Event of Default, the Company will
promptly deliver to the Trustee a written statement specifying the Event of Default. 
 If an Event of Default described in
Section 4.01(1) or Section 4.01(2) occurs, then the principal amount of all of the Outstanding Notes and accrued and unpaid interest, if any, on all Outstanding Notes will become and be immediately due and payable without any declaration
or other act on the part of the Trustee or any Holder, and the Company waives demand, presentment for payment, notice of nonpayment, notice of protest and all other notices with respect to such Event of Default. If any Event of Default occurs and is
continuing, the Trustee may also pursue any other available remedy to collect the payment of principal of and interest on the Notes, or to enforce the performance of any provision of the Notes or this Indenture. 

Section 4.02 Failure to Make Payments. 

If an Event of Default described in Section 4.01(3) or Section 4.01(4) occurs, the Company will, upon demand of the Trustee, pay to
the Trustee, for the benefit of the Holders of such Notes, the whole amount then due and payable with respect to such Notes, with interest upon the overdue principal, and, to the extent permitted by applicable law, upon any overdue installments of
interest at the rate or respective rates, as the case may be, provided for or with respect to such Notes or, if no such rate or rates are so provided, at the rate or respective rates, as the case may be, of interest borne by such Notes, and, in
addition thereto, such further amount of money as will be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel and all other
amounts due to the Trustee under Section 5.07. 
 If the Company fails to pay the money it is required to pay the Trustee, the Trustee,
in its own name and as trustee of an express trust, may institute a judicial proceeding for the collection of the sums so due and unpaid, may prosecute such proceeding to judgment or final decree and may enforce the same against the Company or any
other obligor upon such Notes and collect the moneys adjudged or decreed to be payable in the manner provided by law out of the property of the Company, wherever situated. 

The Trustee may proceed to protect and enforce its rights and the rights of the Holders of Notes by such appropriate judicial proceedings as
the Trustee will deem most effectual to protect and enforce any such rights, whether for the specific enforcement of any covenant or agreement in this Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce any
other proper remedy. 
 Upon an Event of Default, the Company may not declare or pay any dividends or distributions on, or redeem, purchase,
acquire or make a liquidation payment with respect to, any of the Company’s capital stock, other than: (i) any dividends or distributions in shares of, or options, warrants or rights to subscribe for or purchase shares of, any class of
Company’s common stock; (ii) any declaration of a dividend in connection with the implementation of a shareholders’ rights plan, the issuance of stock under any such plan in the future or the redemption or repurchase of any such
rights pursuant thereto; (iii) as a result of a reclassification of Company’s capital stock or the exchange or conversion of one class or series of Company’s capital stock for another class or series of Company’s capital stock;
(iv) the purchase of fractional interests in shares of Company’s capital stock in accordance with the conversion or exchange provisions of such capital stock or the security being converted or exchanged; or (v) purchases of any class
of Company’s common stock related to the issuance of common stock or rights under any benefit plans for Company’s directors, officers or employees or any of Company’s dividend reinvestment plans. 

  
 19 

 Section 4.03 Trustee May File Proofs of Claim. 

In case of any judicial proceeding relative to the Company (or any other obligor upon the Notes), its property or its creditors, the Trustee
will be entitled and empowered, by intervention in such proceeding or otherwise, to take any and all actions authorized under the Trust Indenture Act in order to have claims of the Holders and the Trustee allowed in any such proceeding. In
particular, the Trustee will be authorized to: 
 (1) file and prove a claim for the whole amount, or such lesser amount as may be provided
for in the Notes, of the principal and interest owing and unpaid in respect of such Notes and to file such other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable
compensation, expenses, disbursements and advances of the Trustee, its agents or counsel) and of the Holders of such Notes allowed in such judicial proceeding, and 

(2) collect and receive any moneys or other property payable or deliverable on any such claims and to distribute the same; 

and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is authorized by each
Holder to make such payments to the Trustee and, in the event that the Trustee will consent to the making of such payments directly to the Holders and to pay to the Trustee any amount due it for the reasonable compensation, expenses, disbursements,
and advances of the Trustee, its agents and counsel, and any other amounts due hereunder. 
 No provision of this Indenture will be deemed
to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Notes or the rights of any Holder or to authorize the Trustee to vote in
respect of the claim of any Holder in any such proceeding; provided, however, the Trustee may vote on behalf of the Holders for the election of a trustee in bankruptcy or similar official and may be a member of a creditor or other similar committee.

 Section 4.04 Trustee May Enforce Claims Without Possession of Notes. 

All rights of action and claims under this Indenture or the Notes may be prosecuted and enforced by the Trustee without the possession of any
of the Notes or the production of such Notes in any related proceeding, and any such proceeding instituted by the Trustee will be brought in its own name as trustee of an express trust, and any recovery of judgment will, after provision for the
payment of the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit of the Holders in respect of which such judgment has been recovered. 

Section 4.05 Application of Money Collected. 

Any money collected by the Trustee in accordance with this Article IV or, after an Event of Default, any money or other property distributable
in respect of the Company’s obligations under this Indenture will be applied in the following order, at the date or dates fixed by the Trustee and, in case of the distribution of such money on account of principal or any interest, upon
presentation of the Notes and the notation on such Notes of the payment if only partially paid and upon surrender of such Notes if fully paid: 

FIRST: To the payment of all amounts due the Trustee (including any predecessor trustee), acting in any capacity hereunder, under
Section 5.07; 
 SECOND: To the payment of the amounts then due and unpaid for principal of, and any interest on, the Notes, in respect
of which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the aggregate amounts due and payable on such Notes for principal and interest, respectively; and 

THIRD: The balance, if any, to the Person or Persons entitled thereto. 

Section 4.06 Limitation on Suits. 

No Holder of any Note will have any right to institute any proceeding, judicial or otherwise, with respect to this Indenture or any Notes, or
for the appointment of a receiver or trustee, or for any other remedy under this Indenture, unless: 
 (1) such Holder has previously given
written notice to the Trustee of a continuing Event of Default with respect to the Notes; 

  
 20 

 (2) the Holders of not less than 30% in aggregate principal amount of the Outstanding Notes
will have made written request to the Trustee to institute proceedings in respect of such Event of Default in its own name as Trustee under this Indenture; 

(3) such Holder or Holders have offered to the Trustee security and indemnity satisfactory to the Trustee against the costs, expenses and
liabilities to be incurred in compliance with such request; 
 (4) the Trustee for 60 days after its receipt of such notice, request and
offer of indemnity has failed to institute any such proceeding; and 
 (5) no direction inconsistent with such written request has been given
to the Trustee during such 60-day period by the Holders of a majority of the aggregate principal amount of the Outstanding Notes; 

it being understood and intended that no one or more of such Holders will have any right in any manner whatever by virtue of, or by availing
of, any provision of this Indenture to affect, disturb or prejudice the rights of any other of such Holders, or to obtain or to seek to obtain priority or preference over any other of such Holders or to enforce any right under this Indenture, except
in the manner provided in this Indenture and for the equal and ratable benefit of all of such Holders. 
 Section 4.07 Unconditional
Right of Holders to Payments. 
 Notwithstanding any other provision in this Indenture, the Holder of any Note will have the right, which
is absolute and unconditional, to receive payment of the principal of and (subject to Section 2.07 and Section 2.10) any interest on such Note on the respective Stated Maturity or Maturities expressed in such Note (or, in the case of
redemption, on the Redemption Date), and to institute suit for the enforcement of any such payment and such rights will not be impaired without the consent of such Holder. 

Section 4.08 Restoration of Rights and Remedies. 

If the Trustee or any Holder has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has been
discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to such Holder, then in every such case, subject to any determination in such proceeding, the Company, the Trustee and the Holder will be restored severally
and respectively to their former positions under this Indenture, and thereafter all rights and remedies of the Trustee and the Holders will continue as though no such proceeding had been instituted. 

Section 4.09 Rights and Remedies Cumulative. 

Except as otherwise provided with respect to the replacement or payment of mutilated, destroyed, lost or stolen Notes in the last paragraph of
Section 2.09, no right or remedy conferred in this Indenture upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right and remedy will, to the extent permitted by law, be
cumulative and in addition to every other right and remedy given under this Indenture or now or in the future existing at law or in equity or otherwise. The assertion or employment of any right or remedy under this Indenture or otherwise will not
prevent the concurrent assertion or employment of any other appropriate right or remedy. 
 Section 4.10 Delay or Omission Not
Waiver. 
 No delay or omission of the Trustee or of any Holder of any Notes to exercise any right or remedy accruing upon any Event of
Default will impair any such right or remedy or constitute a waiver of or acquiescence in any such Event of Default. Every right and remedy given by this Article or by law to the Trustee or to the Holders may be exercised from time to time and as
often as may be deemed expedient by the Trustee or by the Holders, as the case may be. 
 Section 4.11 Control by Holders. 

The Holders of a majority in aggregate principal amount of the Outstanding Notes will have the right to direct the time, method and place of
conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the Notes, provided that: 

(1) such direction will not violate any rule of law or this Indenture or the Notes; 

(2) the Trustee may take any other action deemed proper by the Trustee that is not inconsistent with such direction; and 

(3) the Trustee will have the right to decline to follow any such direction if the Trustee will determine in good faith that the proceeding so
directed would involve the Trustee in personal liability. 

  
 21 

 Section 4.12 Waiver of Past Defaults. 

The Holders of not less than a majority in aggregate principal amount of the Outstanding Notes may, on behalf of the Holders of all the Notes,
waive any past default under this Indenture and its consequences, except a default in the payment of the principal of, or interest on, any Note, or in respect of a covenant or provision of this Indenture which, under Article VIII, cannot be modified
or amended without the consent of the Holder of each Outstanding Note. 
 Upon any such waiver, such default will cease to exist, and any
Event of Default arising from such default will be deemed to have been cured for every purpose of this Indenture; but no such waiver will extend to any subsequent or other default or impair any consequent right. 

Section 4.13 Undertaking for Costs. 

All parties to this Indenture agree, and each Holder of any Notes by his acceptance of such Notes will be deemed to have agreed, that any court
may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken, suffered, or omitted by it as Trustee, the filing by any party litigant in such suit
of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in such suit, having due regard to the merits and
good faith of the claims or defenses made by such party litigant; but the provisions of this Section 4.13 will not apply to any suit instituted by the Trustee, any Holder or any group of Holders holding in the aggregate more than 10% in
principal amount of the Outstanding Notes, or to any suit instituted by any Holder for the enforcement of the payment of the principal of or interest, if any, on any Notes on or after the Stated Maturity or Maturities expressed in such Notes (or, in
the case of redemption, on or after the Redemption Date). 
 Article V 

THE TRUSTEE 

Section 5.01 Duties of Trustee. 

(1) If an Event of Default has occurred and is continuing, the Trustee will exercise such rights and powers vested in it hereby and use the
same degree of care and skill in its exercise as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs. 

(2) Except during the continuance of an Event of Default: 

(a) the duties of the Trustee will be determined solely by the express provisions hereof, and the Trustee need perform only those duties that
are specifically set forth herein and no others, and no implied covenants or obligations will be read into this Indenture against the Trustee; 

(b) the Trustee shall not be liable for any acts or omissions, except for such losses, damages or expenses which have been finally adjudicated
by a court of competent jurisdiction to have directly resulted from the Trustee’s bad faith, gross negligence or willful misconduct; and 

(c) in the absence of bad faith, gross negligence or willful misconduct on its part, the Trustee may conclusively rely, as to the truth of the
statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements hereof; however, the Trustee will examine the certificates and opinions to determine whether
or not they conform on their face to the requirements hereof (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated therein). 

(3) Whether or not therein expressly so provided, every provision hereof that in any way relates to the Trustee is subject to paragraphs
(1) and (2) of this Section 5.01 and Section 5.02. 
 (4) No provision hereof will require the Trustee to expend or risk
its own funds or incur any liability. The Trustee will be under no obligation to exercise any of its rights and powers under this Indenture at the request of any Holders, unless such Holder has offered to the Trustee security and indemnity
satisfactory to it against any loss, liability or expense. 
 (5) The Trustee will not be liable for interest on any money received by it
except as the Trustee may agree in writing with the Company. Money held in trust by the Trustee shall be held un-invested and need not be segregated from other funds except to the extent required by law. 

  
 22 

 Section 5.02 Certain Rights of Trustee. 

Subject to Section 315(a) through Section 315(d) of the Trust Indenture Act: 

(1) the Trustee may conclusively rely, and will be protected in acting or refraining from acting, upon any resolution, certificate, statement,
instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document believed by it to be genuine and to have been signed or presented by the proper party or
parties; 
 (2) any request or direction of the Company mentioned herein will be sufficiently evidenced by a Company Request or a Company
Order (unless other evidence in respect thereof be herein specifically prescribed), and any resolution of the Board of Directors may be sufficiently evidenced by a Board Resolution; 

(3) whenever in the administration of this Indenture, the Trustee will deem it desirable that a matter be proved or established prior to
taking, suffering or omitting any action hereunder the Trustee (unless other evidence will be herein specifically prescribed) may require and, in the absence of bad faith on its part, rely upon an Officers’ Certificate or Opinion of Counsel, or
both, which will comply with Section 1.02 and will not be liable for any action it takes or omits to take in reliance on such Officers’ Certificate or Opinion of Counsel; 

(4) before the Trustee acts or refrains from acting, it shall be entitled to request and receive written instructions from the Company and
shall have no responsibility or liability for any losses or damages of any nature that may arise from any action taken or not taken by the Trustee in accordance with the written direction of the Company; 

(5) the Trustee may consult with counsel, and the advice of such counsel or any Opinion of Counsel will be full and complete authorization and
protection from liability in respect of any action taken, suffered or omitted by it hereunder in reliance thereon; 
 (6) the Trustee will be
under no obligation to exercise any of the rights or powers vested in it by or under this Indenture at the request or direction of any Holder(s) under this Indenture, unless such Holder(s) will have offered to the Trustee security or indemnity
satisfactory to the Trustee against the costs, expenses and liabilities that might be incurred by it in compliance with such request or direction; 

(7) the Trustee will not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement,
instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document, but the Trustee, in its discretion, may make such further inquiry or investigation into such
facts or matters as it may see fit, and, if the Trustee will determine to make such further inquiry or investigation, it will be entitled to examine, during business hours and upon reasonable notice, the books, records and premises of the Company,
personally or by agent or attorney, at the sole cost of the Company, and will incur no liability or additional liability of any kind by reason of such inquiry or investigation; 

(8) the Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or
attorneys, and the Trustee will not be responsible for any acts or omissions on the part of any agent or attorney appointed with due care by it hereunder; 

(9) the Trustee will not be liable for any action taken, suffered or omitted to be taken by it or any of its officers, employees or agents in
good faith; 
 (10) the Trustee will not be required to take notice or be deemed to have notice of any Default or Event of Default unless a
Responsible Officer of the Trustee shall have actual knowledge thereof, and in the absence of such knowledge, the Trustee may conclusively assume no Default or Event of Default exists; 

(11) the rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be
indemnified, are extended to, and will be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed or appointed to act hereunder; 

(12) the Trustee may request that the Company deliver a certificate setting forth the names of individuals and/or titles of officers authorized
at such time to take specified actions under this Indenture; 
 (13) the Trustee shall not be required to give any bond or surety in respect
of the performance of its powers and duties hereunder; 
 (14) none of the permissive rights of the Trustee enumerated in this Indenture
shall be construed as a duty and, with respect to such permissive rights, the Trustee shall not be liable or responsible for other than its gross negligence or willful misconduct; 

  
 23 

 (15) the Trustee shall not be liable or responsible for any calculation in connection with
the transactions contemplated hereunder, nor for any information used in connection with such calculation or for any act or omission of the Calculation Agent (if other than the Trustee) or any designee appointed by the Company to make any such
calculation; 
 (16) in no event shall the Trustee be responsible or liable for special, indirect, punitive, incidental or consequential loss
or damage of any kind whatsoever (including, but not limited to, loss of profit), irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action; and 

(17) the Trustee shall not be bound to make any investigation into (i) the performance of or compliance with any of the covenants or
agreements set forth herein, (ii) the occurrence of any default, or the validity, enforceability, effectiveness or genuineness of this Indenture or any other agreement, instrument or document. 

Section 5.03 Notice of Defaults. 

Within 90 days after a Responsible Officer of the Trustee has actual knowledge of the occurrence of any default hereunder with respect to the
Notes, the Trustee will deliver to all Holders entitled to receive reports in accordance with Section 6.03(3) notice of such default hereunder known to the Trustee, unless such default will have been cured or waived; provided, however, that,
except in the case of a default in the payment of the principal of or interest, if any, on any Note, the Trustee will be protected in withholding such notice if and so long as the Trustee in good faith determines that the withholding of such notice
is in the best interest of the Holders. For the purpose of this Section, the term “default” means any event that is, or after notice or lapse of time or both would become, an Event of Default with respect to Notes. 

Section 5.04 Not Responsible for Recitals or Issuance of Notes. 

The recitals contained herein and in the Notes, except the Trustee’s certificate of authentication, will be taken as the statements of the
Company, and neither the Trustee nor any Authenticating Agent assumes any responsibility for their correctness. The Trustee makes no representations as to the validity or sufficiency of this Indenture or of the Notes, except that the Trustee
represents that it is duly authorized to execute and deliver this Indenture, authenticate the Notes and perform its obligations hereunder, and that the statements made by it in any Statement of Eligibility on Form
T-1 supplied to the Company are true and accurate, subject to the qualifications set forth therein. Neither the Trustee nor any Authenticating Agent will be accountable for the use or application by the
Company of the Notes or the proceeds thereof. The Trustee will not be responsible for and makes no representation as to the validity or adequacy of this Indenture or the Notes, it will not be accountable for the Company’s use of the proceeds
from the Notes or any money paid to the Company or upon the Company’s direction under any provision hereof, it will not be responsible for the use or application of any money received by any Paying Agent other than the Trustee and it will not
be responsible for any statement or recital herein or any statement in the Notes or any other document in connection with the sale of the Notes or under this Indenture other than its certificate of authentication. 

Section 5.05 May Hold Notes. 

The Trustee, any Authenticating Agent, any Paying Agent, any Registrar or any other Person that may be an agent of the Trustee or the Company,
in its individual or any other capacity, may become the owner or pledgee of Notes and, subject to Section 310(b) and Section 311 of the Trust Indenture Act, may otherwise deal with the Company with the same rights that it would have if it
were not the Trustee, Authenticating Agent, Paying Agent, Registrar or such other Person. 
 The Trustee is subject to Section 311(a)
of the Trust Indenture Act, excluding any creditor relationship listed in Section 311(b) of the Trust Indenture Act. A Trustee who has resigned or been removed shall be subject to Section 311(a) of Trust Indenture Act to the extent
indicated. 
 Section 5.06 Money Held in Trust. 

Except as provided in Section 3.02(5), Section 3.03 and Section 9.03, money held by the Trustee in trust hereunder need not be
segregated from other funds except to the extent required by law and will be held un-invested. The Trustee will be under no liability for interest on any money received by it hereunder except as otherwise
agreed in writing with the Company. 
 Section 5.07 Compensation and Reimbursement. 

The Company agrees: 
 (1) to pay
to the Trustee from time to time reasonable compensation for all services rendered by the Trustee hereunder (which compensation will not be limited by any provision of law in regard to the compensation of a trustee of an express trust); 

  
 24 

 (2) except as otherwise expressly provided herein, to reimburse the Trustee upon its request
for all reasonable expenses, disbursements and advances incurred or made by the Trustee in accordance with any provision of this Indenture (including the reasonable compensation and the expenses and disbursements of its agents and counsel), except
any such expense, disbursement or advance as may be attributable to the Trustee’s bad faith, gross negligence or willful misconduct; and 

(3) to indemnify each of the Trustee or any predecessor Trustee and their agents for, and to hold them harmless against, any loss, suit,
action, liability or expense (including, without limitation, the reasonable fees and disbursements of the Trustee’s agents, legal counsel, accountants and experts), including taxes (other than taxes based upon, measured by or determined by the
income of the Trustee), arising out of or in connection with the acceptance or administration of its duties hereunder, including the costs and expenses of enforcing this Indenture against the Company (including this Section 5.07) and defending
itself against any claim (whether asserted by the Company, any Holder or any other Person) or liability in connection with the exercise or performance of any of their powers or duties hereunder, or in connection with enforcing the provisions of this
Section, except to the extent that any such loss, liability or expense was due to the Trustee’s bad faith, gross negligence or willful misconduct as determined by a court of competent jurisdiction in a final,
non-appealable order. 
 The obligations of the Company under this Section 5.07 will survive
the satisfaction and discharge of this Indenture. 
 As security for the performance of the obligations of the Company under this Indenture,
the Trustee will have a lien prior to the Notes upon all property and funds held or collected by the Trustee as such, except funds held in trust for the payment of principal of, or interest on, Notes. Such lien will survive the satisfaction and
discharge hereof and the resignation or removal of the Trustee. 
 Any compensation or expense incurred by the Trustee after a default
specified by Section 4.01 is intended to constitute an expense of administration under any then applicable bankruptcy or insolvency law. “Trustee” for purposes of this Section 5.07 will include any predecessor Trustee, but the
negligence or bad faith of any Trustee will not affect the rights of any other Trustee under this Section 5.07. The provisions of this Section 5.07 will, to the extent permitted by law, survive any termination of this Indenture (including,
without limitation, termination in accordance with any Bankruptcy Laws) and the resignation or removal of the Trustee. 

Section 5.08 Corporate Trustee Required; Eligibility. 

(1) There will at all times be a Trustee hereunder that is a corporation, organized and doing business under the laws of the United States, any
state thereof or the District of Columbia, eligible under Section 310(a)(1) of the Trust Indenture Act to act as trustee under an indenture qualified under the Trust Indenture Act and that has a combined capital and surplus (computed in
accordance with Section 310(a)(2) of the Trust Indenture Act) of at least $50,000,000 and is subject to supervision or examination by federal or state authority. The Trustee will also satisfy the requirements of Section 310(a)(5) of the
Trust Indenture Act. If at any time the Trustee will cease to be eligible in accordance with the provisions of this Section, it will resign immediately in the manner and with the effect hereinafter specified in this Article V. 

(2) The Trustee will comply with Section 310(b) of the Trust Indenture Act; provided, however, that there will be excluded from the
operation of Section 310(b)(1) of the Trust Indenture Act this Indenture or any indenture or indentures under which other securities or certificates of interest or participation in other securities of the Company are outstanding if the
requirements for such exclusion set forth in Section 310(b)(1) of the Trust Indenture Act are met. 
 Section 5.09 Resignation
and Removal; Appointment of Successor. 
 (1) No resignation or removal of the Trustee and no appointment of a successor Trustee in
accordance with this Article V will become effective until the acceptance of appointment by the successor Trustee in accordance with Section 5.10. 

(2) The Trustee may resign at any time with respect to the Notes by giving written notice thereof to the Company. If the instrument of
acceptance by a successor Trustee required by Section 5.10 will not have been delivered to the Trustee within 30 days after the giving of such notice of resignation, the resigning Trustee may, at the Company’s expense, petition any court
of competent jurisdiction for the appointment of a successor Trustee. 
 (3) The Trustee may be removed at any time with respect to the Notes
by Act of the Holders of a majority in principal amount of the Outstanding Notes delivered to the Trustee and the Company. 
 If at any
time: 
 (a) the Trustee will fail to comply with the obligations imposed upon it under Section 310(b) of the Trust Indenture Act with
respect to Notes after written request therefor by the Company or any Holder who has been a bona fide Holder for at least six months, 

  
 25 

 (b) the Trustee will cease to be eligible under Section 5.08 and will fail to resign
after written request therefor by the Company or any such Holder, or 
 (c) the Trustee will become incapable of acting or will be adjudged
a bankrupt, insolvent, or a receiver of the Trustee or of its property will be appointed or any public officer will take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation,

 then, in any such case, (i) the Company, by or in accordance with a Board Resolution, may remove the Trustee with respect to the Notes, or
(ii) subject to Section 315(e) of the Trust Indenture Act, any Holder who has been a bona fide Holder for at least six months may, on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the
removal of the Trustee with respect to all Notes and the appointment of a successor Trustee or Trustees. 
 (4) If the Trustee will resign,
be removed or become incapable of acting, or if a vacancy will occur in the office of Trustee for any cause, with respect to the Notes, the Company, by or in accordance with a Board Resolution, will promptly appoint a successor Trustee or Trustees
with and will comply with the applicable requirements of Section 5.10. If, within one year after such resignation, removal or incapability, or the occurrence of such vacancy, a successor Trustee with respect to the Notes shall have been
appointed by Act of the Holders of a majority in principal amount of the Outstanding Notes delivered to the Company and the retiring Trustee, the successor Trustee so appointed will, forthwith upon its acceptance of such appointment in accordance
with the applicable requirements of Section 5.10, become the successor Trustee with respect to the Notes and to that extent supersede the successor Trustee appointed by the Company. If no successor Trustee with respect to the Notes will have
been so appointed by the Company or the Holders and accepted appointment in the manner required by Section 5.10, any Holder who has been a bona fide Holder for at least six months may, on behalf of himself and all others similarly situated,
petition any court of competent jurisdiction for the appointment of a successor Trustee with respect to the Notes. 
 (5) The Company will
give notice of each resignation and each removal of the Trustee with respect to the Notes and each appointment of a successor Trustee with respect to the Notes by delivering written notice of such event by first-class mail, postage prepaid, to the
Holders as their names and addresses appear in the Note Register. Each notice will include the name of the successor Trustee with respect to the Notes and the address of its Corporate Trust Office. 

Section 5.10 Acceptance of Appointment by Successor. 

(1) Upon the appointment hereunder of any successor Trustee with respect to all Notes, such successor Trustee so appointed will execute,
acknowledge and deliver to the Company and the retiring Trustee an instrument accepting such appointment, and thereupon the resignation or removal of the retiring Trustee will become effective and such successor Trustee, without any further act,
deed or conveyance, will become vested with all the rights, powers, trusts and duties hereunder of the retiring Trustee; but, on the request of the Company or such successor Trustee, such retiring Trustee, upon payment of its charges, will execute
and deliver an instrument transferring to such successor Trustee all the rights, powers and trusts of the retiring Trustee and, subject to Section 9.03, will duly assign, transfer and deliver to such successor Trustee all property and money
held by such retiring Trustee hereunder, subject nevertheless to its claim, if any, provided for in Section 5.07. 
 (2) Upon the
appointment hereunder of any successor Trustee with respect to the Notes, the Company, the retiring Trustee and such successor Trustee will execute and deliver an indenture supplemental hereto wherein each successor Trustee will accept such
appointment and which (i) will contain such provisions as will be necessary or desirable to transfer and confirm to, and to vest in such successor Trustee all the rights, powers, trusts and duties of the retiring Trustee with respect to the
Notes, (ii) if the retiring Trustee is not retiring with respect to all Notes, will contain such provisions as will be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties of the retiring Trustee with respect
to the Notes will continue to be vested in the retiring Trustee, and (iii) will add to or change any of the provisions of this Indenture as will be necessary to provide for or facilitate the administration of the trusts hereunder by more than
one Trustee, it being understood that nothing herein or in such supplemental indenture will constitute such Trustees co-trustees of the same trust, that each such Trustee will be trustee of a trust or trusts
hereunder separate and apart from any trust or trusts hereunder administered by any other such Trustee and that no Trustee will be responsible for any notice given to, or received by, or any act or failure to act on the part of any other Trustee
hereunder, and, upon the execution and delivery of such supplemental indenture, the resignation or removal of the retiring Trustee will become effective to the extent provided therein, such retiring Trustee will have no further responsibility for
the exercise of rights and powers or for the performance of the duties and obligations vested in the Trustee under this Indenture with respect to the Notes other than as hereinafter expressly set forth, and such successor Trustee, without any
further act, deed or conveyance, will become vested with all the rights, powers, trusts and duties of the retiring Trustee with respect to the Notes; but, on request of the Company or such successor Trustee, such retiring Trustee, upon payment of
its charges with respect to the Notes and subject to Section 9.03 will duly assign, transfer and deliver to such successor Trustee, to the extent contemplated by such supplemental indenture, the property and money held by such retiring Trustee
hereunder with respect to the Notes, subject to its claim, if any, provided for in Section 5.07. 

  
 26 

 (3) Upon request of any Person appointed hereunder as a successor Trustee, the Company will
execute any and all instruments for more fully and certainly vesting in and confirming to such successor Trustee all such rights, powers and trusts referred to in paragraph (1) or (2) of this Section, as the case may be. 

(4) No Person will accept its appointment hereunder as a successor Trustee unless at the time of such acceptance such successor Person will be
qualified and eligible under this Article. No resigning or removed Trustee shall have any liability or responsibility for the action or inaction of any successor Trustee. 

Section 5.11 Merger, Conversion, Consolidation or Succession to Business. 

Any corporation into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation resulting from any
merger, conversion or consolidation to which the Trustee will be a party, or any corporation succeeding to all or substantially all of the corporate trust business of the Trustee, will be the successor of the Trustee hereunder (provided that such
corporation will otherwise be qualified and eligible under this Article), without the execution or filing of any paper or any further act on the part of any of the parties hereto. In case any Notes will have been authenticated but not delivered by
the Trustee then in office, any such successor to such authenticating Trustee may adopt such authentication and deliver the Notes so authenticated with the same effect as if such successor Trustee had itself authenticated such Notes. In case any
Notes will not have been authenticated by such predecessor Trustee, any such successor Trustee may authenticate and deliver such Notes in either its own name or that of its predecessor Trustee. 

Section 5.12 Appointment of Authenticating Agent. 

The Trustee may appoint one or more Authenticating Agents acceptable to the Company with respect to the Notes which will be authorized to act
on behalf of the Trustee to authenticate Notes issued upon original issue, exchange, registration of transfer, partial redemption, partial repayment or in accordance with Section 2.09, and Notes so authenticated will be entitled to the benefits
of this Indenture and will be valid and obligatory for all purposes as if authenticated by the Trustee hereunder. Wherever reference is made in this Indenture to the authentication and delivery of Notes by the Trustee or the Trustee’s
certificate of authentication, such reference will be deemed to include authentication and delivery on behalf of the Trustee by an Authenticating Agent and a certificate of authentication executed on behalf of the Trustee by an Authenticating Agent.

 Each Authenticating Agent will be reasonably acceptable to the Company and, except as provided in or under this Indenture, will at all
times be a corporation that would be permitted by the Trust Indenture Act to act as trustee under an indenture qualified under the Trust Indenture Act, is authorized under applicable law and by its charter to act as an Authenticating Agent and has a
combined capital and surplus (computed in accordance with Section 310(a)(2) of the Trust Indenture Act) of at least $50,000,000 and is subject to supervision or examination by federal or state authority. If at any time an Authenticating Agent
will cease to be eligible in accordance with the provisions of this Section, it will resign immediately in the manner and with the effect specified in this Section. 

Any corporation into which an Authenticating Agent may be merged or converted or with which it may be consolidated, or any corporation
resulting from any merger, conversion or consolidation to which such Authenticating Agent will be a party, or any corporation succeeding to all or substantially all of the corporate agency or corporate trust business of an Authenticating Agent, will
be the successor of such Authenticating Agent hereunder, provided such corporation will be otherwise eligible under this Section, without the execution or filing of any paper or any further act on the part of the Trustee or the Authenticating Agent.

 An Authenticating Agent may resign at any time by giving written notice thereof to the Trustee and the Company. The Trustee may at any
time terminate the agency of an Authenticating Agent by giving written notice thereof to such Authenticating Agent and the Company. Upon receiving such a notice of resignation or upon such a termination, or in the case that at any time such
Authenticating Agent will cease to be eligible in accordance with the provisions of this Section, the Trustee may appoint a successor Authenticating Agent that will be acceptable to the Company and will deliver written notice of such appointment by
first-class mail, postage prepaid, to all Holders with respect to which such Authenticating Agent will serve, as their names and addresses appear in the Note Register. Any successor Authenticating Agent, upon acceptance of its appointment hereunder,
will become vested with all the rights, powers and duties of its predecessor hereunder, with like effect as if originally named as an Authenticating Agent. No successor Authenticating Agent will be appointed unless eligible under the provisions of
this Section 5.12. 
 The Company agrees to pay each Authenticating Agent from time to time reasonable compensation for its services
under this Section. If the Trustee makes such payments, it will be entitled to be reimbursed for such payments, subject to the provisions of Section 5.07. 

The provisions of Section 2.11, Section 5.04 and Section 5.05 will be applicable to each Authenticating Agent. 

  
 27 

 If an Authenticating Agent is appointed under this Section, the Notes may have endorsed
thereon, in addition to or in lieu of the Trustee’s certificate of authentication, an alternate certificate of authentication in substantially the following form: 

This is one of the Notes designated herein referred to in the within-mentioned Indenture. 

 

			
	  
 As Trustee

		
	By:	 	  

		 	As Authenticating Agent
		
	By:	 	  

	Name:	 	  

	Title:	 	  

 Section 5.13 Preferred Collection of Claims against Company. 

If and when the Trustee will be or become a creditor of the Company (or any other obligor upon the Notes), the Trustee will be subject to the
provisions of the Trust Indenture Act regarding the collection of claims against the Company (or any such other obligor). 
 Article VI 

HOLDERS LISTS AND REPORTS BY TRUSTEE AND COMPANY 

Section 6.01 Holder Lists. 

The Trustee will preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of
the Holders. If the Trustee is not the Registrar, the Company will cause to be furnished to the Trustee at least semiannually on January 1 and July 1 a listing of the Holders dated within 10 days of the date on which the list is furnished
and at such other times as the Trustee may request in writing a list in such form and as of such date of the names and addresses of the Holders. 

Section 6.02 Preservation of Information; Communications to Holders. 

The Trustee will comply with the obligations imposed upon it in accordance with Section 312 of the Trust Indenture Act. 

Every Holder of Notes, by receiving and holding the same, agrees with the Company and the Trustee that neither the Company, the Trustee, any
Paying Agent or any Registrar will be held accountable by reason of the disclosure of any such information as to the names and addresses of the Holders of Notes in accordance with Section 312(c) of the Trust Indenture Act, regardless of the
source from which such information was derived, and that the Trustee will not be held accountable by reason of delivering any material in accordance with a request made under Section 312(b) of the Trust Indenture Act. 

Section 6.03 Reports by Trustee. 

(1) Within 60 days after July 15th of each year commencing with the first July 15th following the date of this Indenture, if required by Section 313(a) of the Trust Indenture Act, the Trustee will transmit, in accordance with Section 313(c) of the Trust Indenture Act, a
brief report dated as of such reporting date with respect to any of the events specified in said Section 313(a) and Section 313(b)(2) that may have occurred since the later of the immediately preceding July 15 and the date of this
Indenture. 
 (2) The Trustee will transmit the reports required by Section 313(a) of the Trust Indenture Act at the times specified
therein. 
 (3) The Trustee shall comply with Sections 313(b) and 313(c) of the Trust Indenture Act. 

(4) Reports under this Section will be transmitted in the manner and to the Persons required by Section 313(c) and Section 313(d) of
the Trust Indenture Act. 
 Section 6.04 Reports by Company. 

(1) The Company, in accordance with Section 314(a) of the Trust Indenture Act, will: 

(a) file with the Trustee, within 30 days after the Company files the same with the Commission, copies of the annual reports and of the
information, documents and other reports (or copies of such portions of any of the foregoing as the Commission may from time to time by rules and regulations prescribe) that the Company may be required to file with the

  
 28 

 
Commission in accordance with Section 13 or Section 15(d) of the Exchange Act; or, if the Company is not required to file information, documents or reports in accordance with either of
said Sections, then it will file with the Trustee such of the supplementary and periodic information, documents and reports that may be required in accordance with Section 13 of the Exchange Act in respect of a security listed and registered on
a national securities exchange as may be prescribed from time to time in the rules and regulations of the Commission; 
 (b) file with the
Trustee and the Commission, in accordance with rules and regulations prescribed from time to time by the Commission, such additional certificates, information, documents and reports with respect to compliance by the Company, with the conditions and
covenants of this Indenture as may be required from time to time by such rules and regulations; and 
 (c) transmit to the Holders, within
30 days after the filing thereof with the Trustee, in the manner and to the extent provided in Section 313(c) of the Trust Indenture Act, such summaries of any information, documents and reports required to be filed by the Company in accordance
with paragraphs (1) and (2) of this Section as may be required by rules and regulations prescribed from time to time by the Commission. Delivery of such reports, information and documents to the Trustee is for informational purposes only
and the Trustee’s receipt of such will not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as
to which the Trustee is entitled to rely exclusively on Officers’ Certificates). 
 (2) The Company intends to file the reports referred
to in Section 6.04(1) with the Commission in electronic form in accordance with Regulation S-T of the Commission using the Commission’s Electronic Data Gathering, Analysis and Retrieval system, or,
if the Commission will not accept such reports or information, the Company intends to post such reports and information on its website. Compliance with the foregoing, or any successor electronic system approved by the Commission, will constitute
delivery by the Company of such reports to the Trustee and Holders in compliance with the provision of Section 6.04(1) and Trust Indenture Act Section 314(a). Notwithstanding anything to the contrary herein, the Trustee will have no duty
to search for or obtain any electronic or other filings that the Company makes with the Commission, regardless of whether such filings are periodic, supplemental or otherwise. Delivery of the reports, information and documents to the Trustee in
accordance with this Section 6.04(2) will be solely for the purposes of compliance with this Section 6.04(2) and the Trust Indenture Act Section 314(a). The Trustee’s receipt of such reports, information and documents is for
informational purposes only and the Trustee’s receipt of such will not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of
its covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officers’ Certificates). The Trustee shall have no liability or responsibility for the filing, content or timeliness of any report hereunder aside from any
report reported under Section 6.03 hereof. 
 Article VII 

SUCCESSORS 

Section 7.01 Merger, Consolidation or Sale of All or Substantially All Assets. 

The Company will not, in any transaction or series of related transactions, consolidate with or merge into any Person or sell, assign,
transfer, lease or otherwise convey all or substantially all its properties and assets to any Person, unless: 
 (1) either the Company will
be the continuing Person (in the case of a merger), or the successor Person (if other than the Company) formed by such consolidation or into which the Company is merged or which acquires by sale, assignment, transfer, lease or other conveyance all
or substantially all the properties and assets of the Company will be a corporation, limited liability company or partnership organized and existing under the laws of the United States, any state thereof or the District of Columbia and will
expressly assume, by an indenture (or indentures, if at such time there is more than one Trustee) supplemental hereto executed by such successor corporation, limited liability company or partnership and delivered to the Trustee, in form satisfactory
to the Trustee, the due and punctual payment of the principal of, and interest on, all the Outstanding Notes and the due and punctual performance and observance of every obligation in this Indenture and the Outstanding Notes on the part of the
Company to be performed or observed; 
 (2) immediately after giving effect to such transaction and treating any indebtedness that becomes an
obligation of the Company or any Subsidiary as a result of that transaction as having been incurred by the Company or any Subsidiary at the time of the transaction, no Event of Default, and no event which, after notice or lapse of time, or both,
would become an Event of Default, will have occurred and be continuing; and 
 (3) either the Company or the successor Person will have
delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that such consolidation, merger, sale, assignment, transfer, lease or other conveyance has occurred and, if a supplemental indenture is required in
connection with such transaction, such supplemental indenture complies with this Article VII and all conditions precedent herein provided for relating to such transaction have been complied with. 

  
 29 

 For purposes of the foregoing, any sale, assignment, transfer, lease or other conveyance of
all or any of the properties and assets of one or more Subsidiaries of the Company (other than to the Company or another Subsidiary), which, if such properties and assets were directly owned by the Company, would constitute all or substantially all
of the Company’s properties and assets, will be deemed to be the transfer of all or substantially all of the properties and assets of the Company. 

Section 7.02 Successor Person Substituted for Company. 

Upon any consolidation by the Company with or merger of the Company into any other Person or any sale, assignment, transfer, lease or
conveyance of all or substantially all of the properties and assets of the Company to any Person in accordance with Section 7.01, the successor Person formed by such consolidation or into which the Company is merged or to which such sale,
assignment, transfer, lease or other conveyance is made will succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor Person had been named as the
Company herein; and thereafter, except in the case of a lease, the predecessor Person will be released from all obligations and covenants under this Indenture and the Notes. 

Article VIII 
 SUPPLEMENTAL
INDENTURES 
 Section 8.01 Supplemental Indentures without Consent of Holders. 

Without the consent of any Holders of Notes, the Company (when authorized by or in accordance with a Board Resolution) and the Trustee, at any
time and from time to time, may enter into one or more indentures supplemental hereto, in form satisfactory to the Trustee, for any of the following purposes: 

(1) to evidence the succession of another Person to the Company, and the assumption by any such successor of the covenants of the Company
contained herein and in the Notes; 
 (2) to add to the covenants of the Company for the benefit of the Holders (as will be specified in such
supplemental indenture or indentures) or to surrender any right or power herein conferred upon the Company with respect to the Notes issued under this Indenture (as will be specified in such supplemental indenture or indentures); 

(3) to permit or facilitate the issuance of Notes in uncertificated or global form, provided any such action will not adversely affect the
interests of the Holders; 
 (4) to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to
the Notes and to add to or change any of the provisions of this Indenture as will be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, in accordance with the requirements of
Section 5.10; 
 (5) to cure any ambiguity or to correct or supplement any provision herein that may be defective or that may be
inconsistent with any other provision herein; 
 (6) to make any other provisions with respect to matters or questions arising under this
Indenture that will not adversely affect the interests of the Holders of the Outstanding Notes in any material respect; 
 (7) to add any
additional Events of Default (as will be specified in such supplemental indenture); 
 (8) to supplement any of the provisions of this
Indenture to such extent as will be necessary to permit or facilitate the Legal Defeasance, Covenant Defeasance and/or satisfaction and discharge of the Notes in accordance with Article III, provided that any such action will not adversely affect
the interests of any Holder in any material respect; 
 (9) to provide for the issuance of Exchange Notes; 

(10) to conform any provision in this Indenture to the requirements of the Trust Indenture Act; or 

(11) to make any change that does not adversely affect the legal rights under this Indenture of any Holder. 

Section 8.02 Supplemental Indentures with Consent of Holders. 

With the consent of the Holders of not less than a majority in principal amount of the Outstanding Notes, by Act of said Holders delivered to
the Company and the Trustee, the Company (when authorized by or in accordance with a Board Resolution) and the Trustee may enter into an indenture or indentures supplemental hereto for the purpose of adding any provisions to or changing in any
manner or eliminating any of the provisions of this Indenture or of the Notes or of modifying in any manner the rights of the Holders under this Indenture; provided that no such supplemental indenture, without the consent of the Holder of each
Outstanding Note affected thereby, will 

  
 30 

 (1) reduce the rate of or change the time for payment of interest, including Defaulted
Interest, on any Notes; 
 (2) reduce the principal of or change the Stated Maturity of any Notes, or change the date on which any Notes may
be subject to redemption or reduce the Redemption Price therefore; 
 (3) make any Note payable in money other than Dollars; 

(4) make any change in provisions of this Indenture protecting the right of each Holder to receive payment of principal of and interest on such
Note on or after the due date thereof or to bring suit to enforce such payment; 
 (5) reduce the percentage in principal amount of the
Outstanding Notes, the consent of whose Holders is required for any such supplemental indenture, or the consent of whose Holders is required for any waiver (of compliance with certain provisions of this Indenture or certain defaults hereunder and
their consequences) provided for in Section 4.12 or Section 9.05 of this Indenture; or 
 (6) modify any of the provisions of this
Section 8.02, Section 4.12 or Section 9.05, except to increase any such percentage or to provide that certain other provisions of this Indenture cannot be modified or waived without the consent of the Holder of each Outstanding Note
affected thereby. 
 It will not be necessary for any Act of Holders under this Section 8.02 to approve the particular form of any
proposed supplemental indenture, but it will be sufficient if such Act will approve the substance thereof. 
 Section 8.03 Execution
of Supplemental Indentures. 
 As a condition to executing or accepting the additional trusts created by any supplemental indenture
permitted by this Article VIII or the modifications thereby of the trust created by this Indenture, the Trustee will be entitled to receive, and (subject to Section 5.01) will be fully protected in relying upon, an Officers’ Certificate
and an Opinion of Counsel to the effect that the execution of such supplemental indenture is authorized or permitted by this Indenture and that such supplemental indenture has been duly authorized, executed and delivered by, and is a valid, binding
and enforceable obligation of, the Company, subject to customary exceptions, and to the extent applicable pursuant to Section 8.01, that such supplemental indenture does not adversely affect the interests of the Holders. The Trustee shall
execute any such supplemental indenture except that the Trustee may, but will not be obligated to, enter into any such supplemental indenture which affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise. 

Section 8.04 Effect of Supplemental Indentures. 

Upon the execution of any supplemental indenture under this Article VIII, this Indenture will be modified in accordance therewith, and such
supplemental indenture will form a part of this Indenture for all purposes; and every Holder theretofore or thereafter authenticated and delivered hereunder. 

Section 8.05 Reference in Notes to Supplemental Indentures. 

Notes authenticated and delivered after the execution of any supplemental indenture in accordance with this Article VIII may, and will, if
required by the Company, bear a notation in form approved by the Company as to any matter provided for in such supplemental indenture. If the Company will so determine, new Notes so modified as to conform, in the opinion of the Company, to any such
supplemental indenture may be prepared and executed by the Company and authenticated and delivered by the Trustee in exchange for Outstanding Notes. 

Section 8.06 Conformity with Trust Indenture Act. 

Every supplemental indenture executed in accordance with this Article will conform to the requirements of the Trust Indenture Act as then in
effect. 
 Article IX 

COVENANTS 

Section 9.01 Payment of Principal and Interest. 

The Company covenants and agrees for the benefit of the Holders that it will duly and punctually pay the principal of, and interest on, the
Notes, in accordance with the terms thereof and this Indenture. Principal and interest will be considered paid on the date due if the Paying Agent, if other than the Company or a Subsidiary thereof, holds as of 11:00 a.m., New York, New York time,
on any Interest Payment Date, an amount in immediately available funds provided by the Company that is designated for and sufficient to pay all principal and interest then due. The Company will pay all Additional Interest, if any, on the dates and
in the amounts set forth in the Registration Rights Agreement. 

  
 31 

 If Additional Interest is payable by the Company in accordance with the Registration Rights
Agreement, the Company will deliver to the Trustee a certificate to that effect stating (i) the amount of such Additional Interest that is payable and (ii) the date on which such Additional Interest is payable. Unless and until a
Responsible Officer of the Trustee receives such a certificate or instruction or direction from the Holders in accordance with the terms of this Indenture, the Trustee may assume without inquiry that no Additional Interest is payable. The foregoing
will not prejudice the rights of the Holders with respect to their entitlement to Additional Interest as otherwise set forth in this Indenture or the Notes and pursuing any action against the Company directly or otherwise directing the Trustee to
take such action in accordance with the terms of this Indenture and the Notes. If the Company has paid Additional Interest directly to persons entitled to it, the Company will deliver to the Trustee a certificate setting forth the particulars of
such payment. 
 Section 9.02 Maintenance of Office. 

The Company will maintain an office or agency in the Borough of Manhattan, New York, New York (which may be an office of the Trustee or an
Affiliate of the Trustee or Registrar) where Notes may be surrendered for registration of transfer or for exchange and where notices and demands to or upon the Company in respect of the Notes and this Indenture may be served. The Company will give
prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the Company fails to maintain any such required office or agency or fails to furnish the Trustee with the address thereof,
such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee. 
 The Company may
also from time to time designate one or more other offices or agencies where the Notes may be presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided that no such designation or rescission
will, in any manner, relieve the Company of its obligation to maintain an office or agency in the Borough of Manhattan, New York, New York. The Company will give prompt written notice to the Trustee of any such designation or rescission and of any
change in the location of any such other office or agency. 
 The Company hereby designates the Corporate Trust Office of the Trustee as one
such office or agency of the Company in accordance with Section 9.02. 
 Section 9.03 Money for Notes Payments to Be Held in
Trust. 
 If the Company will at any time act as its own Paying Agent, it will, on or before each due date of the principal of, or
interest on, any of the Notes, segregate and hold in trust for the benefit of the Persons entitled thereto a sum in Dollars sufficient to pay the principal or interest, as the case may be, so becoming due until such sums will be paid to such Persons
or otherwise disposed of as herein provided, and will promptly notify the Trustee of its action or failure so to act. 
 Whenever the
Company will have one or more Paying Agents, it will, on or prior to each due date of the principal of, or interest on, any Notes, deposit with any Paying Agent a sum in Dollars sufficient to pay the principal or interest, as the case may be, so
becoming due, such sum to be held in trust for the benefit of the Persons entitled thereto, and (unless such Paying Agent is the Trustee) the Company will promptly notify the Trustee of its action or failure so to act. 

The Company will cause each Paying Agent other than the Trustee to execute and deliver to the Trustee an instrument in which such Paying Agent
will agree with the Trustee, subject to the provisions of this Section that such Paying Agent will: 
 (1) hold all sums held by it for the
payment of the principal of, or interest on, the Notes in trust for the benefit of the Persons entitled thereto until such sums will be paid to such Persons or otherwise disposed of as provided in or under this Indenture; 

(2) give the Trustee notice of any default by the Company in the making of any payment of principal, or interest on, the Notes; and 

(3) at any time during the continuance of any such default, upon the written request of the Trustee, pay to the Trustee all sums so held in
trust by such Paying Agent. 
 The Company may at any time, for the purpose of obtaining the satisfaction and discharge of this Indenture or
for any other purpose, pay, or by Company Order, direct any Paying Agent to pay, to the Trustee all sums held in trust by the Company or such Paying Agent, such sums to be held by the Trustee upon the same terms as those upon which such sums were
held by the Company or such Paying Agent; and, upon such payment by any Paying Agent to the Trustee, such Paying Agent will be released from all further liability with respect to such sums. 

  
 32 

 Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in
trust for the payment of the principal of, or interest on, any Note, remaining unclaimed for two years after such principal or interest will have become due and payable, will be paid to the Company upon a Company Request, or (if then held by the
Company) will be discharged from such trust; and the Holder of such Note will thereafter, as an unsecured general creditor, look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such
trust money, and all liability of the Company as trustee thereof will thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may, not later than 30 days after the Company’s
request for such repayment, at the expense of the Company, cause to be published once, in an Authorized Newspaper in each Place of Payment or to be delivered to such Holders of Notes, or both, notice that such money remains unclaimed and that, after
a date specified therein which will not be less than 30 days from the date of such publication or delivery, nor will it be earlier than two years after such principal and/or interest will have become due and payable, any unclaimed balance of such
money then remaining will be repaid to the Company. 
 Section 9.04 Financial Covenants. 

(1) The Company shall maintain cash on hand at least equal to the next twelve months of interest payments on the Notes so long as the Notes
remain Outstanding. 
 (2) The Company shall not incur, and shall not permit any of its Subsidiaries to incur, directly or indirectly, any
indebtedness, unless the Company’s Consolidated Indebtedness to GAAP Capitalization Ratio for the most recently completed fiscal quarter immediately preceding the date on which such additional indebtedness would be incurred would have been no
greater than 40%, determined on a pro forma basis (including a pro forma application of the net proceeds therefrom) as if the additional indebtedness and all other indebtedness incurred since the immediately preceding fiscal quarter had been
incurred as of such day (except to the extent such indebtedness has been or will be used to prepay other indebtedness) and the proceeds therefrom applied as of such day. 

(3) Other than existing secured indebtedness of the Company or any of its Subsidiaries, the Company will not incur or permit to exist any
mortgage, pledge, encumbrance or lien or charge securing indebtedness on any property or asset of the Company or any of its Subsidiaries in excess of 20% of the Consolidated Indebtedness of the Company when combined with any existing secured
indebtedness of the Company or any of its Subsidiaries. 
 (4) The Company will use reasonable best efforts to maintain a rating of the Notes
from Egan-Jones Ratings Company, provided that, in the event Egan-Jones Ratings Company is no longer available to rate the Notes, the Company shall use its reasonable best efforts to maintain a rating of the Notes with another Ratings Agency. 

Section 9.05 Waiver of Certain Covenants. 

The Company may omit in any particular instance to comply with any term, provision or condition set forth in Section 9.02 to
Section 9.04, inclusive, with respect to the Notes, if before the time for such compliance the Holders of at least a majority in principal amount of the Outstanding Notes, by Act of such Holders, either will waive such compliance in such
instance or generally will have waived compliance with such term, provision or condition, but no such waiver will extend to or affect such term, provision or condition except to the extent so expressly waived, and, until such waiver will become
effective, the obligations of the Company and the duties of the Trustee in respect of any such term, provision or condition will remain in full force and effect. 

Section 9.06 Company Statement as to Compliance. 

The Company will deliver to the Trustee, within 120 days after the end of each fiscal year, an Officers’ Certificate covering the
preceding calendar year, stating whether or not, to the best of his or her knowledge, the Company is in default in the performance and observance of any of the terms, provisions and conditions of this Indenture (without regard to notice requirements
or periods of grace) and if the Company will be in default, specifying all such defaults and the nature and status thereof of which he or she may have knowledge. 

Article X 
 REDEMPTION OF
SECURITIES 
 Section 10.01 Applicability of Article. 

(1) Except as provided in this Section 10.01, the Notes are not subject to redemption at the option of the Company or the Holders. 

  
 33 

 (2) On and after November 30, 2023, the Company may redeem all or a part of the Notes,
from time to time, at the following redemption prices (expressed as a percentage of the principal amount) plus accrued and unpaid interest and Additional Interest, if any, on the Notes redeemed to, but not including, the applicable Redemption Date
(subject to the rights of Holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the twelve-month period beginning on November 30 of the years indicated below: 

 

			
	 Year
	  	Redemption Price
	 2023
	  	102.81250%
	 2024
	  	101.40625%
	 2025, and thereafter
	  	100.00000%

 Section 10.02 Election to Redeem; Notice to Trustee. 

The election of the Company to redeem any Notes will be evidenced by a Company Order. In case of any redemption of less than all of the Notes,
the Company will, at least 30 days but not more than 60 days prior to the Redemption Date fixed by the Company (unless a shorter notice will be satisfactory to the Trustee), notify the Trustee of such Redemption Date and of the principal amount of
Notes to be redeemed.
 In the case of any redemption of Notes (i) prior to the expiration of any restriction on such redemption
provided in the terms of such Notes or elsewhere in this Indenture or (ii) in accordance with an election of the Company that is subject to a condition specified in the terms of such Notes or elsewhere in this Indenture, the Company will
furnish to the Trustee an Officers’ Certificate evidencing compliance with such restriction or condition. 
 Section 10.03
Selection by Trustee of Notes to be Redeemed. 
 If less than all of the Notes are to be redeemed, the Notes will be redeemed on a pro
rata basis as to the Holders, and if the Notes are represented by Global Notes held by the Depositary and such redemption is processed through the Depositary, such redemption will be made on a “Pro Rata Pass-Through Distribution of
Principal” basis in accordance with the procedures of the Depositary. In the event a pro rata redemption as provided in the preceding sentence is not permitted under applicable law or applicable requirements of the Depositary, the Notes to be
redeemed will be selected by lot or such method as the Trustee will deem fair and appropriate. 
 The Trustee will promptly notify the
Company and the Registrar (if other than itself) in writing of the Notes selected for redemption and, in the case of any Notes selected for partial redemption, the principal amount thereof to be redeemed. 

For all purposes of this Indenture, unless the context otherwise requires, all provisions relating to the redemption of Notes will relate, in
the case of any Notes redeemed or to be redeemed only in part, to the portion of the principal of such Notes which has been or is to be redeemed. 

Section 10.04 Notice of Redemption. 

Notice of redemption will be given in the manner provided in Section 10.05 not less than 30 nor more than 60 days prior to the Redemption
Date to the Holders of Notes to be redeemed. Failure to give notice by delivering in the manner herein provided to the Holder of any Notes designated for redemption as a whole or in part, or any defect in the notice to any such Holder, will not
affect the validity of the proceedings for the redemption of any other Notes or portions thereof. 
 Any notice that is delivered to the
Holder of any Notes in the manner herein provided will be conclusively presumed to have been duly given, whether or not such Holder receives the notice. 

All notices of redemption will state: 

(1) the Redemption Date, 
 (2) the
Redemption Price, 
 (3) if less than all Outstanding Notes are to be redeemed, the identification (and, in the case of partial redemption,
the principal amount) of the particular Note or Notes to be redeemed, 
 (4) that, in case any Note is to be redeemed in part only, on and
after the Redemption Date, upon surrender of such Note, the Holder of such Note will receive, without charge, a new Note or Notes of authorized denominations for the principal amount thereof remaining unredeemed, 

  
 34 

 (5) that, on the Redemption Date, the Redemption Price will become due and payable upon each
such Note or portion thereof to be redeemed, together (if applicable) with accrued and unpaid interest and Additional Interest, if any, thereon (subject, if applicable, to the provisos to the first paragraph of Section 10.06), and, if
applicable, that interest thereon will cease to accrue on and after said date, 
 (6) the place or places where such Notes are to be
surrendered for payment of the Redemption Price and any accrued interest pertaining thereto, and 
 (7) the section hereunder providing for
such redemption. 
 The notice of redemption shall include the “CUSIP” number reference numbers of such Notes, if any (or any
other numbers used by a Depositary to identify such Notes). 
 Notice of redemption of Notes to be redeemed at the election of the Company
will be given by the Company or, at the Company’s request, delivered at least 10 days before the date such notice is to be given (unless a shorter period will be acceptable to the Trustee) by the Trustee in the name and at the expense of the
Company. 
 Section 10.05 Deposit of Redemption Price. 

On or prior to 11:00 am., New York, New York time, on any Redemption Date, the Company will deposit, with respect to the Notes called for
redemption in accordance with Section 10.04, with the Trustee or with a Paying Agent (or, if the Company is acting as its own Paying Agent, segregate and hold in trust as provided in Section 9.03) an amount sufficient to pay the Redemption
Price of, and (except if the Redemption Date will be an Interest Payment Date) any accrued interest on, all such Notes or portions thereof which are to be redeemed on that date. 

Section 10.06 Notes Payable on Redemption Date. 

Notice of redemption having been given as provided above, the Notes so to be redeemed will, on the Redemption Date, become due and payable at
the Redemption Price therein specified, together with accrued and unpaid interest and Additional Interest, if any, thereon and from and after such date (unless the Company will default in the payment of the Redemption Price and accrued interest, if
any) such Notes will cease to bear interest. Upon surrender of any such Note for redemption in accordance with said notice, such Note will be paid by the Company at the Redemption Price, together with any accrued and unpaid interest and Additional
Interest, if any, thereon to but excluding the Redemption Date; provided, however, that installments of interest on Notes whose Stated Maturity is on or prior to the Redemption Date will be payable to the Holders of such Notes registered as such at
the close of business on the Regular Record Dates therefor according to their terms and the provisions of Section 2.10. 
 If any Note
called for redemption will not be so paid upon surrender thereof for redemption, the principal, until paid, will bear interest from the Redemption Date at the rate prescribed therefor in the Note or, if no rate is prescribed therefor in the Note, at
the rate of interest, if any, borne by such Note. 
 Section 10.07 Notes Redeemed in Part. 

Any Note which is to be redeemed only in part will be surrendered at any office or agency for such Note (with, if the Company or the Trustee
so requires, due endorsement by, or a written instrument of transfer in form satisfactory to the Company and the Trustee duly executed by, the Holder thereof or his attorney duly authorized in writing) and the Company will execute, and the Trustee
will authenticate and deliver to the Holder of such Note without service charge, a new Note or Notes, containing identical terms and provisions, of any authorized denomination as requested by such Holder in aggregate principal amount equal to and in
exchange for the unredeemed portion of the principal of the Note so surrendered. If a Global Note is so surrendered, the Company will execute, and the Trustee will authenticate and deliver to the Depositary for such Global Note as will be specified
in the Company Order with respect thereto to the Trustee, without service charge, a new Global Note in a denomination equal to and in exchange for the unredeemed portion of the principal of the Global Note so surrendered. 

Upon surrender of a Note that is redeemed in part, the Company will issue, and the Trustee will authenticate for the Holder at the expense of
the Company, a new Note equal in principal amount to the unredeemed portion of the Note surrendered representing the same indebtedness to the extent not redeemed. Notwithstanding anything in this Indenture to the contrary, only a Company Order and
not an Opinion of Counsel or an Officers’ Certificate of the Company is required for the Trustee to authenticate such new Note. 

[Signature Page Follows] 

  
 35 

 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly signed as of
the date first written above. 
  

			
	Universal Insurance Holdings, Inc.
		
	By:	 	 /s/ Frank C. Wilcox

	Name:	 	Frank C. Wilcox
	Title:	 	Chief Financial Officer
	
	UMB Bank National Association
	
	As Trustee
		
	By:	 	 /s/ Mauri Cowen

	Name:	 	Mauri Cowen
	Title:	 	Senior Vice President

  
 36 

 EXHIBIT A-1 

(FORM OF DEFINITIVE SENIOR UNSECURED NOTE) 

UNIVERSAL INSURANCE HOLDINGS, INC. 

5.625 % SENIOR UNSECURED NOTE DUE NOVEMBER 30, 2026 

THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT’), OR UNDER ANY APPLICABLE STATE SECURITIES LAW. THESE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE
SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, INCLUDING (BUT NOT LIMITED TO) IN ACCORDANCE AND IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, IF REQUESTED, OR (II) UNLESS SOLD IN ACCORDANCE WITH RULE 144 UNDER SAID ACT. 

THIS SECURITY AND THE OBLIGATIONS OF THE COMPANY (AS DEFINED HEREIN) AS EVIDENCED HEREBY ARE NOT DEPOSITS WITH OR HELD BY THE COMPANY AND ARE
NOT INSURED OR GUARANTEED BY ANY FEDERAL AGENCY OR INSTRUMENTALITY, INCLUDING, WITHOUT LIMITATION, THE FEDERAL DEPOSIT INSURANCE CORPORATION. 
 CERTAIN
ERISA CONSIDERATIONS: 
 THE HOLDER OF THIS SECURITY, OR ANY INTEREST HEREIN, BY ITS ACCEPTANCE HEREOF OR THEREOF AGREES, REPRESENTS AND
WARRANTS THAT (A) IT IS NOT AN EMPLOYEE BENEFIT PLAN, INDIVIDUAL RETIREMENT ACCOUNT OR OTHER PLAN OR ARRANGEMENT SUBJECT TO TITLE I OF THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”), OR SECTION 4975 OF
THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”) (EACH A “PLAN”), OR AN ENTITY WHOSE UNDERLYING ASSETS INCLUDE “PLAN ASSETS” BY REASON OF ANY PLAN’S INVESTMENT IN THE ENTITY, AND (B) NO PERSON
INVESTING “PLAN ASSETS” OF ANY PLAN WILL ACQUIRE OR HOLD THIS SECURITY OR ANY INTEREST HEREIN, UNLESS SUCH PURCHASER OR HOLDER IS ELIGIBLE FOR THE EXEMPTIVE RELIEF AVAILABLE UNDER U.S. DEPARTMENT OF LABOR PROHIBITED TRANSACTION CLASS
EXEMPTION 96-23, 95-60, 91-38, 90-1 OR 84-14 OR
ANOTHER APPLICABLE EXEMPTION OR ITS PURCHASE AND HOLDING OF THIS SECURITY, OR ANY INTEREST HEREIN, ARE NOT PROHIBITED BY SECTION 406 OF ERISA OR SECTION 4975 OF THE CODE WITH RESPECT TO SUCH PURCHASE AND HOLDING. ANY PURCHASER OR HOLDER OF
THIS SECURITY OR ANY INTEREST HEREIN WILL BE DEEMED TO HAVE REPRESENTED BY ITS 

  
 A-1-1 

 
PURCHASE AND HOLDING THEREOF THAT EITHER (i) IT IS NOT AN EMPLOYEE BENEFIT PLAN OR OTHER PLAN TO WHICH TITLE I OF ERISA OR SECTION 4975 OF THE CODE IS APPLICABLE, A TRUSTEE OR OTHER
PERSON ACTING ON BEHALF OF ANY SUCH EMPLOYEE BENEFIT PLAN OR PLAN, OR ANY OTHER PERSON OR ENTITY USING THE “PLAN ASSETS” OF ANY SUCH EMPLOYEE BENEFIT PLAN OR PLAN TO FINANCE SUCH PURCHASE, OR (ii) SUCH PURCHASE OR HOLDING WILL NOT
RESULT IN A PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA OR SECTION 4975 OF THE CODE FOR WHICH FULL EXEMPTIVE RELIEF IS NOT AVAILABLE UNDER APPLICABLE STATUTORY OR ADMINISTRATIVE EXEMPTION. 

ANY FIDUCIARY OF ANY PLAN WHO IS CONSIDERING THE ACQUISITION OF ANY OF THE SECURITIES SHOULD CONSULT WITH HIS OR HER LEGAL COUNSEL PRIOR TO
ACQUIRING SUCH SECURITIES. 

  
 A-1-2 

			
	No. [•]	  	CUSIP Accredited Investors: 91359V AB3
		  	CUSIP QIBs: 91359V AA5

 UNIVERSAL INSURANCE HOLDINGS, INC. 

5.625% SENIOR UNSECURED NOTE DUE NOVEMBER 30, 2026 

1. Indenture; Holders. This note is one of a duly authorized issue of notes of Universal Insurance Holdings, Inc., a Delaware
corporation (the “Company”), designated as the “5.625% Senior Unsecured Notes due 2026” (the “Notes”) in an aggregate principal amount of $100,000,000 and initially issued on November 23, 2021. The
Company has issued this Note under that certain Indenture dated as of November 23, 2021, as the same may be amended or supplemented from time to time (“Indenture”), between the Company and UMB Bank National Association,
as Trustee. All capitalized terms not otherwise defined in this Note will have the meanings assigned to them in the Indenture. The terms of this Note include those stated in the Indenture and those made part of the Indenture by reference to the
Trust Indenture Act. This Note is subject to all such terms, and the Holder is referred to the Indenture and the Trust Indenture Act for a statement of such terms. To the extent any provision of this Note irreconcilably conflicts with the express
provisions of the Indenture, the provisions of the Indenture will govern and be controlling. 
 2. Payment. 

(a) The Company, for value received, promises to pay to [•], or its registered assigns, the principal sum of [•] Dollars (U.S.)
($[•]), plus accrued but unpaid interest on November 30, 2026 (the “Maturity Date”). The Company will pay interest at a rate of 5.625% per annum (subject to adjustment as described below), computed on the basis of a 360-day year consisting of twelve 30-day months and payable semi-annually on May 30 and November 30 of each year (each payment date, an “Interest Payment
Date”). Beginning November 30, 2021, in the event the Notes are downgraded by the Ratings Agency below A- but equal to or above BBB-, the rate of interest
on the Notes shall increase by 0.50% to 6.125%. If the rating is subsequently increased back to A- or higher, the rate of interest will decrease by 0.50% to 5.625%. If the rating is further downgraded to BB+
or lower, the rate of interest will increase by another 0.50% to 6.625%. If the rating is subsequently improved back to BBB- or higher, the rate of interest will decrease by 0.50% to 6.125%. Each adjustment
required by any event described herein will take effect from the first Interest Payment Date following the date on which the Company receives notice that such event has occurred. As such, interest will not accrue at such increased or decreased rate
until the next Interest Payment Date following the date on which the event occurs. If the Ratings Agency changes its rating of the Notes more than once prior to any particular Interest Payment Date or ceases to provide a rating of the Notes, the
last change by the Ratings Agency prior to such Interest Payment Date will control for purposes of any interest rate increase or decrease. 

(b) In the event that any Interest Payment Date falls on a day that is not a Business Day (as defined below), the interest payment due on that
date shall be postponed to the next day that is a Business Day and no additional interest shall accrue as a result of that postponement. The term “Business Day” means any day other than a Saturday or Sunday or any other day on which
banking institutions in the State of New York are generally authorized or required by law or executive order to be closed. 

  
 A-1-3 

 The Company will pay interest on this Note to the Person who is the registered Holder as of
the close of business on the fifteenth (15th) calendar day prior to the applicable Interest Payment Date, except as provided in Section 2.10 of the Indenture with respect to Defaulted Interest. This Note will be payable as to principal and
interest at the office or agency of the Paying Agent, or, at the option of the Company, payment of interest may be made by check delivered to the Holder at its address set forth in the Note Register or by wire transfer to an account appropriately
designated by the Person entitled to payment; provided, that the Paying Agent will have received written notice of such account designation at least five Business Days prior to the date of such payment (subject to surrender of this Note in
the case of a payment of interest at Maturity). 
 3. Paying Agent and Registrar. UMB Bank National Association, the Trustee
(“Trustee”) under the Indenture, will act as the initial Paying Agent and Registrar through its offices presently located at 5555 San Felipe, Suite 870, Houston, Texas 77056. The Company may change any Paying Agent or Registrar
without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity. 
 4. Redemption. The Company may,
at any time or from time to time on or after November 30, 2023, redeem this Note, in whole or in part, without premium or penalty, but in all cases in a principal amount with integral multiples of $1,000. 

This Notes is not subject to redemption as the option of the Holder. On or after November 30, 2023, the Company may on any one or more occasions redeem
all or a part of the Notes, upon notice as provided in the Indenture, at the redemption prices (expressed as percentages of principal amount of this Note, or portion thereof, to be redeemed) set forth below, plus accrued and unpaid interest,
if any, on the Notes redeemed, to, but excluding, the applicable redemption date, if redeemed during the twelve-month period beginning on November 30 of the years indicated below: 

 

					
	 Year
	  	Percentage	 
	 2023
	  	 	102.81250	% 
	 2024
	  	 	101.40625	% 
	 2025, and thereafter
	  	 	100.00000	% 

 Unless the Company defaults in the payment of the redemption price, interest will cease to accrue on the Notes
or portions thereof called for redemption on the applicable redemption date. 
 If less than the then outstanding principal amount of this
Note is redeemed, (i) a new note shall be issued representing the unredeemed portion without charge to the Holder thereof and (ii) such redemption shall be effected on a pro rata basis as to the Holder, and if the Notes are represented by
Global Notes held by the Depositary and such redemption is processed through the Depositary, such redemption will be made on a “Pro Rata Pass-Through Distribution of Principal” basis in accordance with the procedures of the Depositary. In
the event a pro rata redemption as provided in the preceding sentence is not permitted under applicable law or applicable requirements of the Depositary, the Notes to be redeemed will be selected by lot or such method as the Trustee will deem fair
and appropriate. 

  
 A-1-4 

 5. Events of Default; Acceleration. An “Event of Default” means any
one of the events described in Section 4.01 of the Indenture. If an Event of Default described in Section 4.01(1) or Section 4.01(2) of the Indenture occurs, then the principal amount of all of the Outstanding Notes, and accrued and
unpaid interest, if any, on all Outstanding Notes will become and be immediately due and payable without any declaration or other act on the part of the Trustee or the Holder, and the Company waives demand, presentment for payment, notice of
nonpayment, notice of protest, and all other notices with respect to such Event of Default. If any Event of Default occurs and is continuing, the Trustee may also pursue any other available remedy to collect the payment of principal of, and interest
on, the Notes or to enforce the performance of any provision of the Notes or the Indenture. 
 6. Failure to Make Payments. If the
Company fails to make any payment of interest on this Note when such interest becomes due and payable and such default continues for a period of 30 days, or if the Company fails to make any payment of the principal of this Note when such principal
becomes due and payable, the Company will, upon demand of the Trustee, pay to the Trustee, for the benefit of the Holder, the whole amount then due and payable with respect to this Note, with interest upon the overdue principal, any premium and, to
the extent permitted by applicable law, upon any overdue installments of interest at the rate or respective rates, as the case may be, provided for or with respect to this Note or, if as such rate or rates are so provided, at the rate or respective
rates, as the case may be, of interest borne by this Note. 
 Upon an Event of Default, the Company may not declare or pay any dividends or
distributions on, or redeem, purchase, acquire, or make a liquidation payment with respect to, any of the Company’s capital stock, other than: (i) any dividends or distributions in shares of, or options, warrants or rights to subscribe for
or purchase shares of, any class of Company’s common stock; (ii) any declaration of a dividend in connection with the implementation of a shareholders’ rights plan, or the issuance of stock under any such plan in the future, or the
redemption or repurchase of any such rights pursuant thereto; (iii) as a result of a reclassification of Company’s capital stock or the exchange or conversion of one class or series of Company’s capital stock for another class or
series of Company’s capital stock; (iv) the purchase of fractional interests in shares of Company’s capital stock in accordance with the conversion or exchange provisions of such capital stock or the security being converted or
exchanged; or (v) purchases of any class of Company’s common stock related to the issuance of common stock or rights under any of benefit plans for Company’s directors, officers or employees or any of Company’s dividend
reinvestment plans. 
 7. Denominations, Transfer, Exchange. The Notes are issuable only in registered form without interest coupons
in minimum denominations of $100,000 and integral multiples of $1,000 in excess thereof. The transfer of this Note may be registered and this Note may be exchanged as provided in the Indenture. The Registrar may require the Holder, among other
things, to furnish appropriate endorsements and transfer documents and the Company may require the Holder to pay any taxes and fees required by law or permitted by the Indenture. 

  
 A-1-5 

 8. Charges and Transfer Taxes. No service charge will be made for any registration of
transfer or exchange of this Note, or any redemption or repayment of this Note, or any conversion or exchange of this Note for other types of securities or property, but the Company may require payment of a sum sufficient to pay all taxes,
assessments or other governmental charges that may be imposed in connection with the transfer or exchange of this Note from the Holder requesting such transfer or exchange. 

9. Persons Deemed Owners. The Company and the Trustee and any agent of the Company or the Trustee may treat the Person in whose name
this Note is registered as the owner hereof for all purposes, whether or not this Note is overdue, and neither the Company, the Trustee nor any such agent will be affected by notice to the contrary. 

10. Amendments; Waivers. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification
of the rights and obligations of the Company and the rights of the Holders of the Notes at any time by the Company and the Trustee with the consent of the holders of a majority in principal amount of the then Outstanding Notes. The Indenture also
contains provisions permitting the holders of specified percentages in principal amount of the then Outstanding Notes, on behalf of the holders of all Notes, to waive certain past defaults under the Indenture and their consequences. Any such consent
or waiver will be conclusive and binding upon the Holders and upon all future holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or
waiver is made upon this Note. 
 11. Sinking Fund; Convertibility. This Note is not entitled to the benefit of any sinking fund.
This Note is not convertible into or exchangeable for any of the equity securities, other securities or assets of the Company or any Subsidiary. 

12. No Recourse Against Others. No recourse under or upon any obligation, covenant or agreement contained in the Indenture or in this
Note, or for any claim based thereon or otherwise in respect thereof, will be had against any past, present or future shareholder, employee, officer, or director, as such, of the Company or of any predecessor or successor, either directly or through
the Company or any predecessor or successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all such liability being expressly waived and
released by the acceptance of this Note by the Holder and as part of the consideration for the issuance of this Note. 
 13.
Authentication. This Note will not be valid until authenticated by the manual signature of the Trustee or an Authenticating Agent. 

14. Abbreviations. Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM (= tenants in common),
TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= custodian), and U/G/M/A (= Uniform Gifts to Minors Act). Additional abbreviations may also be used though not in the
above list. 
 15. Available Information. The Company will furnish to the Holder upon written request and without charge a copy of
the Indenture. Requests by Holders to the Company may be made to: Universal Insurance Holdings, Inc., 1110 W. Commercial Blvd., Fort Lauderdale, FL 33309, Attn: Chief Financial Officer. 

  
 A-1-6 

 16. Governing Law. THIS NOTE WILL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF
THE STATE OF NEW YORK AND WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES THEREOF. 

[Signature Page Follows] 

  
 A-1-7 

 IN WITNESS WHEREOF, the undersigned has caused this Note to be duly executed. 

 

							
	Dated:	 		 	Universal Insurance Holdings, Inc.
				
		 		 	By:	 	 
		 		 		 	Name:
		 		 		 	Title:

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Notes of Universal Insurance Holdings, Inc. referred to in the within-mentioned Indenture: 

 

							
		 		 	UMB Bank National Association as Trustee
				
		 		 	By:	 	 
		 		 		 	Name:
		 		 		 	Title:

							
		 		 	Dated:	 	

  
 A-1-8 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: (I) or (we) assign and transfer this Note to: 

(Print or type assignee’s name, address and zip code) 

(Insert assignee’s social security or tax I.D. No.) 

and irrevocably appoint _______________________ agent to transfer this Note on the books of the Company. The agent may substitute another to act for him. 

 

			
	 Date:
	  	 Your signature:
(Sign exactly as your name appears on the
face of this Note)

 
 Tax Identification No:

 Signature Guarantee: (Signatures must be guaranteed by an eligible guarantor institution (banks,
stockbroker’s, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15). 

The undersigned certifies that it [is / is not] an Affiliate of the Company and that, to its knowledge, the proposed transferee [is / is not]
an Affiliate of the Company. 
 In connection with any transfer or exchange of this Note occurring prior to the date that is one year after
the later of the date of original issuance of this Note and the last date, if any, on which this Note was owned by the Company or any Affiliate of the Company, the undersigned confirms that this Note is being: 

CHECK ONE BOX BELOW: 
  

					
		 	☐ (1)	  	acquired for the undersigned’s own account, without transfer;
			
		 	☐ (2)	  	transferred to the Company;
			
		 	☐ (3)	  	transferred in accordance and in compliance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”);
			
	        	 	☐ (4)	  	transferred under an effective registration statement under the Securities Act;
			
		 	☐ (5)	  	transferred in accordance with and in compliance with Regulation S under the Securities Act;
			
		 	☐ (6)	  	transferred to an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act) or an “accredited investor” (as defined inRule 501(a)(4) under the Securities
Act), that has furnished a signed letter containing certain representation’s and agreements; or

  
 A-1-9 

					
	        	 	☐ (7)	  	transferred in accordance with another available exemption from the registration requirements of the Securities Act of 1933, as amended.

 Unless one of the boxes is checked, the Paying Agent will refuse to register this Note in the name of any
person other than the registered Holder thereof; provided, however, that if box (5), (6) or (7) is checked, the Paying Agent may require, prior to registering any such transfer of this Note, in its sole discretion, such legal opinions,
certifications and other information as the Paying Agent may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act such
as the exemption provided by Rule 144 under such Act. 
  

	
	 Signature:

 Signature Guarantee: (Signatures must be guaranteed by an eligible guarantor institution (banks,
stockbroker’s, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-l5). 

TO BE COMPLETED BY PURCHASER IF BOX (1) OR (3) ABOVE IS CHECKED. 

The undersigned represents and warrants that it is purchasing this Note for its own account or an account with respect to which it exercises
sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act of 1933, as amended, and is aware that the sale to it is being made in reliance on
Rule 144A and acknowledges that it has received such information regarding the Issuer as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that the transferor is relying upon
the undersigned’s foregoing representations in order to claim the exemption from registration provided by Rule 144A. 
  

			
	 Date:
	  	 Signature:

  
 A-1-10 

 EXHIBIT A-2 

(FORM OF GLOBAL NOTE) 

THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT’), OR UNDER ANY APPLICABLE STATE SECURITIES LAW. THESE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE
SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, INCLUDING (BUT NOT LIMITED TO) IN ACCORDANCE AND IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, IF REQUESTED, OR (II) UNLESS SOLD IN ACCORDANCE WITH RULE 144 UNDER SAID ACT. 

THIS NOTE IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF CEDE & CO AS
NOMINEE OF THE DEPOSITORY TRUST COMPANY (“DTC”) OR A NOMINEE OF DTC. THIS NOTE IS EXCHANGEABLE FOR NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN DTC OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND NO
TRANSFER OF THIS NOTE (OTHER THAN A TRANSFER OF THIS NOTE AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC) MAY BE REGISTERED EXCEPT IN LIMITED CIRCUMSTANCES SPECIFIED IN THE INDENTURE. 

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF DTC TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR
PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO, OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY
AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

TRANSFERS OF THIS NOTE WILL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR A SUCCESSOR THEREOF OR SUCH
SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS NOTE WILL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 

 THIS SECURITY AND THE OBLIGATIONS OF THE COMPANY (AS DEFINED HEREIN) AS EVIDENCED HEREBY ARE
NOT DEPOSITS WITH OR HELD BY THE COMPANY AND ARE NOT INSURED OR GUARANTEED BY ANY FEDERAL AGENCY OR INSTRUMENTALITY, INCLUDING, WITHOUT LIMITATION, THE FEDERAL DEPOSIT INSURANCE CORPORATION. 

CERTAIN ERISA CONSIDERATIONS: 
 THE HOLDER
OF THIS SECURITY, OR ANY INTEREST HEREIN, BY ITS ACCEPTANCE HEREOF OR THEREOF AGREES, REPRESENTS AND WARRANTS THAT (A) IT IS NOT AN EMPLOYEE BENEFIT PLAN, INDIVIDUAL RETIREMENT ACCOUNT OR OTHER PLAN OR ARRANGEMENT SUBJECT TO TITLE I OF THE
EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”), OR SECTION 4975 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”) (EACH A “PLAN”), OR AN ENTITY WHOSE UNDERLYING ASSETS
INCLUDE “PLAN ASSETS” BY REASON OF ANY PLAN’S INVESTMENT IN THE ENTITY, AND (B) NO PERSON INVESTING “PLAN ASSETS” OF ANY PLAN WILL ACQUIRE OR HOLD THIS SECURITY OR ANY INTEREST HEREIN, UNLESS SUCH PURCHASER OR
HOLDER IS ELIGIBLE FOR THE EXEMPTIVE RELIEF AVAILABLE UNDER U.S. DEPARTMENT OF LABOR PROHIBITED TRANSACTION CLASS EXEMPTION 96-23, 95-60,
91-38, 90-1 OR 84-14 OR ANOTHER APPLICABLE EXEMPTION OR ITS PURCHASE AND HOLDING OF THIS SECURITY, OR ANY INTEREST HEREIN, ARE
NOT PROHIBITED BY SECTION 406 OF ERISA OR SECTION 4975 OF THE CODE WITH RESPECT TO SUCH PURCHASE AND HOLDING. ANY PURCHASER OR HOLDER OF THIS SECURITY OR ANY INTEREST HEREIN WILL BE DEEMED TO HAVE REPRESENTED BY ITS PURCHASE AND HOLDING
THEREOF THAT EITHER (i) IT IS NOT AN EMPLOYEE BENEFIT PLAN OR OTHER PLAN TO WHICH TITLE I OF ERISA OR SECTION 4975 OF THE CODE IS APPLICABLE, A TRUSTEE OR OTHER PERSON ACTING ON BEHALF OF ANY SUCH EMPLOYEE BENEFIT PLAN OR PLAN, OR ANY
OTHER PERSON OR ENTITY USING THE “PLAN ASSETS” OF ANY SUCH EMPLOYEE BENEFIT PLAN OR PLAN TO FINANCE SUCH PURCHASE, OR (ii) SUCH PURCHASE OR HOLDING WILL NOT RESULT IN A PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA OR
SECTION 4975 OF THE CODE FOR WHICH FULL EXEMPTIVE RELIEF IS NOT AVAILABLE UNDER APPLICABLE STATUTORY OR ADMINISTRATIVE EXEMPTION. 

ANY FIDUCIARY OF ANY PLAN WHO IS CONSIDERING THE ACQUISITION OF ANY OF THE SECURITIES SHOULD CONSULT WITH HIS OR HER LEGAL COUNSEL PRIOR TO
ACQUIRING SUCH SECURITIES. 

			
	No. [•]	  	CUSIP Accredited Investors: 91359V AB3

 CUSIP QIBs: 91359V AA5 

UNIVERSAL INSURANCE HOLDINGS, INC. 

5.625% SENIOR UNSECURED NOTE DUE NOVEMBER 30, 2026 

1. Indenture; Holders. This note is one of a duly authorized issue of notes of Universal Insurance Holdings, Inc., a Delaware
corporation (the “Company”) designated as the “5.625% Senior Unsecured Notes due 2026” (the “Notes”) in an aggregate principal amount of $100,000,000 and initially issued on November 23, 2021. The
Company has issued this Note under that certain Indenture dated as of November 23, 2021, as the same may be amended or supplemented from time to time (“Indenture”), between the Company and UMB Bank National Association, as
Trustee. All capitalized terms not otherwise defined in this Note will have the meanings assigned to them in the Indenture. The terms of this Note include those stated in the Indenture and those made part of the Indenture by reference to the Trust
Indenture Act. This Note is subject to all such terms, and the Holder is referred to the Indenture and the Trust Indenture Act for a statement of such terms. To the extent any provision of this Note irreconcilably conflicts with the express
provisions of the Indenture, the provisions of the Indenture will govern and be controlling. 
 2. Payment. 

(a) The Company, for value received, promises to pay to CEDE & CO., or its registered assigns, the principal sum of ONE HUNDRED
MILLION Dollars (U.S.) ($100,000,000), plus accrued but unpaid interest on November 30, 2026 (the “Maturity Date”). The Company will pay interest at a rate of 5.625% per annum (subject to adjustment as described below),
computed on the basis of a 360-day year consisting of twelve 30-day months and payable semi-annually on May 30 and November 30 of each year (each payment date,
an “Interest Payment Date”). Beginning November 30, 2021, in the event the Notes are downgraded by the Ratings Agency below A- but equal to or above BBB-,
the rate of interest on the Notes shall increase by 0.50% to 6.125%. If the rating is subsequently increased back to A- or higher, the rate of interest will decrease by 0.50% to 5.625%. If the rating is
further downgraded to BB+ or lower, the rate of interest will increase by another 0.50% to 6.625%. If the rating is subsequently improved back to BBB- or higher, the rate of interest will decrease by 0.50% to
6.125%. Each adjustment required by any event described herein will take effect from the first Interest Payment Date following the date on which the Company receives notice that such event has occurred. As such, interest will not accrue at such
increased or decreased rate until the next Interest Payment Date following the date on which the event occurs. If the Ratings Agency changes its rating of the Notes more than once prior to any particular Interest Payment Date or ceases to provide a
rating of the Notes, the last change by the Ratings Agency prior to such Interest Payment Date will control for purposes of any interest rate increase or decrease. 

(b) In the event that any Interest Payment Date falls on a day that is not a Business Day (as defined below), the interest payment due on that
date shall be postponed to the next day that is a Business Day and no additional interest shall accrue as a result of that postponement. The term “Business Day” means any day other than a Saturday or Sunday or any other day on which
banking institutions in the State of New York are generally authorized or required by law or executive order to be closed. 

 The Company will pay interest on this Note to the Person who is the registered Holder as of
the close of business on the fifteenth (15th) calendar day prior to the applicable Interest Payment Date, except as provided in Section 2.10 of the Indenture with respect to Defaulted Interest. This Note will be payable as to principal and
interest at the office or agency of the Paying Agent, or, at the option of the Company, payment of interest may be made by check delivered to the Holder at its address set forth in the Note Register or by wire transfer to an account appropriately
designated by the Person entitled to payment; provided, that the Paying Agent will have received written notice of such account designation at least five Business Days prior to the date of such payment (subject to surrender of this Note in
the case of a payment of interest at Maturity). 
 3. Paying Agent and Registrar. UMB Bank National Association, the Trustee
(“Trustee”) under the Indenture, will act as the initial Paying Agent and Registrar through its offices presently located at 5555 San Felipe, Suite 870, Houston, Texas 77056. The Company may change any Paying Agent or Registrar
without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity. 
 4. Redemption. The Company may,
at any time or from time to time on or after November 30, 2023, redeem this Note, in whole or in part, without premium or penalty, but in all cases in a principal amount with integral multiples of $1,000. 

This Notes is not subject to redemption at the option of the Holder. On or after November 30, 2023, the Company may on any one or more occasions redeem
all or a part of the Notes, upon notice as provided in the Indenture, at the redemption prices (expressed as percentages of principal amount of this Note, or portion thereof, to be redeemed) set forth below, plus accrued and unpaid interest,
if any, on the Notes redeemed, to, but excluding, the applicable redemption date, if redeemed during the twelve-month period beginning on November 30 of the years indicated below: 

 

					
	 Year
	  	Percentage	 
	 2023
	  	 	102.81250	% 
	 2024
	  	 	101.40625	% 
	 2025, and thereafter
	  	 	100.00000	% 

 Unless the Company defaults in the payment of the redemption price, interest will cease to accrue on the Notes or portions
thereof called for redemption on the applicable redemption date. 
 If less than the then outstanding principal amount of this Note is
redeemed, (i) a new note shall be issued representing the unredeemed portion without charge to the Holder thereof and (ii) such redemption shall be effected on a pro rata basis as to the Holder, and if the Notes are represented by Global
Notes held by DTC and such redemption is processed through DTC, such redemption will be made on a “Pro Rata Pass-Through Distribution of Principal” basis in accordance with the procedures of DTC. In the event a pro rata redemption as
provided in the preceding sentence is not permitted under applicable law or applicable requirements of DTC, the Notes to be redeemed will be selected by lot or such method as the Trustee will deem fair and appropriate. 

 5. Events of Default; Acceleration. An “Event of Default” means any
one of the events described in Section 4.01 of the Indenture. If an Event of Default described in Section 4.01(1) or Section 4.01(2) of the Indenture occurs, then the principal amount of all of the Outstanding Notes, and accrued and
unpaid interest, if any, on all Outstanding Notes will become and be immediately due and payable without any declaration or other act on the part of the Trustee or the Holder, and the Company waives demand, presentment for payment, notice of
nonpayment, notice of protest, and all other notices with respect to such Event of Default. If any Event of Default occurs and is continuing, the Trustee may also pursue any other available remedy to collect the payment of principal of, and interest
on, the Notes or to enforce the performance of any provision of the Notes or the Indenture. 
 6. Failure to Make Payments. If the
Company fails to make any payment of interest on this Note when such interest becomes due and payable and such default continues for a period of 30 days, or if the Company fails to make any payment of the principal of this Note when such principal
becomes due and payable, the Company will, upon demand of the Trustee, pay to the Trustee, for the benefit of the Holder, the whole amount then due and payable with respect to this Note, with interest upon the overdue principal, any premium and, to
the extent permitted by applicable law, upon any overdue installments of interest at the rate or respective rates, as the case may be, provided for or with respect to this Note or, if no such rate or rates are so provided, at the rate or respective
rates, as the case may be, of interest borne by this Note. 
 Upon an Event of Default, the Company may not declare or pay any dividends or
distributions on, or redeem, purchase, acquire, or make a liquidation payment with respect to, any of the Company’s capital stock, other than: (i) any dividends or distributions in shares of, or options, warrants or rights to subscribe for
or purchase shares of, any class of Company’s common stock; (ii) any declaration of a dividend in connection with the implementation of a shareholders’ rights plan, or the issuance of stock under any such plan in the future, or the
redemption or repurchase of any such rights pursuant thereto; (iii) as a result of a reclassification of Company’s capital stock or the exchange or conversion of one class or series of Company’s capital stock for another class or
series of Company’s capital stock; (iv) the purchase of fractional interests in shares of Company’s capital stock in accordance with the conversion or exchange provisions of such capital stock or the security being converted or
exchanged; or (v) purchases of any class of Company’s common stock related to the issuance of common stock or rights under any of benefit plans for Company’s directors, officers or employees or any of Company’s dividend
reinvestment plans. 
 7. Denominations, Transfer, Exchange. The Notes are issuable only in registered form without interest coupons
in minimum denominations of $100,000 and integral multiples of $1,000 in excess thereof. The transfer of this Note may be registered and this Note may be exchanged as provided in the Indenture, The Registrar may require the Holder, among other
things, to furnish appropriate endorsements and transfer documents and the Company may require the Holder to pay any taxes and fees required by law or permitted by the Indenture. 

 8. Charges and Transfer Taxes. No service charge will be made for any registration of
transfer or exchange of this Note, or any redemption or repayment of this Note, or any conversion or exchange of this Note for other types of securities or property, but the Company may require payment of a sum sufficient to pay all taxes,
assessments or other governmental charges that may be imposed in connection with the transfer or exchange of this Note from the Holder requesting such transfer or exchange. 

9. Persons Deemed Owners. The Company and the Trustee and any agent of the Company or the Trustee may treat the Person in whose name
this Note is registered as the owner hereof for all purposes, whether or not this Note is overdue, and neither the Company, the Trustee nor any such agent will be affected by notice to the contrary. 

10. Amendments; Waivers. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification
of the rights and obligations of the Company and the rights of the Holders of the Notes at any time by the Company and the Trustee with the consent of the holders of a majority in principal amount of the then Outstanding Notes. The Indenture also
contains provisions permitting the holders of specified percentages in principal amount of the then Outstanding Notes, on behalf of the holders of all Notes, to waive certain past defaults under the Indenture and their consequences. Any such consent
or waiver will be conclusive and binding upon the Holders and upon all future holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or
waiver is made upon this Note. 
 11. Sinking Fund: Convertibility. This Note is not entitled to the benefit of any sinking fund.
This Note is not convertible into or exchangeable for any of the equity securities, other securities or assets of the Company or any Subsidiary. 

12. No Recourse Against Others. No recourse under or upon any obligation, covenant or agreement contained in the Indenture or in this
Note, or for any claim based thereon or otherwise in respect thereof, will be had against any past, present or future shareholder, employee, officer, or director, as such, of the Company or of any predecessor or successor, either directly or through
the Company or any predecessor or successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all such liability being expressly waived and
released by the acceptance of this Note by the Holder and as part of the consideration for the issuance of this Note. 
 13.
Authentication. This Note will not be valid until authenticated by the manual signature of the Trustee or an Authenticating Agent. 

14. Abbreviations. Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM (= tenants in common),
TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= custodian), and U/G/M/A (= Uniform Gifts to Minors Act). Additional abbreviations may also be used though not in the
above list. 
 15. Available Information. The Company will furnish to the Holder upon written request and without charge a copy of
the Indenture. Requests by Holders to the Company may be made to: Universal Insurance Holdings, Inc., 1110 W. Commercial Blvd., Fort Lauderdale, FL 33309, Attn: Chief Financial Officer. 

 16. Governing Law. THIS NOTE WILL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF
THE STATE OF NEW YORK AND WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES THEREOF. 

 IN WITNESS WHEREOF, the undersigned has caused this Note to be duly executed. 

 

							
	 Dated:
	 		 	 Universal Insurance Holdings, Inc.

				
		 		 	 By:
	 	 
		 		 		 	 Name:

		 		 		 	 Title:

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Notes of Universal Insurance Holdings, Inc. referred to in the within-mentioned Indenture: 

 

							
		 		 	 UMB Bank National Association

as Trustee

				
		 		 	 By:
	 	 
		 		 		 	 Name:

		 		 		 	 Title:

		 		 	 Dated:
	 	

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: (I) or (we) assign and transfer this Note to: 

(Print or type assignee’s name, address and zip code) 

(Insert assignee’s social security or tax I.D. No.) 

and irrevocably appoint _______________________ agent to transfer this Note on the books of the Company. The agent may substitute another to act for him. 

 

			
	 Date:
	  	 Your signature:

(Sign exactly as your name appears on the face of this Note)

 
 Tax Identification No:

 Signature Guarantee: (Signatures must be guaranteed by an eligible guarantor institution (banks,
stockbroker’s, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15). 

The undersigned certifies that it [is / is not] an Affiliate of the Company and that, to its knowledge, the proposed transferee [is / is not]
an Affiliate of the Company. 
 In connection with any transfer or exchange of this Note occurring prior to the date that is one year after
the later of the date of original issuance of this Note and the last date, if any, on which this Note was owned by the Company or any Affiliate of the Company, the undersigned confirms that this Note is being: 

CHECK ONE BOX BELOW: 
  

	 	☐	 (1)     acquired for the undersigned’s own account, without transfer;

  

	 	☐	 (2)     transferred to the Company; 

 

	 	☐	 (3)     transferred in accordance and in compliance with Rule 144A under the Securities Act
of 1933, as amended (the “Securities Act”); 

  

	 	☐	 (4)     transferred under an effective registration statement under the Securities Act;

  

	 	☐	 (5)     transferred in accordance with and in compliance with Regulation S under the
Securities Act; 

  

	 	☐	 (6)     transferred to an institutional “accredited investor” (as defined in Rule
501(a)(1), (2), (3) or (7) under the Securities Act) or an “accredited investor” (as defined in Rule 501(a)(4) under the Securities Act), that has furnished a signed letter containing certain representation’s and agreements; or

	 	☐	 (7)     transferred in accordance with another available exemption from the registration
requirements of the Securities Act of 1933, as amended. 

 Unless one of the boxes is checked, the Paying Agent will
refuse to register this Note in the name of any person other than the registered Holder thereof; provided, however, that if box (5), (6) or (7) is checked, the Paying Agent may require, prior to registering any such transfer of this Note, in
its sole discretion, such legal opinions, certifications and other information as the Paying Agent may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act such as the exemption provided by Rule 144 under such Act. 
  

	
	 Signature:

 Signature Guarantee: (Signatures must be guaranteed by an eligible guarantor institution (banks,
stockbroker’s, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-l5). 

TO BE COMPLETED BY PURCHASER IF BOX (1) OR (3) ABOVE IS CHECKED. 

The undersigned represents and warrants that it is purchasing this Note for its own account or an account with respect to which it exercises
sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act of 1933, as amended, and is aware that the sale to it is being made in reliance on
Rule 144A and acknowledges that it has received such information regarding the Issuer as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that the transferor is relying upon
the undersigned’s foregoing representations in order to claim the exemption from registration provided by Rule 144A. 
  

			
	 Date:
	  	
		  	 Signature:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]